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General introduction 
 Peptides (from the Greek πεπτίδια, "small digestible") are compounds consisting 
of chains of amino acids that are linked in a defined order by amide bonds. Peptides 
with a molecular mass exceeding 6,000 Da are usually called proteins, many of which 
act as enzymes or play a structural role. Smaller peptides normally have no catalytic 
activity, but they often are involved in the regulation of physiological processes in living 
cells and organisms, and therefore may be of high medical relevance. Besides that, 
many peptides are important for synthetic chemistry, biotechnology, and food 
technology. For example, because of their special taste or antimicrobial activity, 
peptides are widely recognized as important food components and they may be used as 
food additives 45.  
 The discovery of new peptides, the elucidation of their physiological role and 
bioactivity, the development of new delivery strategies, as well as the design of better 
methods for their synthesis and purification have contributed to an expanding interest in 
exploring new practical applications of peptides. This growing interest, in turn, has 
stimulated the demand for peptides in large amounts, and thus for cheaper, more 




 Potential of peptides as therapeutic agents. Many peptides display a 
bioactivity that has important therapeutic potential, for example in blood pressure 
control, as growth-stimulating hormone, or as agents that regulate important processes 
like digestion and reproduction. Examples of such peptides are  corticotropin (stimulates 
production of adrenocorticotropic hormone (ACTH), which influences steroid meta-
bolism), growth hormone, arginine- and lysine-vasopressins (used for controlling 
pressor and antidiuretic activitities), insulin (glucose metabolism regulator, indicated for 
treatment of type 1 or 2 diabetes mellitus) and glucagon-like peptide-1 (also used in 
diabetes therapy), defensin (antimicrobial agent that functions in the immune system by 
permeabilizing bacterial membranes) and gastrin-releasing peptides (control functions 
of the gastrointestinal system)114. Another particularly promising area of biomedical 
application is the prevention of infections by inhibition of host-pathogen interactions 
Chapter 1     General introduction 
 
   
 9
through mimicking binding sites of the pathogen or host proteins 28. Also the classical β-
lactam antibiotics can be regarded as peptides or peptide-derived compounds. See 
Table 1 for a number of examples of bioactive peptides and their activity and 
application. 
 Limitations & obstacles. For many years, the major obstacle to the success of 
using peptides as pharmaceuticals was their lack of oral availability. As a result, 
relatively few peptides reached the market as approved drugs. Consequently, several 
major pharmaceutical companies abandoned their research efforts in this area, in favour 
of investigations on small-molecule mimics of peptides or proteins that can be 
considered as lead compounds 114. In recent years, however, advances in formulation 
and the development of novel drug delivery systems have revitalized the field, leading to 
several highly promising peptide drugs {Futaki, Suzuki, et al. 2001 355 /id}3,34. For 
example, peptide conjugates with doxorubicin covalently linked to neuropeptide Y have 
been described for tumor-specific chemotherapy, and peptide drugs unable to pass the 
blood-brain barrier could be delivered using a chimeric strategy in which non-
transportable drugs were coupled with blood-brain barrier  transport vectors like 
cationized albumin or antibodies that undergo receptor-mediated transcytosis. This way 
pharmacologic effects in the central nervous system were achieved 11;66. 
 Besides difficulties with delivery, the stability of peptides in the body may be an 
issue. Despite the high affinity of peptides to their specific target, the use of peptides 
has been limited due to their susceptibility to proteolytic enzymes that are widely 
distributed in body tissues. To make peptides pharmacologically more useful, it is 
necessary to increase their serum half-life by enhancing resistance to proteolysis. The 
pathways of proteolysis can be difficult to determine but usually an inspection of a 
peptide sequence provides clues about the possible sites of proteolytic degradation. 
Peptidases can be divided in exopeptidases, which cleave peptide bonds at the termini 
of the peptide chain, and endopeptidases, which cleave internal peptide bonds. 
Endopeptidases have usually specificity for a particular set of amino acids, whereas 
exopeptidases can be divided in aminopeptidases, cleaving off the N-terminal amino 
acid, and carboxypeptidases, which cleave the C-terminal amino acid from a peptide 
chain. Different strategies can be applied to stabilize a peptide against proteolysis by 
peptidases. For example acetylation of the amino terminus can block aminopeptidases, 
and endoprotease cleavage can be suppressed by modification of amino acid side 
chains (e.g. glycosylation), side chain cross-linking (to enhance α-helix conformational 
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stability) or inversion of chirality 96;108. The peptide bond itself can be replaced by 
hydrolytically inert isosteric structures like trans olefins or by substitution of α-hydrogens 
or amide hydrogens by methyl groups 6. Despite their efficacy with regard to increasing 
peptide stability, it has to be kept in mind that all these methods involve some 
modification of the peptide and therefore can also influence the biological activity of the 
molecule.  
 Sources of therapeutic peptides. Until the late 1970s many naturally occurring 
peptides and proteins for therapeutic use were isolated from human tissue or urine, 
including insulin, growth hormone, and coagulation factor VIII 114. Other natural sources 
such as bacterial and fungal cultures, plant biomass, or animal tissue were also used 27.  
 As with most drug classes, non-natural therapeutic peptides with new properties, 
were developed through the confluence of improved tools for chemical synthesis and 
analysis, as well as a growing understanding of their biological action. Peptide leads 
with new activities that were traditionally obtained in low amounts by modification of 
natural peptides are nowadays rapidly prepared in the form of large libraries by 
chemical (combinatorial) synthesis. Computer docking using receptor structures (in 
silico screening), genome sequencing, and research in cell biology have identified many 
new potential targets. For activity screening, high-throughput methods and more 
sensitive assays have become available 107.  
 Market. The general property that makes peptides attractive therapeutic agents 
and potential blockbuster drugs are their high target specificities 23;34;111. Today, more 
than 60 different peptides are on the market, around 270 are in clinical trials 128;131. This 
field is rapidly expanding, and the annual market growth of pharmaceutical peptides (7-
15% per year) clearly exceeds the average growth of pharmaceuticals (~5% per year). 
This increasing demand is especially due to the growing need for synthetic peptides that 
can be used in therapeutic research and in clinical development. Furthermore, the 
availability of peptide libraries for drug screening, epitope mapping and structure-activity 
studies increases the number of hits that require further exploration. The growing 
interest includes the use of peptides as carriers for the delivery of exogenous proteins 
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Table 1. Examples of therapeutic peptides and their activity or application. 
Peptide Activity Effect or application 
Oxytocin and analogues (9 aa) 
peripheral (hormonal) actions/ 
action on oxytocin receptors in the 
brain and spinal cord 
labor induction 
Vasopressin analogues (9 aa) regulation of body’s water 
retention increasing arterial blood 
pressure 
antidiuretic/ vasoconstriction/ 
esophageal varices/ septic shock 
Insulin (21 + 30 aa) regulation of glucose 
intake/regulation of DNA 
replication and protein synthesis 
diabetes/ insulinoma/ metabolic 
syndrome  
Glucagon (29 aa) regulation of carbohydrate 
metabolism/ stimulation of insulin 
release 
hypoglycemia 
Secretin (27 aa) control of duodenal secretions 
and water homeostasis/ 
stimulation of insulin 
release/inhibition of gastrin 
release 
pancreatic functioning test 
Calcitonin (32 aa)  regulation of bone minerals 
metabolism/regulation of feeding 
and appetite, calcium 
homeostasis 
postmenopausal osteoporosis/ 
hypercalcemia/ paget’s disease/ 
bone metastases 
Luteinizing hormone-releasing 
hormone (LH-RH) and 
analogues (10 aa) 
stimulus for ovulation and corpus 
luteum maturation/ regulation of 
testosterone production 
hypothalamic hypogonadism/ 
kallmann syndrome/ infertility 
therapy 
Parathyroid hormone (PTH)(84 
aa) 
regulation of serum calcium 




hormone (CRH)(41 aa) 
trigger for parturition/ stimulation 





regulation of steroidogenesis/ 
regulation of cholesterol transport 
in mitochondria/ stimulation of 
lipoprotein uptake 
adrenal insufficiency/ ACTH 
stimulation test 
Growth hormone-releasing 
hormone (44 aa) 
stimulation of growth hormone 
production 
dwarfism 
Somatostain and analogues (14 
aa) 
endocrine regulation, cell 
proliferation 
acromegaly/ neuroendocrine 
tumors/ acute variceal bleeding 
Thyroliberin (TRH)(3 aa) stimulation of pituitary gland diagnostic tests of thyroid 
disorders/ acromegaly 




Thymopentin (TP-5) (5 aa) Immunostimulant immune system stimulation 
Cyclosporin (11 aa) Immunosuppressor post-allogeneic organ transplant 
treatment 
Integrilin (8 aa) blocks platelet glycoprotein 
receptor 
acute cardiac ischemic events/ 
angina/ myocardial infarction 
Data adopted from Andersson et al. 67 and papers cited in the text. 
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  Structures of bioactive peptides.  The types of bioactive peptides that can be 
used in medical applications are highly diverse, ranging from simple dipeptides to more 
complex linear or cyclic structures, which are often modified through glycosylation, 
phosphorylation or acylation of amino acid residues. The structure presents both key 
residues for functionality as well as a stable fold that serves as scaffold. The diversity 
and complexity of the modifications that are observed in bioactive peptides clearly 
reflect the versatility of functions in cell physiology and regulation.  
 As mentioned above, several artificial modifications can alter the properties of 
peptides in such a way that degradation is prevented and stability increased. Thus, 
modification at the C- or N-terminus may be used to block degradation by exo-
peptidases 123. Examples are N-terminal acetylation or glycosylation and C-terminal 
amidation. The use of unnatural amino acids as building blocks or the introduction of 
disulfide bonds may prevent cleavage of the peptide chain by endoproteases 65. 
Polyethylene glycol (PEG) can also be attached at the N or C termini of peptides to 
increase their overall stability in vivo and prevent renal clearance 107. Hematide™ is a 
synthetic peptide analog of erythropoietin, substituted with PEG to extent its in vivo half-
life 122;130. Other strategies to extend plasma residence time are chemical conjugation of 
peptides to albumin 4, to Fabs 90 or to scaffolds such as fibronectin or ankyrin repeats 13.  
 
Peptides as food ingredients 
 Bioactive food peptides. Oligopeptides are also increasingly important as 
health-enhancing food ingredients. Furthermore, the importance of peptides in the 
sensory perception of food has been recognized for a long time 12. Many biologically 
active peptides in food exert — beyond their nutritional value — a physiological, 
hormone-like effect in humans. In many diets, bovine milk and dairy products including 
cheese are the largest source of bioactive peptides. In addition, bioactive peptides and 
proteins are present in eggs, gelatin, meat and fish of various   kinds, as well as in many 
plants (e.g. wheat, soy, rice)86. Most bioactive peptides that occur as food ingredients 
are formed by processing of larger polypeptides. They may be inactive within the 
sequence of their parent protein and can be released through hydrolysis by digestive 
enzymes (e.g. trypsin)138, by proteases from microorganisms, or through the action of 
proteolytic enzymes from plants. Activation may occur either during gastrointestinal 
digestion or already during food processing (e.g. during cheese ripening and milk 
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fermentation) 61. Food peptides that contribute to taste or that show activities that can 
be related to health issues usually contain 2–20 amino acid residues per molecule, but 
in some cases they may consist of more than 20 amino acids. 
 Bioactivity and health effects. After digestion, bioactive peptides from food can 
either be absorbed in the gastrointestinal tract to enter the blood circulation in intact 
form and then exert systemic effects, or they may produce local effects in the 
gastrointestinal tract 110. Absorbed peptides can exhibit diverse activities. Potent ACE 
(angiotensin converting enzyme)-inhibiting peptides that are present in dairy products, 
fish and soy can cause reduction of blood pressure 29 and may improve blood lipid 
profiles 124. Another example is the antioxidant activity of peptides released from casein 
during hydrolysis by digestive enzymes 106, which exhibit similar antioxidant activity as 
vitamin C and E, polyphenols and carotenoids released from vegetarian food sources. 
Cyto- or immunomodulatory effects such as modulation of lymphocyte proliferation can 
be stimulated by casein 87, lactoferrin 104, lactoperoxidase 135 and milk immunoglobulin 
G, while antithrombotic activities are reported for peptides derived by hydrolysis from κ-
casein 86. Many studies have been devoted to the effects of peptides derived from milk 
proteins. Caseinophosphopeptides (CPP) were reported to have an influence on the 
regulation of digestive enzymes and modulation of nutrient absorption via an opioid 
activity 61 but they can also enhance the mucosal immunity 73.. 
 Because of their health-enhancing potential and safety profiles, bioactive 
peptides may be used as additives or their level may be enriched by modification of a 
manufacturing process in functional foods and nutraceuticals. The results are attractive 
products for health-conscious people and persons with specific demands 29. 
Consequently, a significant research effort has been aimed at characterizing and 
controlling protein hydrolysis technology to obtain bioactive peptides and as a result of 
these studies, numerous new products are now on the market or under development by 
food companies 46. One example is the sour milk product Calpis™, available on the 
market, which contains antihypertensive tripeptides proven to have beneficial effects on 
blood pressure in human trials 112. Another example is Nisaplin®, a commercial product 
having nisin as active component. Nisin is an antibacterial peptide that exerts a broad 
activity against Gram-positive bacteria by inhibiting peptidoglycan biosynthesis and by 
forming pores in the bacterial membrane. Nisaplin® was approved as antimicrobial for 
use in food 32. 
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 The challenge for food technology is the development of foods and nutraceuticals 
in which the active compound is able to resist degradation during digestion and can be 
absorbed, attaining appropriate concentrations in serum. Moreover, bioactive 
ingredients need to possess a good shelf stability and the undesired bitter taste that is 
characteristic of many peptide hydrolysates has to be avoided 86. 
 
Methods for peptide synthesis 
Need and sources of peptides 
 The growing interest in the use of peptides requires cost-efficient methodologies 
for their production, isolation, and analysis.  Three main approaches to peptide 
synthesis are currently available, i.e. solid-phase or solution-phase chemical peptide 
synthesis, chemo-enzymatic peptide synthesis, and fermentative peptide production. 




 Chemical synthesis often is a good option for preparing short to medium-sized 
peptides (2-10 amino acids). It is also an essential tool for exploring the structure-
function relationship of peptides since it enables introduction of numerous changes in 
the structure that will lead to modified properties. For example, non-proteinogenic amino 
acids can be introduced in the sequence of a polypeptide for labeling purposes 59;93 or 
for stabilisation 114. Unfortunately, the synthesis of small defined peptides can be quite 
troublesome due to the requirement of activation and protection of amino acid building 
blocks. Furthermore, racemization of the building blocks during synthetic steps is 
frequently observed. It has been stated that "as the biosynthesis even of complicated 
proteins in vivo occurs within seconds or minutes, the relatively tedious classical 
chemical synthesis of peptides and proteins in the laboratory appears to be a somewhat 
hopeless enterprise, especially with regard to speed" 114. An example of this laborious 
process is the first chemical synthesis of insulin, which during the early 1960s took over 
two years to complete 57. Chemical peptide synthesis can be performed in three 
variantions: solid-phase synthesis, solution synthesis, and a hybrid approach. 
 Solution-phase chemical synthesis is the method of choice for the large-scale 
production of relatively short peptides. Its main advantage is its high flexibility: the 
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intermediate products can be isolated and purified after each step, deprotected and 
elongated to obtain larger peptides 45. However, this technology suffers from a few 
inherent drawbacks: 1) occurrence of racemization during peptide activation and 
peptide bond formation, which reduces product purity; 2) the requirement for global 
protection of amino groups, carboxyl groups and side-chain functionalities, which is 
expensive and leads to significant yield loss during all steps; 3) the poor solubility of 
fully protected peptide segments, even in organic solvents, which causes slow and 
incomplete coupling reactions and gives high levels of by-products. Moreover, the 
process is less than ideal from an environmental point of view due to the use of toxic 
organic solvents and reagents 45. This makes it necessary to improve these processes. 
For example, it is desirable to eliminate diethyl ether as a peptide precipitation agent 
because of the high risk of explosion in large scale operations, and dichloromethane 
must be substituted since it is a volatile agent that when emitted damages the ozone 
layer. Corrosive agents like trifluoroacetic acid (TFA), hydrofluoric acid (HF), or 
hydrazoic acid (HN3) used in classical azide coupling reactions must be avoided as well 
114. One example of this is the NutraSweet process for the synthesis of aspartame 129 
 Solid-phase synthesis of peptides was first described by Merrifield in 1963 82. 
It consists of attaching the carboxylic acid group of the C-terminal amino acid to a solid 
support and subsequently coupling to the free amino group the activated carboxylate 
group of an incoming N-protected amino acid, thus forming a peptide bond. Next, the N-
protecting group is removed and steps are repeated until the peptide of the desired 
sequence and length has been synthesized 93. Initially, this method met considerable 
skepticism due to the high costs of the process, the lack of adequate in-process 
controls, and the low purity with which the final products were generally obtained 67. 
With the advent of new coupling methodologies, better support resins, and more 
sensitive in-process monitoring techniques, as well as the use of reverse-phase HPLC 
for purification, most of the original concerns about the suitability of solid-phase peptide 
synthesis for scale-up are no longer valid. Moreover, the reactions can be automated 
and the problem of solubilization of the peptide no longer exists since the growing 
peptide is linked to an insoluble support. Due to these characteristics, solid-phase 
synthesis is without doubt the technique of choice for the preparation of small amounts 
of oligopeptides (mg to g scale, length 2-100 amino acids) 16. Even though solid-phase 
synthesis can be troublesome in practice for peptides of more than 10 residues, 
improved chemistry and better protocols allow the synthesis of quite long peptides. For 
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example, the 99 residue HIV-1 protease was made this way 59;84. Moreover, solid-phase 
synthesis has become a powerful tool for preparing peptide libraries via combinatorial 
chemistry, as well as for making peptide arrays that can be used for the screening of 
peptides as receptor ligands, enzyme substrates, and enzyme inhibitors 25;132.  
 The hybrid approach is the production of short or medium-sized peptides by the 
use of solid-phase synthesis of protected fragments, which are subsequently assembled 
by solution-phase or solid-phase methods. The approach is advantageous for 
synthesizing medium-sized to large peptides or proteins (more than 100 amino acids) 
since it combines rapid solid-phase synthesis of pure protected fragments (up to 5-10 
amino acids) with coupling reactions in solution. The final stage of the process can be 
fully monitored and all intermediates can be purified and characterized 67 95. One 
successful example of the hybrid approach is the synthesis of an insulinotropic peptide, 
exenatide (39 amino acids, 4.2 kDa) which is a possible therapeutic agent for the 
treatment of type 2 diabetes. Because of the need of kilogram to metric ton amounts of 
product, the synthesis strategy was changed from solid-phase synthesis to a hybrid 
approach, based on the assembly of three fragments 22 
However, the disadvantage is that some racemization occurs of the residue on the C-
terminal side of the peptide bond that is formed during the fragment coupling reactions. 
In practice, chemical fragment coupling can only be performed without racemization at 
the C-terminal side of a Gly or Pro residue. 
 
Fermentative production 
 Ribosomal synthesis. This technology is the most suitable one for large 
peptides and proteins (up to several hundreds of amino acids). The starting point is a 
DNA fragment encoding a protein sequence, which is obtained by gene isolation, 
enzymatic synthesis from mRNA using reverse transcriptase, or by chemical synthesis. 
Making use of modern methods of cloning and gene expression, this DNA fragment is 
efficiently transformed into the recombinant protein of interest inside the recombinant 
organism. Subsequently the protein is isolated from the broth. One of the first examples 
of the use of this technology was the synthesis of insulin peptide chains 37. The two 
chains (chain A, 21 amino acids, and chain B, 30 amino acids) were expressed in two 
separate bacterial strains and joined in vitro by using S-sulfonated derivatives to create 
the two disulfide bonds that hold them together. Many other examples have been 
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reported of bacterial strains expressing useful proteins like human growth hormone 38, 
interferon 127 or vaccines 139. Despite the successful expression of several peptides and 
proteins, a major disadvantage of ribosomal synthesis may be the instability of the 
recombinant proteins, which are easily degraded by the intrinsic host proteases, 
especially in case of smaller peptides. Overcoming this stability issue was possible in 
some cases by constructing hybrid polypeptides (containing the desired protein fused 
with a host peptide) or by expressing a multidomain polypeptide. Proinsulin 115, 
neuropeptide substance P 58 and α-human atrial natriuretic peptide 70 are examples of 
peptides expressed as concatamers that could be subsequently converted into the 
desired peptides by cleavage. Other methods make use of bacterial hosts lacking 
certain proteases, such as the well known E. coli BL21 strains which are devoid of 
OmpT, an outer membrane protease. 
 Another drawback of ribosomal synthesis is the frequently observed low yield of 
the target peptide, especially in case of short peptides (<50 amino acids). To overcome 
expression problems, the use of genetically fused well-expressed tags was tested in 
several cases. Lee and coworkers expressed a positively charged antimicrobial target 
peptide in fusion with acidic residues to form a non-charged peptide that was better 
expressed 68, and several other tags such as maltose binding protein (MBP), 
glutathione-S-transferase (GST), solubility-enhancing tag (SET) were tested to enhance 
bacterial expression and/or facilitate purification of specific target peptides 31;94.  Good 
results were obtained in several cases but it is important to notice that none of these 
tags works equally well with each partner peptide 100. 
 Another strategy to increase expression of peptides is to vary the used host 
strain. Although E. coli remains the standard host, it suffers from some disadvantages, 
such as the inability to perform post-translational modification or the endogenous 
production of endotoxins that have to be separated from the desired protein before its 
pharmaceutical use 114. Eukaryotic systems including mammalian, yeast and insect cells 
which allow specific post-translational glycosylation are becoming more accessible and 
less expensive and can replace bacterial hosts 39. 
 Despite the good results obtained in the last years, ribosomal synthesis is still the 
preferred method only for the synthesis of large peptides (50 to over 100 amino acids) 
since productivity, extraction and recovery of short peptides remains a challenge. 
Furthermore, a drawback of this technology is the inability (with some exceptions) of 
incorporation of unnatural amino acids 64 
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 Non-ribosomal fermentative peptide synthesis. A major class of small 
peptides such as antifungal and antibiotic molecules is synthesized in nature via non-
ribosomal peptide synthetases (NRPSs) 133;140. Herein, peptide assembly takes place in 
large multimeric enzyme complexes independently from mRNA and ribosomes. The 
peptide synthetase acts both as a template, conferring the required amino acid 
specificity and as the biosynthetic machinery for peptide synthesis. Such an NRPS 
complex is a modular structure composed of catalytically independent sets of domains, 
which are responsible for different activities, i.e. amino acid recognition, activation, 
coupling, modification and product release 116. NRPSs are mainly present in bacteria, 
fungi and yeasts, but these multi-enzyme complexes were also described in higher 
eukaryotes 105. In recent years, the attention for NRPSs was fueled by the potential to 
obtain peptides with novel biological activities by domain engineering. The first example 
of a peptide (D-Phe-Pro-DKP)(DKP is diketopiperazine) produced in E. coli by 
heterologous expression of an NRPS was reported by Grünewald and coworkers 41, but 
more recently several other examples were disclosed 42;125. Watanabe and coworkers 
demonstrated the successful heterologous expression of the echinomicin NRPS from 
Streptomyces in E. coli and the synthesis of des-N-tetramethyl triostin A by introduction 
of mutations in the synthetic modules of the echinomycin NRPS 134.  
 A major advantage of fermentative peptide synthesis via NRPSs is the possibility 
to produce polypeptides that are different in size and amino acid sequence and have 
various modifications including N-methylation, cyclization, and incorporation of D-amino 
acids. Moreover, the use of NRPS does not require amino acid protection and the 
reactions can be performed in water without the use of expensive reactants or toxic 
chemicals.  
 Despite these advantages the major challenge is the generation of synthases 
that are specific for a desired peptide. A possible approach is the use of rational 
engineering to alter the action of the single domains, although progress is still limited 
due to the high complexity of the modular arrangement of the functional units that 
catalyze the successive reactions 20. Furthermore, the low productivity of the 
engineered synthetases and the high costs restrict the application of this technique on 
large scale 48 
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Chemo-enzymatic peptide synthesis 
 General considerations. For many years chemo-enzymatic peptide synthesis 
has been accompanied by alternating periods of hope and disappointment, interest and 
deception. Chemo-enzymatic technology has currently proven to be suitable for short 
sequences of less than 10 residues. In this strategy the peptide is elongated stepwise 
by enzymatic synthesis of peptide bonds or obtained via preparation of two or more 
fragments that are subsequently assembled to form the desired structure. 
 Compared to the classical chemical methods, enzymatic peptide synthesis has 
several advantages: 1) Reactions take place under very mild conditions and 
accompanying chemical and operational hazards are reduced; 2) The high regio-
specificity of enzymes allows the use of minimally protected substrates which are often 
inexpensive and readily available. This can simplify the synthesis considerably by 
omitting intermediate protection and deprotection steps; 3) Reactions are stereospecific, 
allowing the use of racemic starting materials and the recycling of reactants. This is 
achieved by combining the synthesis with resolution, followed by racemization of the 
unreacted isomer and the start of a new cycle 72;117.  
 In nature, peptide bond formation is catalyzed by the ribozyme peptidyl 
transferase, which posesses  full catalytic activity independent of the side chain of the 
amino acids being coupled. However, this highly specific activity requires various 
ribosomal factors including rRNA 17. Consequently, the ribosomal peptidyltransferase 
activity is not suitable for practical in vitro use as a biocatalyst for peptide bond 
formation. 
 The most relevant enzymes for peptide synthesis are microbial and plant derived 
proteases, which are available at low costs due to their industrial production for other 
purposes. Proteases constitute one of the most important groups of industrial enzymes, 
accounting for at least a quarter of the total global enzyme production sales, and they 
are used in detergents, brewing, meat softening, photography, leather processing and in 
the pharmaceutical industry 64. Proteases can not only catalyze peptide bond cleavage 
but also formation of peptide bonds. Moreover, they catalyze other types of reactions, 
such as esterification and transesterification, which can be used for the resolution of 
racemic alcohols and carboxylic acids 85, the kinetic resolution of racemic mixtures 19, 
and the synthesis of glycoconjugates 126. Many proteases are good process biocatalysts 
since they are robust and stable enough to withstand the conditions of an industrial 
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process. Their pH optima are in the range of 6 to 8 and they are often active in the 
presence of organic solvents, supercritical fluids, ionic liquids and salts 15. In addition, 
they do not require stoichiometric cofactors and may be highly stereo- and regio-
selective 15. 
Proteases have been widely used and currently still are the most important 
enzymes for peptide synthesis 49;51;64 97. The first peptides that were synthesized with 
proteases were Bz-Leu-Leu-NHPh and Bz-Leu-Gly-NHPh (-NHPh is -aniline), which 
were made in 1938 using papain and chymotrypsin 9;10. Another important example of 
chemo-enzymatic synthesis of peptides is the production of the non-caloric sweetener 
aspartame, which involves the use of the metalloprotease thermolysin 89. Also the 
chemo-enzymatic production of human insulin starting from porcine insulin is a good 
example 88.  
 Kinetically vs. thermodynamically controlled synthesis. The equilibrium of a 
protease-catalyzed peptide bond formation (and cleavage) reaction is usually situated 
on the side of the thermodynamically more stable cleavage products. Different 
manipulations are possible to obtain synthesis products, in spite of the unfavourable 
equilibrium. These methods for peptide synthesis can be divided in two approaches: 
thermodynamic and kinetic control of synthesis reactions. 
 In the thermodynamically controlled synthesis (Scheme 2.1) the final yield of the 
reaction is solely determined (and limited) by the position of the thermodynamic 
equilibrium under the chosen reaction conditions 56. In this process, peptide bond 






Scheme 1: Thermodynamically controlled chemo-enzymatic peptide synthesis. 
 
 
The enzyme accelerates the reaction rate without effecting the equilibrium 
concentrations, and the formation and hydrolysis of the peptide bond proceed by the 
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which do not form a covalent acyl-enzyme intermediate. Various strategies have been 
proposed to shift the equilibrium toward synthesis: 
 The use of an excess of one of the reactants;  
 The removal of the product by precipitation, complexation, or extraction; 
 The addition of organic solvent to the reaction mixture which can cause the pKas of 
the amino and carboxyl group to approach one another; 
 The pH of the reaction medium (manipulation of equilibrium of ionization); 
Accordingly, for each application of thermodynamically controlled peptide synthesis a 
study of process alternatives is needed. The choice of process conditions will depend 
on the reaction characteristics, on the biocatalyst, and on the properties of substrate 
and products. In many cases the economic embodiment of a thermodynamically 
controlled process is not possible.  
 In the kinetically controlled synthesis of peptides, the acyl-donating amino acid is 
activated, for example as an ester (Scheme 2.2). The protease then acts as a 
transferase and catalyzes the transfer of the acyl group of the activated acyl donor to 
the nucleophile, which in case of peptide synthesis is the amino group of the amino acid 
or peptide to be coupled. The reaction proceeds with transient formation of an acyl-
enzyme intermediate. Besides the standard proteases (cysteine and serine proteases), 
a limited number of other hydrolases which are capable of forming acyl-enzyme 
intermediates (e.g. lipases or penicillin-G acylase) may be used for this reaction. As a 
side reaction, hydrolysis of the acyl-enzyme intermediate is competing with the synthetic 
acyl transfer reaction, leading to undersirable hydrolysis of the activated acyl donor. The 
synthesized peptide can also be subject to hydrolysis by the protease. The ratio of acyl 
transfer to nucleophile (synthesis) compared to substrate hydrolysis is an enzyme 
property that influences the yield 64;117. It is therefore desirable to remove the product in 
order to avoid unwanted secondary hydrolysis. The product level passes through a 
temporary maximum, the height of which is determined by the kinetics of the biocatalyst 
after which the reaction proceeds (slowly) to the thermodynamic equilibrium.  
The main factors that influence a kinetically controlled synthesis reaction are: 
 pH. The nucleophilic group (H2N-R) that attacks the acyl-enzyme complex must be 
uncharged but at the same time the ester should not be chemically hydrolyzed. The 
pH optimum is generally the pKa of the amino function of the nucleophile; 
 Ionic strength; 
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 Presence of organic (co)solvents. These help to dissolve the ester and to diminish the 
hydrolysis of ester and peptide; 
 Enzyme specificity. The reaction rate is determined by the specificity of the enzyme 
for the acyl donor, but the binding of the nucleophile to the S’ subsite of the protease 
is essential for high yields. Thus, efficiency can differ from one protease to another. 
The sensitivity of the acyl-enzyme intermediate towards hydrolysis and cleavage by 
the nucleophile is also dependent on the enzyme environment. 
 
 
Scheme 2: Peptide synthesis by kinetic control. 1, Acyl donor; 2, acyl-enzyme complex; 3, nucleophile, 4, 
reaction product; 5, hydrolyzed acyl donor, 
 
In order to achieve reasonable yields, the process has to be stopped a long time before 
the equilibrium is reached. This can be understood from a comparison between the time 
course of kinetically controlled and thermodynamically controlled reactions (Figure 2.1). 
 In the initial phase of the conversion, the kinetically controlled synthesis is usually 
rapid since the concentration of acyl donor and nucleophile are high. Once the 
maximum yield is reached, the effect of product hydrolysis becomes visible. Thus, the 
yield will decrease to finally reach the equilibrium. Additionally, part of the ester will be 
hydrolysed to give the free acid and nucleophile (resp. 3 and 5 in Scheme 2). The 
concentration of these two species and the product slowly proceed to equilibrium, so 
that the final yield will be determined again by the equilibrium position.  
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 Water can have a negative effect in both approaches because it competes with 
the nucleophile in the kinetic approach while it influences the equilibrium position in the 
thermodynamic approach. Both these effects may be overcome by working in reaction 
media different than diluted aqueous solutions, the so-called “non conventional” media, 
such as organic solvents or ionic liquids. 
 
 Direction of chemoenzymatic peptide synthesis.  Several strategies which 
differ in the order of peptide bond formation steps can be applied for enzymatic peptide 
synthesis. As described above, peptides can be synthesized by a convergent strategy, 
coupling small fragments, or stepwise, starting from the C- or N-terminal side. When 
stepwise peptide synthesis is performed in the CN direction the growing peptide chain 
acts as the acyl acceptor (nucleophile) during each coupling step. This way of synthesis 
is quite laborious since each amino acid building block needs to be N-protected and the 
peptide terminal -NH2 must be deprotected after each step. When NC synthesis is 
chosen as elongation strategy (C-terminal extension), the amino acids used as building 
blocks are acyl acceptors (nucleophiles) and should be added in excess of the growing 
peptide chain in C-protected form. A drawback in this case is that selective C-
deprotection and activation is required after each step, and these reactions may need 
harsh conditions or expensive and toxic reagents. In this case acyl groups are activated 
by introduction of an electron accepting moiety, favouring the nucleophilic attack of the 
amino component. Many activating moieties are available, including acyl azides, 
carbodiimides, active esters and mixed anhydrides.  
 
 
Scheme 3: Time courses of kinetically controlled and thermodynamically controlled peptide synthesis. 
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 Protection of functional groups. The proper introduction and removal of 
protecting groups is one of the most important and widely carried out synthetic 
transformations. In particular in the highly selective construction of complex poly-
functional molecules, a given functional group has to be selectively protected or 
deprotected under mild conditions, usually in the presence of functionalities of similar 
reactivity 54.  
The selection of protecting groups is obviously dependent on the strategy 
applied. In fact, protecting group orthogonality is an important criterion in peptide 
synthesis 2, which means that a subset of protecting groups can be cleaved selectively 
during the synthesis of the desired molecule, while leaving all the others intact. For the 
manipulation of protecting groups, numerous chemical methods have been developed. 
Moreover, in recent years the arsenal of useful (de)protection groups has substantially 
increased by the application of biocatalysis 60. In addition to their stereo-discriminating 
properties, enzymes offer the opportunity to carry out highly chemo- and regioselective 
transformations, offering viable alternatives to classical chemical methods 53. 
 Cα-Carboxyl protection. Protection of Cα-carboxy groups is mainly employed 
when peptide synthesis is conducted from the N-terminus to the C-terminus. Since this 
is not the usual synthetic strategy, C-terminal protection has not been widely 
investigated. Methyl, ethyl, benzyl or tert-butyl groups are the most used C-protecting 
groups. Cleavage of these protecting groups proceeds via mild alkaline (methyl and 
ethyl) or acidic (tert-butyl) hydrolysis or by hydrogenation (benzyl). A drawback of the 
use of methyl and ethyl esters as C-terminal protecting groups is that they are reactive 
in kinetically controlled peptide bond formation, giving product mixtures, whereas the 
removal of benzyl or tert-butyl groups is often accompanied by the simultaneous 
removal of N-protecting or side-chain protecting groups. Enzyme-catalyzed deprotection 
is an alternative that may solve these issues 114.  
 Side-chain protection. In chemical peptide synthesis it is mandatory to protect 
side-chain functionalities of the amino acids. The ω-protecting groups are termed 
“semipermanent” because they are usually cleaved off only after the last coupling step.  
The type of protection that is chosen largely depends on the peptide synthesis method 
that is used and can go from minimal to maximal protection, the latter especially in case 
of solid phase peptide synthesis. One of the greatest advantages of chemo-enzymatic 
peptide synthesis is that due to the selectivity of the coupling enzymes protection of the 
side chains is not needed. 
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 N-terminal protection. More than a hundred functional groups have been 
developed for the protection of α-amino groups of amino acids and peptides. The most 
important ones are based on the acyl or carbamate function, such as the 
benzyloxycarbonyl (“Z” group in honor of its inventor, Leonidas Zervas), tert-
butoxycarbonyl (Boc) and 9-fluorenylmethoxycarbonyl (Fmoc). Their popularity is due to 
their easy introduction and cleavage, which are carried out under relatively mild 
conditions 54;114. A drawback of their use in CN peptide synthesis is the need to purify 
each intermediate and chemically deprotect the product after each coupling step, which 
results in expensive procedures that are unattractive for commercial application, 
although racemisation hardly occurs. A better solution would be the use of an 
enzymatically cleavable group like formyl, which in principle could be removed by a 
peptide deformylase. The formyl group (For) seems industrially attractive because its 
introduction uses only acetic anhydride and formic acid and consequently formylation is 
a very cost-efficient protection method (Murakami, 2000). Its removal by acid is also 
cheap  but gives rise to significant hydrolysis of internal peptide bonds. Hence, there is 
a large incentive to study the enzymatic removal of formyl groups.  
 The obvious enzymes to use for the removal of formyl groups are peptide 
deformylases. These enzymes are generally present in prokaryotes where they are 
involved in the removal of formyl groups from nascent peptide chains during ribosomal 
protein synthesis. In prokaryotes the initiator codon on mRNA is recognized by a tRNA 
carrying formylmethionine, and the formyl group of the N-terminal methionine is 
removed after synthesis of the protein. The properties of peptide deformylases that 




 In 1966 Capecchi observed that N-formyl-methionine is the unique initiator amino 
acid in bacterial protein synthesis. A consequence of having such common initiator is 
the existence of a widely distributed enzymatic cascade that results in removal of the 
formylmethionine, exposing other amino-terminal amino acids 18. One year later, Adams 
proved for the first time the existence of an enzyme that is able to remove formate from 
formylmethionyl peptides in E. coli and Bacillus stearothermophilus 1. Since then it has 
been discovered that the steps of tRNA binding, peptide bond formation and ribosome 
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translocation are virtually identical in all organisms. However, a striking difference 
between prokaryotes and eukaryotes is that in eubacteria as well as in mitochondria 
and chloroplasts, all nascent polypeptides synthesized by the ribosomal pathway initially 
contain an N-formylated methionine residue at their N-terminus 62, which is not the case 
in eukaryotes. 
 
 In eubacteria the transfer of the formyl group to the methionine moiety loaded to 
the tRNA for formylmethionine is catalyzed by methionine-tRNAfMet formyltransferase 
(MTF, coded by the fmt gene), which uses 10-formyltetrahydrofolate as the formyl donor 
109. After elongation of the polypeptide chain, the formyl group is removed by the action 
of peptide deformylase (PDF) 1;5. This deformylation has to take place before the N-
















Scheme 4. Formylation/deformylation cycle of the prokaryotic translation initiation methionine. Step (1): 
aminoacyl tRNA synthetase transfers methionine to the initiating tRNA for formylmethionine. Step (2):  
methionyl-tRNAfMet formyltransferase formylates the tRNA-bound methionine. Step (3): the formylated 
methionyl-tRNAfMet is moved to the ribosome by the initiation factor and protein synthesis begins. Step 
(4): the formyl group on the N-terminal methonine of the peptide chain is removed by the activity of PDF. 
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many cases is the second step of the maturation of the polypeptide (14;83. It has been 
reported that only 40% of the polypeptide chains in E. coli retain the N-terminal 
methionine. Furthermore, the catalytic efficiency of MAP was found to be dependent on 
the size of the side-chain of the penultimate amino acid 47. Removal of this methionine 
can be required for the biological activity and/or stability of individual proteins 69. 
 Peptide deformylation is essential. Mazel et al. demonstrated that the 
inactivation of PDF, under conditions where formylation of Met-tRNAfMet occurs, is lethal 
to E. coli. This supports the hypothesis that at least one essential protein requires 
processing by PDF and/or methionine aminopeptidase for folding or functionality 43;76. 
The growth defect of peptide deformylase negative mutants could be a direct result of 
the formyl-blocked N-terminus of proteins, or it may be due to lack of removal of the 
methionine residue 119. More recently, however, it was shown that N-terminal 
formylation is a dispensable feature. In fact, def fmt double null mutant strains, which 
lack both formylation and deformylation, are still able to grow, although poorly, thus 
adopting a process of translation initiation more similar to that of eukaryotes and 
Archeae. Despite the recent discoveries of active PDFs in eukaryotes, peptide 
deformylase is still considered an interesting antibacterial target. Thanks to the 
increasing knowledge on 3D structures and catalytic mechanisms, it may be possible to 
develop antibiotics specifically active against bacterial PDF but with little or no activity 
against mammalian ones 33. 
 
 PDF structure and catalytic mechanism 
 Structure of PDFs. Peptide deformylases (PDF; EC 3.5.1.88) belong to the 
superfamily of zinc metalloproteases. They contain Zn2+ or Fe2+, the latter representing 
the biologically most active species.  The Zn2+ form is more stable since it is not 
sensitive to oxidation. Nevertheless it was discovered that in its active form E. coli PDF 
(EcPDF) contains iron in the ferrous state (Fe2+) 8. More than 50 peptide deformylase 
crystal structures are available at the moment. Amino acid sequence alignments of 
PDFs originating from different organisms revealed a low level of overall sequence 
identity, but a study of the 3D structures showed a remarkably conserved topology 44;118.  
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The crystal structure of the EcPDF revealed that it is a monomeric α/β type 
enzyme of 168 amino acid residues composed of a single domain and containing one 
tightly bound metal ion 76;77;79. The E. coli enzyme contains 5 α-helices and 7 β-strands 
organized in 3 β-sheet regions, and a potentially critical 3-10 helix. The overall fold 
resembles a hand composed of a five-stranded anti-parallel β-sheet and a two-stranded 
anti-parallel β-sheet that wraps around the central α-helix (helix II). While two of the 
major α-helixes (helix II and V) appear to play structural roles, residues in the third 
major helix (helix III) are also involved in catalysis. 
The zinc ion is tetrahedrally coordinated by the Sγ-atom of Cys-90 (E. coli 
numbering), the Nε2-atom of His-132 and His-136 and a water molecule 79;80. The two 






























































































































Scheme 5. Reaction cycle of the Fe2+-PDF. The reaction consists of 2 main steps. The first step is the 
nucleophilic attack of a metal-coordinated hydroxide on the carbonyl carbon of the formyl group. After 
formation of a tetrahedral transition-state like intermediate, the C-N bond between the formyl group and the 
peptide nitrogen is cleaved. The oxyanion is stabilized by side-chain groups of Gln-50 and Leu-91. The 
cycle is completed by peptide and formate release and reentrance of water. Adopted form Becker et al.8 
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the three conserved motifs that are distant from each other in the primary sequence but 
in close proximity in the 3D structure, and that are found in many zinc metallopeptidases 
78. These three motifs are residues 43-52 (E. coli PDF numbering) with motif 1 
(sequence  GIGLAATQV), residues 88-92 with motif 2 (EGCLS), and the aformentioned 
motif 3 at residues 130-139 (QHEMDHL) 8;21;24;75. The third motif contains besides the 
two histidines (His-132 and His-136, in bold and underlined) involved in metal ligation a 
glutamate residue (italics) required for catalytic activity. Other essential residues for 
catalysis are the glutamine of motif 1 and the glutamate of motif 2. In the latter, Glu-88 
forms hydrogen bonds with His-132, Arg-102, and indirectly with Asp-135 which 
reinforce the enzyme structure in the vicinity of the metal ion. Moreover Glu-88 
contributes to the metal ion binding via a steric effect, since its side-chain forms a lid on 
top of the Fe2+. 
 The cysteine that coordinates the metal is present in motif 2 (italics). Moreover, a 
network of hydrogen bonding and hydrophobic interactions contributes to create a very 
well-defined structure around the active site. 
Reaction mechanism. Based on the X-ray structure and by analyzing the 
structural resemblance with other metalloproteases like thermolysin, a first model of the 
catalytic cycle of EcPDF was proposed by Chan and co-workers in 1997 21. As 
described above, the ligands of the metal are the side chains of Cys-90, His-132, and 
His-136 (residing in the conserved motif HEXXH) and a bound water molecule 21.  
 In this model the reaction starts by substrate binding and coordination of the 
formyl oxygen to the zinc, resulting in formation of a five-coordinated metal. 
Subsequently, the water molecule shifts position to become hydrogen-bonded to both 
Gln-50 and Glu-133. A proton of this water is abstracted by (or hydrogen bonded to) the 
amide NH of the substrate, which becomes a leaving group while the deprotonated 
hydroxyl attacks as a nucleophile 7;24;36;79. This first mechanism was completed by 
Becker et al. by proposing that substrate binding is accompanied by release of a water 
molecule that is hydrogen bonded to the water which acts as a ligand of the metal, and 
by attributing a role to Leu-91 (main chain NH) and Gln-50 (side chain NH) in formation 
of an oxyanion hole that binds the carbonyl oxygen. In agreement with this model, 
various substitutions at position Gln-50 and Glu-133 led to a huge decrease of the 
catalytic efficiency99 102. The reaction proceeds with the release of the peptide and the 
hydrolysis of the activated enzyme-formate complex releasing formate. Finally two 
water molecules are taken up 8;136;137.  
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Activity and specificity. The small size of the active site prevents groups larger 
than an N-terminal formyl from accessing the metal center 50;77. Thus, PDF has a very 
high specificity for N-formylated peptides. Furthermore, the crystal structure of EcPDF in 
complex with H-Met-Ala-Ser-OH highlights the deep hydrophobic pocket of the S1’ 
subsite in which the side chain of the methionine is positioned 8. The shape of this 
pocket explains the general preference for hydrophobic residues at the P1' position and 
the dramatically lower deformylation efficiency in case of hydrophilic or charged 
residues 50;99. 
 The substrate specificity and recognition of EcPDF were comprehensively 
studied by Ragusa and coworkers 99 illustrating that methionine in position P1’ is the 
best substrate for PDF compared to any other natural amino acid (Table 2). The 
catalytic efficiency for substrates with another N-terminal residue than methionine can 
be 2 to 5 orders of magnitude lower. 
 The S2’ and S3’ subsites can be described as shallow pockets, which permit 
different hydrophobic and bulky side chains to bind. This is in line with the natural role of 
PDF to accept a diverse range of peptide sequences as substrates. Furthermore, 
















Figure 1. Close-up of the active site and pocket of EcPDF. A: Representation of H-Met-Ala-OH (in green) 
in the active site of PDF. The residues composing the hydrophobic pocket where the side chain of 
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activity of PDF. It was shown that the catalytic efficiency for N-formyl-Met-OH was about 
three orders of magnitude lower than for N-formyl-Met-Ala-OH and N-formyl-Met-Ala-
Ser-OH 81. For PDF from higher plants, Serero et al. reported a catalytic efficiency 
(kcat/Km) that is comparable with that of EcPDF, and the Michaelis-Menten constant (Km) 
values were one order of magnitude lower. Indeed, deformylation was proven to be an 
essential function in chloroplasts 113. 
 
Engineering studies. Based on analysis of the 3D structures of EcPDF 7, and on 
sequence alignments Ragusa and coworkers 99 proved a role for several residues in 
substrate recognition. To validate this, a site-directed mutagenesis approach was 
followed. From the stability and activity data obtained, the S1’ hydrophobic pocket, 
accommodating the side chain of methionine (P1’), was proposed to be composed of 3 
parts: 
 Ceiling: framed by the side chains of residues Glu-88 and His-132 
 Floor: lined by Ile-44 and Cys-129 
 Bottom: lined by the side chains of Ile-86, Leu-125 and Ile-128. 
The side chains of these amino acids give the cleft a hydrophobic character. As 
described above, among these residues only two (Glu-88 in sequence motif 2 and His-
132 in motif 3 (metal binding)) are highly conserved and play an important role in the 
hydrogen bond network and in 3D folding. To evaluate the role played by the side 
chains of the other amino acids composing the pocket, several mutants were tested for 
their catalytic efficiency. The residues present at the bottom of the cleft, specifically Leu-
125 and Ile-128, strongly influence the affinity of the enzyme for the substrate, probably 
due to the interaction with the methyl group of the methionine side chain. Other residues 
that shape the S1' pocket are not conserved despite the very similar selectivity of PDFs 
63;80. Therefore, the high specificity must be due to the overall size and hydrophobicity of 
the crevice. An experimental study aimed at broadening the substrate specificity of 
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Table 2: Effect of the nature of the N-terminal amino acid residue on the hydrolysis of a combinatorial 
peptide library by EcPDF 99. 
Formylated N-terminal amino 
acid  
kcat/Km (M-1s-1x103) Relative kcat/Km 
Methionine 131±11 100 
Phenylalanine 37±4 28 
Leucine 3.0±0.3 2.3 
Tyrosine 2.4±0.3 1.8 
Isoleucine 1.8±0.08 1.4 
Glutamine 1.8 ±0.02 1.4 
Alanine 0.84±0.08 0.6 
Valine 0.19±0.02 0.14 
Histidine 0.07±0.01 0.05 
Lysine 0.05±0.01 0.04 
Serine 0.04±0.01 0.03 
Threonine 0.034±0.004 0.026 
Glutamic acid 0.018±0.002 0.014 
Glycine 0.017±0.002 0.013 
Arginine 0.015±0.002 0.011 
Asparagine 0.011±0.001 0.008 
Aspartic acid 0.0009±0.00001 0.0007 
Proline «0.00003 «0.00002 
Tryptophan NS NS 
 
 
PDF stability and inactivation 
 As mentioned above, the first attempts to purify and characterize PDF from E. 
coli were hampered by its high instability leading to rapid inactivation of the enzyme. 
This prevented purification and thorough biochemical characterization of the enzyme for 
over 30 years. Groche et al. were the first to propose that this instability could be due to 
the involvement of a Fe2+ ion in the catalytic cycle of PDF which is prone to oxidation to 
Fe3+ by atmospheric O2 and other reactive oxygen species such as H2O2 40;101;103. In 
1998, another study of Meinnel and co-workers showed that PDF activity could be 
maintained by addition of Ni2+ or Mn2+ 98.  
 The inactivation of PDF was proposed to proceed in two steps, both requiring an 
oxidative agent, such as atmospheric oxygen. First, a ferric intermediate is generated by 
a one-electron oxidation by O2. The generated superoxide can diffuse out of the active 
site or proceed in a second reaction, the oxidation of Cys-90, one of the metal ligands, 
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into cysteic acid. Moreover, the superoxide can disproportionate into H2O2 and O2 and 
oxidize another enzyme molecule. It has been proven that only about 50% of all PDFs 
undergo cysteine oxidation, and that this covalent modification does not allow the 
recovery of activity even after incubation in the presence of Fe2+ or Co2+ 101.  
 In agreement with an oxidative inactivation mechanism in which peroxide plays a 
role, enzyme inactivation can be prevented by the combined use of catalase, for the 
removal of H2O2, and tris-(carboxyethyl)phosphine (TCEP) to arrest the first O2-
dependent step 101. Similarly, Pei and co-workers proved that PDF activity can be 
maintained by exclusion of H2O2 and O2 using glucose + glucose oxidase + catalase 101. 
Other scavengers (like thiols or ascorbate) either have no effect or accelerate enzyme 
inactivation. This is due to their ability to convert O2 in other reactive species which can 
oxidize the ferrous ion.  
 Another method that can be applied to avoid inactivation is substitution of the 
Fe2+ ion with a transition metal ion that is insensitive to oxidation, such as Ni2+ 40;98, Co2+ 
102 or Mn2+ 98. These modified PDF forms are active and extremely stable. It is now 
accepted that the Zn2+-containing PDFs that are obtained by purification from 
recombinant PDF-expressing bacteria, must be an artefact of the overexpression and 
purification process. The Zn2+ ions present in the buffers may displace the Fe2+ ions, 
since zinc ions bind much more tightly to PDF than iron 40. The Zn2+ form of the enzyme 
has a lower catalytic activity than the Fe2+ form 8. In 1998, structural studies with EcPDF 
showed that in Zn-PDF one of the water molecules involved in catalysis is absent and 
the other is displaced, leading to a different hydrogen bonding pattern that is not optimal 
for catalysis 7. Subsequent studies by Wagner and co-workers suggested that the lower 
catalytic activity of the Zn2+ form is due to its difficulty in transformation between the 
tetrahedral and 5-fold coordinated form during the reaction 8;40. More recent publications 
explain the lower activity by a difference in interaction between the metal (Fe2+ or Zn2+) 
and formate. In the case of Fe2+- containing PDFs, the metal ion is bound to formate in 
a bidentate way, with both formate oxygen coordinated with the metal ion. In the case of 
Zn2+-PDFs, only one of the formate oxygens is positioned at a distance that allows 
coordination with the formate, creating a monodentate binding. This difference in 
formate binding could also be the reason for the 100-fold lower activity of Zn2+- 
containing PDFs since in these enzymes the formyl-carbonyl formed during the first step 
of the reaction cycle (Scheme 5) is only activated by the hydrogen bonds to the enzyme 
and not by the metal ion 52;55. 
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Diversity of PDFs 
 PDFs can be divided in three major subfamilies. Originally, type I included all 
eukaryotic PDFs and most PDFs from Gram-negative bacteria, type II mainly 
encompassed PDFs from Gram-positive bacteria, and type III represented PDFs 
coming from Archaea and trypanosomes 33;63;69. However, the availability of crystal 
structures of many PDFs has made clear that the correlation between type I and II and 
phylogenetic position of the bacterial host is not always valid. Moreover, the analysis of 
several genomes showed that the number of different PDFs per organism may vary 
from one (E. coli) to four (S. coelicolor) and that type I and II PDFs can be present in the 
same organism 44. The main difference between type I and type II is the presence of an 
additional stretch of amino acids at the N- and C-terminus of the type II enzymes 63. 
 The high conservation of the catalytic core supports the idea of common catalytic 
properties although more structural data about the enzyme-substrate complex will be 
needed to confirm this hypothesis 26. This does not hold true in the case of higher 
eukaryotes, where the role of PDF has not yet been completely clarified. Human PDF 
(HsPDF) has been reported to exhibit in vitro activity towards N-formyl-peptides but its 
catalytic efficiency is very poor compared to EcPDF 30;35;91. Another important difference 
between distinct peptide deformylases is their preference between zinc and other 
divalent cations. Despite the wide preference for zinc in many metallohydrolases, 
peptide deformylases predominantly prefer iron as metal ion. In several structural 
studies 7 the only difference at the active site of Zn2+, Fe2+ and Ni2+ reported was a 
smaller tetrahedral volume at the zinc metal center which has been associated with 
tighter binding of this metal ion, which is reflected in differences in activity, as mentioned 
above 26.  
 Recently PDFs whose zinc forms are almost as active as the Fe2+-containing 
EcPDF have been identified. These include Arabidopsis thaliana PDF1A (AtPDF1A) 
33;113, Leptospira interrogans PDF (LiPDF)71;141, Borrelia burgdorferi PDF (BbPDF) and 
Lactobacillus plantarum PDF (LpPDF) 92. These enzymes share the same conserved 
fold as EcPDF.  
 Based on the activity reported for BbPDF, containing Zn2+ in its catalytic core, 
Nguyen and co-workers propose that the activity differences between Fe-EcPDF and 
Zn-EcPDFs can not be due to an intrinsic property of the ion but must be related to the 
combination of the metal and its ligand environment, creating a slightly different metal-
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ligand bond length and geometry. Consequently, the two metals may bind to the same 
enzyme differently so that the formyl group is more or less optimally aligned in the 
active site for the first nucleophilic attack. This could cause the observed differences in 
activity 92. 
 
Biocatalytic potential of PDF 
 Because of its catalytic activity, PDF can be seen as an attractive biocatalyst in 
chemo-enzymatic peptide synthesis. The enzymatic deprotection of formylated peptides 
used in a CN synthetic strategy could in fact be performed using peptide 
deformylases. Although much information is available on the use of this enzyme as a 
target for antibacterial, antiparasitic and chemotherapeutic agents 30;69;74, data on other 
applications are poor.  
Concerning the use of PDF in organic synthesis, the single literature information 
available focuses on the application in the kinetic resolution of amines and amino acid 
derivatives 121. Using the native EcPDF, the authors showed that peptide deformylase 
could be used for the kinetic resolution of N-formylated α-amino acids and β-amino 
acids. The latter were converted more slowly. Also α-amino acid amides and α-amino 
nitriles were accepted and converted with good yield. In all cases, the (S)-enantiomers 
of the amino acid derivatives were preferentially deformylated. Very high enan-
tioselectivities (E>300) were found with the N-amidated derivatives of phenylglycine, 3-
amino-3-phenylpropionic acid, phenylglycine amide, and tert-leucine amide, and the 
catalytic rates were considered high enough for the development of a biocatalytic 
process. The deformylation reaction also proceeded with the dipeptide N-formyl-Leu-
Tle-NHCH3 (Tle is L-tert-leucine).  
The EcPDF could also be used in the reverse reaction, in agreement with an 
earlier observation by D. Groche (1995, PhD thesis, Univ. Heidelberg). The enzyme 
catalyzed stereoselective formylation of α-amino acid nitriles when a high concentration 
of formate (thermodynamically controlled reaction) or a suitable formyl donor (kinetically 
controlled reaction) was used. The transformylation reaction suggested a ping-pong 
mechanism in which the formyl group stays bound to the enzyme after cleavage of the 
C-N bond in the formyl donor. The carbonyl carbon then should be cleaved by attack of 
the amino group of the amino acid or peptide that acts as acceptor. In agreement with 
the selectivity for methionine, N-formyl-Met-Ala-OH worked much better as a formyl 
donor for transfer to H-Met-Ala-Ser-OH than for formylation of phenylalanine nitrile. 
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Formylation of 2-amino-3-phenylpropionitrile proceeded much more efficiently with an 
ammonium formate solution under thermodynamic conditions, in which concentrations 
up to 6 M sodium formate were used 121. These formylation reactions can be explained 
by the reverse of the reaction mechanism shown in Scheme 5, and the observed 
substrate specificities confirmed that the selectivity is mainly in the S1’ pocket of 
EcPDF. 
A disadvantage of the application of PDF in peptide synthesis is the need to 
rigorously separate the enzyme from peptidases and amidases that originate form the 
E. coli strain used for its overexpression because use of a crude extract will result in 
extensive peptide bond hydrolysis. A solution for this issue will be presented in Chapter 
2 of this thesis. 
 
Outline of this thesis 
The goal of the research reported in this thesis is to explore the potential of the use of 
peptide deformylase in chemo-enzymatic peptide synthesis. PDF is suitable for the 
selective N-terminal deformylation of certain N-formyl-peptides without concurrent 
peptide bond hydrolysis. The challenge of applying PDF industrially prompted us to 
focus on the development of a new purification method to remove proteins with 
peptidase activity from the PDF. Other aspects such as improving the stability and 
modifying the substrate specificity are also investigated. In order to broaden the 
specificity of PDF, we decided to use saturated mutagenesis at positions that play an 
important role in substrate recognition. A fast assay for the rapid selection of improved 
peptide deformylase variants in E. coli colonies was developed to analyze the 
constructed libraries. 
 Chapter 2 describes the search for a cost-efficient and industrially applicable 
purification method. Peptide deformylase can be obtained via overexpression of the def 
gene in E. coli production strains. Unfortunately, its use in peptide synthesis is limited by 
the presence of amidases and peptidases in the cell-free extract preparation. A 
purification method was developed by Sonke at al. using affinity chromatography 121. 
Despite the high purity obtained with this technique, the high cost of the affinity matrix is 
a prohibitive disadvantage for its application in an industrial setting. In order to reduce 
these costs, ultrafiltration and anion-exchange chromatography were explored, in 
combination with enzyme engineering. The first engineering approach involved the 
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construction of a short version of EcPDF for application in an ultrafiltration purification 
step. Additionally, purification via ion-exchange chromatography was facilitated by the 
construction of a polyglutamic acid tag, inserted on a flexible and exposed loop of 
peptide deformylase.  
 An approach to find peptide deformylases with higher stability and better catalytic 
properties for application in peptide synthesis is the screening of genomic databases 
and related information. In Chapter 3, eight peptide deformylases chosen from 
phylogenetically different classes were successfully overexpressed in E. coli. Partial 
characterization of these enzymes revealed different temperature stabilities and 
temperature optimum profiles but no major differences in co-solvent stability and 
substrate acceptance. Therefore, to obtain PDFs with tuned catalytic properties other 
approaches like directed evolution or rational design need to be used. 
 In Chapter 4, we discuss the advantages and pitfalls of various screening and 
selection methods for the discovery of the best candidates in a directed evolution 
library. The screening example given in this chapter is related to the growth-based 
selection of enzymes possessing a different substrate specificity compared with the 
wild-type from a library of mutants.  
 Chapter 5 deals with the need to obtain a peptide deformylase with broader 
substrate specificity for application in deprotection steps in a peptide synthesis process. 
The four non conserved residues known to be involved in substrate binding in the 
EcPDF were simultaneously randomized by site-saturated mutagenesis. The library 
obtained was screened for increased activity towards different substrates using a 
growth selection strategy. Various clones displaying new substrate specificity were 
recovered, sequenced and partially characterized. 
 In the last Chapter 6, the obtained results are shortly summarized and discussed 
with respect to their importance for the biocatalytic application of peptide deformylase.  
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Abstract 
 Peptide deformylases (PDFs) catalyze the removal of the N-terminal formyl group 
from the N-terminal methionine in nascent polypeptide chains in prokaryotes. This 
activity makes PDFs attractive candidates for the biocatalytic deprotection of formylated 
peptides which can be used in chemoenzymatic peptide synthesis. PDFs can also be 
applied for the synthesis of enantiomerically pure amino acid derivatives.  For 
application in peptide deprotection, it is essential to use PDF preparations that are free 
of contamination by amidases and peptidases since their presence would cleave 
internal bonds in the peptide that is under synthesis. To be able to explore the use of E. 
coli PDF (EcPDF) in these biocatalytic applications, a simple and industrially applicable 
purification procedure was developed based on a single anion-exchange 
chromatography step. To achieve separation, the E. coli PDF was engineered with an 
anionic tag composed of 8 glutamic acid residues. The activity and stability of the 
engineered enzyme were similar to those of the wild-type PDF. This purification 
furnished a PDF preparation with a 1,500-fold decreased level of contamination by 
amidases and peptidases as compared to cell-free extract. It was shown that the 




 Chemical peptide synthesis, either in solution or by solid phase methods, 
generally proceeds by elongation at the N-terminal side of the nascent peptide chain. In 
academic practice N-protecting groups like tert-butoxycarbonyl (Boc), benzyloxy-
carbonyl (Cbz) and especially fluorenylmethoxycarbonyl (Fmoc) are used in combi-
nation with advanced coupling reagents like carbodiimides, phosphonium salts, or 
uronium/guanidinium salts. Examples of coupling reagents are 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiimide N-hydroxysuccinimide (EDC/HOSu), 1-ethyl-3-(3-dimethyl-
aminopropyl) N-hydroxybenzotriazole (EDC/HOBt) or benzotriazolyloxy-tris-
(pyrrolidino)-phosphonium hexafluorophosphate (ByBOP) 11. Although these coupling 
methods work well on a laboratory scale and proceed without substantial racemisation 
of the amino acid building blocks, commercial application requires cheaper protecting 
groups and coupling reagents. In this respect, a particularly interesting amino protecting 
Chapter 2              Purification of recombinant E. coli peptide deformylase  
 
    49
group is the formyl moiety, which can be readily introduced at low cost using formic acid 
and acetic acid anhydride 26. The removal of the formyl group after the coupling reaction 
can be performed either chemically or enzymatically. Acid hydrolysis in water and/or 
methanol is a conventional method for removing formyl groups from the amino group of 
amino acids and the amino terminus of peptides 35. However, the low pH and harsh 
reaction conditions lead to significant peptide bond hydrolysis when this method is 
applied in peptide synthesis. A mild enzymatic method would thus be more attractive. 
 One class of enzymes that can be used for the removal of formyl-protecting 
groups consists of the peptide deformylases. The cellular ribosome-mediated synthesis 
of proteins starts with a methionine residue. In eubacteria and eukaryotic organelles 
(mitochondria and chloroplasts), the methionyl moiety carried by the initiator tRNA.fMet 
is N-formylated prior to its incorporation into a polypeptide 28. Following initiation of 
translation, the enzyme peptide deformylase (PDF, EC 3.5.1.88) cleaves the formyl 
group from the nascent polypeptide chain 2. Next, methionyl aminopeptidase may 
remove the N-terminal methionine from the deformylated polypeptide, leading to a 
mature protein 8. Because of its deformylase activity, PDF could be an attractive 
biocatalyst for the deprotection of formylated peptides.  
 Although much information is available on PDFs as a target for antibacterial, 
antiparasitic and chemotherapeutic agents 15;22;23, data on biocatalytic applications are 
scarce. Concerning the use of PDF in organic synthesis, the only  information available 
in the literature describes the application of the enzyme in the synthesis of enantiopure 
amines and amino acid derivatives, based on its ability to stereoselectively hydrolyse N-
formyl α-aminonitriles, and N-formyl derivatives of non-functionalized amines and β-
amino alcohols 32. In this paper, the authors also describe an example of the use of PDF 
for the selective deprotection of N-formyl-dipeptides. A prerequisite of the application of 
PDFs in peptide synthesis is the possibility to isolate the enzyme in a form that is free of 
contaminating peptidases and amidases that may originate form the E. coli host strain 
used for overexpression. The presence of peptidases would result in peptide bond 
hydrolysis in the peptide that is under synthesis.  
 The aim of the research described here is to obtain a method for the rapid, 
upscalable, and cheap production of purified PDF that is capable of removing N-
terminal formyl groups from peptides without concurrent peptide bond hydrolysis. A one-
step purification method for PDF based on affinity chromatography with a Met-Lys 
modified Sepharose matrix was described before 32. This strategy is in practice only 
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suitable for use on laboratory scale since the matrix is not commercially available and 
its preparation involves a complicated chemo-enzymatic preparation process making 
use of expensive materials. In this Chapter, we describe the development of two simple 
and industrially applicable purification methods for EcPDF.  
 Because EcPDF is a monomeric enzyme of 168 aa (19.24 kDa), which is rather 
small as compared to the average E. coli amidases and peptidases, the use of ultra-
filtration methods was first explored. Membrane ultrafiltration (UF) is a pressure-
modified, convective process that uses semi-permeable membranes to separate 
species in aqueous solutions by molecular size, shape and/or charge 14. The surface of 
the UF membrane contains pores with diameters small enough to distinguish between 
the sizes and shapes of dissolved molecules. Those above a predetermined size range 
are rejected, whereas those below that range pass trough the membrane with the 
solvent flow 14. 
 A second option that is described makes use of ion-exchange chromatography 
(IEC) as a single purification step, combined with the use of negatively charged tags 
fused onto specific enzyme domains. Anion exchange chromatography is a widely used 
protein separation technique. By improving the selectivity of IEC through modification of 
the target protein, this method could be a cheap and robust alternative to the traditional 
affinity systems. One way to do so is to change the charge distribution on the surface to 
allow for stronger absorption to the ion exchanger 21. To apply this principle for the 
purification of EcPDF, we decided to insert a poly-anionic sequence containing eight 
glutamic acid residues in a solvent exposed loop on the surface of EcPDF. This allowed 
efficient purification using ion-exchange chromatography.  
 
Materials and methods 
Materials 
 All standard chemicals were of the highest grade obtainable. H-Phe-NH2, H-
TyrOMe, N-Formyl-Met-Ala-OH, H-Met-Ala-OH, N-formyl-Met-Lys-OH, H-Leu-Phe-OH, 
H-Phe-Leu-OH, H-Asp-Phe-OH, H-Phe-Asp-OH, H-Arg-Phe-OH, H-Phe-Arg-OH, H-Gly-
Phe-OH, and H-Phe-Gly-OH were purchased from Bachem (Bubendorf, Switzerland); 
tris-(2-carboxyethyl)-phosphine (TCEP) was obtained from Fluka (Buchs, Switzerland). 
If desired, amino acid derivatives were formylated in a refluxing mixture of formic acid 
and 1 eq. of acetic acid anhydride. 
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 The mono Q HR 5/5 and HiLoad Q sepharose anion exchange columns were 
purchased from GE Healthcare Bio-Sciences Ltd (United Kingdom). Centriprep and 
Centricon centrifugal filter devices were purchased from Millipore Corporation (Billerica, 
Massachusetts). 
 E. coli strains CJ236 and JM109 were from Bio-Rad Laboratories GmbH 
(Munich, Germany). Helper phage M13K07 was from GE Healthcare Bio-Sciences Ltd 
(United Kingdom). 
 Restriction enzymes, T4 DNA ligase, T4 DNA polymerase, and polynucleotide 
kinase were obtained from New England Biolabs (Schwalbach, Germany). Adenosine 
triphosphate and deoxynucleoside triphosphates were purchased from Roche 
(Mannheim, Germany). Catalase from bovine liver was obtained from Sigma (St. Louis, 
MO). Synthesis of oligonucleotides for site-directed mutagenesis and DNA sequencing 
were performed by MWG Biotech AG (Ebersberg, Germany). 
 
Construction of E. coli PDFwt expression vector 
 Wild-type peptide defomylase from E. coli (EcPDFwt) was produced with the 
expression vector pBAD/Myc-His-DEST using Gateway cloning technology (Invitrogen). 
Vector pBAD/Myc-His-DEST is a derivative of plasmid pBAD/Myc-HisC 31 and has been 
constructed by insertion of an attR1-cat/ccdB-attR2 cassette at the position of the 
Shine-Dalgarno sequence in pBAD/Myc-HisC, which is located downstream of the 
strong and tightly controllable araBAD promoter 25 10. The PDF gene was first amplified 
by PCR using forward primer 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTAG-
GAGGAATTAACCAATGTCCGTGCTTCAAGTGTTACATATTCC – 3’ as (attB1 site in 
italics, parts complementary to the def gene underlined, start codon in boldface), and 
reverse primer 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTTTAAGCCCGGGCTTT 
-CAGACGATCCAGTTTTTC–3’ as (attB2 site in italics, parts complementary to the def 
gene underlined, stop codon in boldface) and plasmid pTL7-1. The PCR reaction was 
performed using AccuPrime Taq DNA polymerase (1U) and accompanying buffer 
(Invitrogen). The amplification reaction was started with an initial denaturation of 2 min 
at 95°C, followed by 30 cycles of 15 s at 95°C, 30 s at 58°C and 1 min at 68°C, with an 
additional cycle of 5 min at 68°C. The amplification product was purified using the 
QIAquick PCR purification kit (Qiagen), after which this product was introduced into the 
pDONR201 vector via a Gateway BP recombination reaction in a vector:fragment molar 
ratio of 1:2. After transformation of E. coli TOP 10, recombinant cells were selected by 
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plating on LB plates containing kanamycin (50 μg/mL), followed by overnight incubation 
at 28°C. The PDF-encoding gene in pDONR201 was subsequently recombined to 
expression vector pBAD/Myc-His-DEST in a standard LR recombination reaction with a 
molar ratio of destination vector vs. entry vector of 1:2.4 (150:300 ng). 
 After transformation of E. coli TOP10 recombinant cells were selected by plating 
on LB plates containing carbenicillin (100 μg/mL) followed by overnight incubation at 
28°C. Finally, a correct clone, as established by plasmid DNA isolation and restriction 
enzyme analysis was designated pBAD/Myc-His-DEST PDFwt. 
 
Construction of EcPDF variant expression vector 
 The method we used for site-directed mutagenesis of the def gene is based on 
the procedure described by Kunkel 24 using uracil-containing ssDNA. It is also described 
in the instruction manual of the Muta-Gene phagemid in vitro mutagenesis kit by Bio-
Rad (Bio-Rad Laboratories GmbH, Munich, Germany). 
 The def gene from E. coli K12 (EMBL Nucleotide Sequence Database accession 
number U00096, nucleotides 343,1712 to 343,2221) was cloned between the EcoRI 
and HindIII sites of phagemid pTZ18U 24 putting the gene under the control of the lac 
promoter 10. The resulting phagemid was named p1074 and was used to prepare 
ssDNA in which some thymidine residues were replaced by uracil. This was done by 
superinfection of E. coli strain CJ236 (ung-, dut-) harboring plasmid p1074 with helper 
phage M13K07. E. coli strain CJ236 harboring p1074 was grown in 2xYT medium (16 
g/L Bacto-Tryptone, 10 g/L yeast extract, 5 g/L NaCl, 10 mM KH2PO4 pH 7.5) 
supplemented with 30 µg/mL chloramphenicol, 150 µg/mL ampicillin and 1 mM thiamine 
hydrochloride at 37°C with gently shaking (150 rpm). Then 0,5 mL of the culture 
(OD550nm = 5) were diluted in 100 mL of the same medium and infected with M13K07 At 
an MOI of 10 (MOI = phages per mL/cells per mL). Infected cells were grown at 37°C 
and 150 rpm for 20 h (final OD OD550nm = 2.9). After removal of cells by centrifugation 
(17,000g, 20 min) the uracil-containing ssDNA of p1074 was isolated from the 
supernatant by precipitation with PEG 6000 (final concentration 5% PEG 6000, 0.625 M 
NaCl) and purified by extraction with phenol. The yield was 215 µg of pure ssDNA. 
The uracil-containing ssDNA of p1074 was used as template for in vitro synthesis 
of the second strand with the 5’-phosphorylated oligonucleotide as mutagenic primer: as 
template for the in vitro synthesis of the second strand. 
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The obtained dsDNA was used to transform E. coli JM109 (ung+) which contains 
a proficient uracil N-glycosylase that efficiently inactivates the uracil-containing strand of 
the phagemid leaving the mutated strand for replication. Silent mutations which 
introduce a new restriction site were incorporated in the mutagenic primers for easy 
detection of mutants. The mutatations were verified by DNA sequencing of the complete 
def gene.  
 For the construction of PDFEtag and PDFshort, two oligonucleotides were used in 
separate reactions. These were: prPDF-Etag (5’- CGTCACGGTCCTCTTCTTCTTCCT-
CCTCTTCCTCTTCCGAAACATC), which introduces 8 additional codons for Glu 
between Glu64 and Asn65 and changes Asn65 to Asp, and prPDFstop (GTTGTTT-
CACTTAAGACAGATAATCC) which changes the pdf Pro148 codon (CCG) into a stop 
codon (TAA). The oligoglutamate tag is encoded by a mixture of CTC and CTT codons, 
to prevent hairpin formation. The new restriction sites (AvaII in PDFEtag and AflII in 
PDFshort) are underlined. The resulting PDFEtag- and the PDFshort-encoding plasmids 
were respectively called pTL7-1 and pTL7-2.  
 For expression, the mutated genes were cloned into the pBAD/Myc-His-DEST 
vector as described above. For amplification of EcPDFEtag primer prPDF-for and 
prPDF-long-rev were used, whereas for the amplification of EcPDFshort prPDF-for and 




GAAAGCTGGGTTTAAGACAGATAATCCATAAACAGTTTGCCG. Plasmids pTL7-1 and 
pTL7-2 were used as template in the PCR reactions, respectively, and the resulting 
constructs were called pBAD-PDFEtag and pBAD-PDFshort. 
 
Cultivation and cell free extract preparation 
 EcPDFwt, EcPDFEtag and EcPDFshort were isolated from overproducing E. coli 
TOP10 cells transformed with the respective plasmids. Cells were grown at 28°C for 14-
16 h in 1.5 L LB medium containing 100 µg/mL carbenicillin. When the OD620 reached 
0.6, PDF expression was induced by addition of 0.02 % L-arabinose. Cells were 
harvested by centrifugation and about 12 g (wet weight) of cell paste was suspended in 
40 ml buffer (20 mM HEPES/KOH, 100 mM KCl, pH 7.7, supplemented with 10 µg/mL 
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catalase from bovine liver). After disintegration by sonication (Branson B12, 10 min) at 
0°C, cell-free extract (CFE) was obtained by centrifugation at 33,300 x g for 1 h at 4°C. 
 
Purification of PDF using anion exchange chromatography 
 After preparation of CFE with EcPDFwt and EcPDFEtag, 1 mL of the clear extract 
(5 mg/mL of total protein for PDFEtag and 7.8 mg/mL for PDFwt) was fractionated using a 
1 mL Mono Q 5/50 GLcolumn that was equilibrated with a buffer solution composed of 
20 mM HEPES/KOH, 1 mM TCEP, 100 mM KCl, pH 7.7. After washing with 15 mL of 
the same buffer to remove the unbound proteins, PDF was eluted with 60 mL of 20 mM 
HEPES/KOH, 1 mM TCEP, 1 M KCl, pH 7.7. The fractions with PDF activity were 
detected using the HPLC method described below and concentrated using Centriprep 
30 kDa filters (Millipore) to 10 mg/mL of protein. 
 This purification procedure was also scaled up. An amount of 44 mL of CFE (30 
mg/mL total protein) was loaded on a HiLoad 26/10 Q Sepharose HP column after 
equilibrating the column with 20 mM HEPES/KOH, 1mM TCEP, 100 mM KCl, pH 7.7. 
Unbound proteins were washed off with 100 mL of the same buffer solution and the 
PDF was eluted with 600 mL of 20 mM HEPES/KOH, 1 mM TCEP, 1 M KCl, pH 7.7. 
The fractions with PDF activity were concentrated using Centriprep 30 kDa filters to 20 
mg/mL of protein. 
 
 
Purification of PDF using affinity chromatography 
 For purification by affinity column chromatography EcPDFwt CFE was prepared 
as described above but the cell paste was resuspended in a buffer containing KF as a 
salt. The buffer composition was 20 mM HEPES/KOH pH 7.7, 100 mM KF, 
supplemented with 10 µg/mL catalase from bovine liver. 
 An amount of 10 ml of the clear extract (6.4 mg/mL of total protein) was 
fractionated using a 20 mL Met-Lys-Sepharose column  that had been equilibrated with 
buffer solution composed of 20 mM HEPES/KOH, 100 mM KF, 0.2 mM TCEP, pH 7.7 
32. After washing with 42 mL of the same buffer to remove unbound proteins, the PDF 
was eluted with 40 mL of 20 mM HEPES/KOH, 100 mM KCl, and 0.2 mM TCEP, pH 
7.7. The fractions with PDF activity were concentrated by ultrafiltration using Centriprep 
10 kDa filters to 10 mg/mL. 
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Purification of PDF using ultrafiltration 
 E. coli TOP10 cells containing pBAD-PDFwt were cultivated as described above 
and about 4 g (wet weight) of cell paste was suspended in 20 mL buffer (20 mM 
HEPES/KOH, 100 mM KCl, pH 7.7 supplemented with 10 µg/mL catalase from bovine 
liver). After disintegration by sonication at 0°C, cell-free extract was obtained by 
centrifugation at 33,300 x g for 1 hour. Partial purification of EcPDFwt was performed 
using Centriprep centrifugal filter units with an Ultracel YM-50 or YM-100 membrane 
(Millipore). The nominal cut-off of these filters is 50 and 100 kDa, respectively. Before 
loading the CFE (protein concentration 15 mg/mL) to the Centriprep filter device, the 
sample was centrifuged for 2 h at 16,100 x g and 4oC, the supernatant was collected 
and subsequently diluted 5-fold with buffer composed of 20 mM HEPES/KOH, 100 mM 
KCl, supplemented with 10 µg/mL catalase and 2 mM TCEP, pH 7.7. The diluted 
material (3 mg/mL) was then loaded on a Centriprep YM-50 or YM-100 filter and 
centrifuged for 2.5 h at 1,000 x g and 4°C. When using Centricon YM-30, YM-50 or YM-
100 devices the CFE was prepared following the same protocol but centrifugation step 
was performed for up to 2 h at 1,000 x g for the YM-100 and up to 2 h at 3,500 x g for 
the YM-30 and 50. 
 
Purification of PDF using gel filtration chromatography 
 Cell-free extracts containing EcPDFwt, EcPDFEtag or EcPDFshort were produced 
according to the standard protocol. Theextracts had protein concentrations of 10 
mg/mL, 8 mg/mL and 12 mg/mL, respectively. The samples were diluted with standard 
dilution buffer (SDB), which was composed of 20 mM MOPS/NaOH, 100 mM NaCl, 
supplemented with 10 µg/mL catalase from bovine liver and 2 mM TCEP, pH 7.7, to a 
protein concentration of 5 mg/ml. Subsequently 100 µL samples of the extracts were 
chromatographed on a TSK-GEL G2000SWXL column (TOSOH Bioscience). The flow 
rate used during all the purification steps was 0.5 mL/min.  
 
Enzyme and protein assays 
 Deformylase activity of PDF was routinely measured at 30°C in a total volume of 
500 µL. Samples of 50 µL of different dilutions of PDF in SDB, were mixed with 450 µL 
of substrate solution composed of 110 mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 
0.1 mg/mL bovine liver catalase and 5.5 mM of the substrate N-formyl-Met-Ala-OH. The 
dilutions of the enzyme were chosen such that approx. 10% of the substrate was 
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converted in 15 min. After starting the reaction by the addition of the PDF, 100 µL 
aliquots were withdrawn from the reaction mixture every 5 min and added to 100 µL of 
1M phosphate buffer (H3PO4-NaOH, pH 2.66) to stop the reaction. Analysis of substrate 
and product was performed using the HPLC method described below. To obtain an 
enzymatic blank, 500 µL of the same phosphate stopping buffer and 50 µL of diluted 
PDF were mixed together prior to the addition of 450 µL of the substrate solution given 
above. 
 Peptidase activity in samples was determined using a mixture of the following 8 
dipeptides: H-Leu-Phe-OH, H-Phe-Leu-OH, H-Asp-Phe-OH, H-Phe-Asp-OH, H-Arg-
Phe-OH, H-Phe-Arg-OH, H-Gly-Phe-OH, H-Phe-Gly-OH. An amount of 450 µL of a 
solution composed of 110 mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 0.1 mg/mL 
bovine liver catalase, and 0.625 mM of each of the 8 dipeptides, was mixed with 50 µL 
of different dilutions of PDF in SDB. The dilution was chosen such that approx. 10% of 
the substrate was converted in 15 min. After starting the reaction at 30°C by the addition 
of the PDF, 50 µL samples were withdrawn from the incubation mixture every 5 min and 
added to 150 µl methanol to stop the reaction. For the enzymatic blank, the methanol 
was added prior to the enzyme. Analysis of substrate and product was performed using 
the HPLC method described below.  
 Protein concentrations were determined using the Bradford method with bovine 
serum albumin (BSA, Sigma) as standard protein 34. 
 
PDF stability in the presence of cosolvents 
 The effect on enzyme stability of several water miscible organic cosolvents 
[methanol, tetrahydrofuran (THF), dimethylformamide (DMF), tert-butanol, dimethyl 
sulfoxide (DMSO) and N-methyl-2-pyrrolidone (NMP)] in a 10, 20 or 40% (v/v) concen-
tration was measured by measuring the activity of diluted purified EcPDFwt and its 
variants at 30°C in a solution containing 20 mM MOPS/NaOH, pH 7.7, 100 mM NaCl, 
10 µg/mL bovine liver catalase, and 2 mM TCEP. To this mixture was added 450 µL of 
substrate solution composed of 110 mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 
0.1 mg/mL bovine liver catalase and 5.5 mM of the substrate N-formyl-Met-Ala-OH. 
Samples were periodically withdrawn from the incubation mixture to measure the 
specific activity. The residual activity is reported as a percentage of the specific activity 
of the enzyme that was found when no cosolvent was added to the reaction mixture.  
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Effect of temperature on PDF stability 
 The temperature stability of the enzymes was analyzed by preincubating purified 
PDFs (30 µg/mL) for 60 min at temperatures between 4 and 60 °C in standard dilution 
buffer. After an incubation of 10 min on ice, 50 µL samples of the pretreated enzyme 
solutions were used to determine the remaining activity according to the standard assay 
at 30 °C.  
 
HPLC analyses  
 HPLC was carried out using a stainless-steel analytical column (250 mm length, 
4.6 mm ID) packed with Inertsil ODS-3 material, 5 µm particle size from Alltech Applied 
Science (Breda, The Netherlands). The flow rate was 1 mL/min. Detection was 
performed at 40°C at a wavelength of 210 nm. The injection volume was 5 µL.  
 For-Met-Ala-OH and H-Met-Ala-OH were analyzed using the following gradient of 
acetonitrile in 10 mM H3PO4: t=0-4 min, 0.1 % (v/v) acetonitrile isocratic; t=4-15 min, 
0.1%-50% acetonitrile linear increase; t=15-15.1 min, 50%-0.1% linear decrease; 
t=15.1-20 min, 0.1% acetonitrile isocratic (retention times: For-Met-Ala-OH = 13.54 min, 
Met-Ala-OH = 5.39 min).  
 The peptides H-Leu-Phe-NH2, N-formyl-Leu-Phe-NH2, and N-formyl-Tyr-Leu-
Phe-NH2 were analyzed using the following gradient of acetonitrile in 10 mM H3PO4: 
t=0-5 min, 2.5% (v/v) acetonitrile isocratic; t=5-20 min, 2.5%-75% acetonitrile linear 
increase; t=20-20.1 min, 75%-2.5% linear decrease; t=20.1-27 min, 2.5% acetonitrile 
isocratic (retention times: H-Leu-Phe-NH2 = 12 min, N-formyl-Leu-Phe-NH2 = 16.81 min, 
N-formyl-Tyr-Leu-Phe-NH2 = 19.46 min. 
 For peptidase activity measurements, the production of phenylalanine was 
analyzed using the following gradient of acetonitrile in 10 mM H3PO4: t=0-15 min, 0-30% 
acetonitrile linear gradient; t=15-15.1 min, 30-0% acetonitrile decrease; t=15.1-20 min, 
0% acetonitrile isocratic. 
 
Protection and synthesis of amino acids and peptides  
 Amino acids, amino acid derivatives, and peptides were formylated using a 
refluxing mixture of formic acid and 1 equivalent of acetic acid anhydride.  
For-Leu-Phe-NH2 was synthesized as follows. 7.9 g N-formyl-Leu-OH and 10 g 
H-Phe-NH2 were dissolved in 200 mL of water containing 0.4 mM NaCl and 15 mM 
CaCl2 keeping the pH at 6 by addition of NaOH (20% w/v). Then, 4 g of thermolysin 
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(Sigma) was added and the mixture was stirred for 30 h at room temperature. The 
precipitate was isolated by filtration and washed with 50 mL of water. The identity and 
purity (>96%) for For-Leu-Phe-NH2 were confirmed by HPLC analysis  
PDF-catalyzed deprotection of For-Leu-Phe-NH2 was performed as follows. To a 
solution of 55 mM N-formyl-Leu-Phe-NH2, synthesized as described above, in 260 mM 
aqueous MOPS-NaOH buffer containing 675 mM NaCl and 0.1 g/L of catalase (pH 7.2) 
was added purified PDFEtag (obtained using ion-exchange chromatography) to a final 
concentration of 5 µM. The reaction mixture was incubated at 28°C for 46 h. Product 
was isolated by extraction with ethyl acetate/H2O at pH 9.5 and purity was checked by 
HPLC (>98%). 
For the synthesis of For-Tyr-Leu-Phe-NH2, a solution of 400 mM N-formyl-Tyr-
OH, 350 mM H-Leu-Phe-NH2 and 0.1 g of thermolysin was prepared in 4 mL of water 
containing 0.4 mM NaCl and 15 mM CaCl2. The mixture was incubated at room 
temperature for 3 days. Product was isolated by filtration and washed first with 10 mL 
water followed by washing with 5 mL diethyl ether. The identity and purity (>65%) were 
checked by HPLC. 
 
Results and discussion 
 It is virtually impossible to predict in a rational manner which separation and 
purification protocol will be optimal for the isolation of a certain protein. This is due to a 
lack of knowledge on the molecular properties that determine the exact behavior of the 
proteins to be separated. A range of purification techniques is available such as 
fractional precipitation, anion- and cation-exchange chromatography, hydrophobic 
interaction chromatography, affinity chromatography, gel filtration, and ultra- and 
microfiltration. Evidently, when being confronted with a complex mixture of proteins, 
there are many different steps and routes one can take to separate a target protein from 
components that need to be removed 3. Optimization of a protocol therefore is very 
much a matter of trial-and-error, which may make research and development costly. For 
EcPDFwt and its variants, the major restraints for the choice of a purification strategy are 
process costs when operated on large scale and industrial applicability. For this reason 
two methods were investigated: ion-exchange chromatography and ultrafiltration.  
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Purification of E. coli PDF via affinity chromatography 
 To obtain an expression construct, the E. coli def genes coding for EcPDFwt or 
variants thereof were cloned into pBAD/Myc-His-DEST via standard molecular biology 
procedures. This resulted in a 1,000-2,000 fold overexpression in E. coli. EcPDFwt, Etag, 
short were present in soluble form (Fig. 1). The specific activity of PDFwt in cell-free 
extract was 229 U/mg as measured with the standard assay, compared to 16 U/mg in a 
non-overexpressed cell-free extract. The PDF proteins were produced in E. coli at levels 
of 10-20 % of the total soluble protein in CFEs. 
 For purification of EcPDFwt, we first tested the single-step procedure using a Met-
Lys-Sepharose affinity column as described in Materials and Methods. In the Met-Lys-
Sepharose matrix, the ligand is bound via the ε-NH2 group of the Lys side-chain to the 
N-hydroxysuccinimide-activated Sepharose. The affinity chromatography method is 
based on the binding of active PDF to the Met-Lys-Sepharose affinity matrix in the 
presence of fluoride ions, which significantly increase the affinity of EcPDFwt for small 
formylated peptides, most likely because fluoride mimics formate 32. 
 The result of a typical purification experiment starting from ca. 15 g (wet weight) 
E. coli TOP10 cells containing pBAD- PDFwt is given in Table 1. The specific activity of 
the purified PDF toward the substrate formyl-Met-Ala-OH was 1,880 U/mg protein at pH 
7.2 and 30°C. This is somewhat higher than the 1,175 U/mg reported for a homo-
geneous preparation of PDF(Fe) 32 20, indicating that this approach furnishes pure PDF.  
 Because it has been shown that the purity of the PDF obtained by affinity 
chromatography allows its use as a catalyst to deformylate N-formyl peptides without 
concurrent hydrolysis of internal peptide bonds, this method was used here as a 
reference when measuring the amidase and peptidase content of various enzyme 
samples. To enable rapid determination of amidase and peptidase activity, enzyme 
samples were incubated with a mixture of different dipeptides, all containing one Phe 
residue at the N- or at the C- terminal position. From the activity data obtained the 
increase of purity was determined by calculating the ratio of the amidase and peptidase 
activity to the PDF activity for the CFE, and dividing this ratio by the 
deformylase/amidase ratio found with purified PDF. This calculation showed that in PDF 
samples isolated by affinity chromatography the level of contamination by amidases 
was reduced by 1,045-fold. 
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Figure 1. SDS-PAGE of induced E. coli cells overexpressing EcPDF. 
Lane 1, reference protein ladder; 
Lane 2, CFE of E. coli cells overexpressing EcPDFwt; 
Lane 3, CFE of E. coli cells overexpressing EcPDFEtag; 
Lane 4, CFE of E. coli cells overexpressing EcPDFshort. 
 
 
Besides a relatively low yield of only 57%, the main disadvantage of this 
purification method is the high cost of the affinity matrix. In fact, the modified Sepharose 
is not commercially available and its preparation involves a complex chemo-enzymatic 
process. Moreover, the use of fluoride makes it necessary to take special precautions in 
order to avoid corrosion of the equipment when applied on industrial scale. Therefore 
we explored the use of alternative large-scale purification procedures.  
   
Purification of PDF via ultrafiltration  
 Data on the use of ultrafiltration (UF) for protein purification purposes are limited. 
Most of the published applications of ultrafiltration for protein isolation concern the 
separation of artificial mixtures. While this has led to a better understanding of the 
mechanism of protein behavior and separation, lack of application based research has 
kept ultrafiltration in the blind spot of potential users 17. Despite this, ultrafiltration could 
offer a simple and cost effective way of separating PDF from amidases and peptidases 
present in CFEs. UF processes are cost effective, easy to scale-up and can be fine-
tuned to achieve high productivity and product purity at the same time 18. 
 
 
Table 1. Purification of EcPDFwt from E. coli TOP10 using Met-Lys-Sepharose affinity chromatography. 















CFE 14.7 64.5 229 100 1 0.23 995 
Met-Lys-
Sepharose column 8.4 4.5 1,880 57 8.2 0.002 1*10
6 
Obtained using For-Met-Ala as substrate. 
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 The size of EcPDF, a monomeric globular protein of about 19 kDa 6 is rather 
small compared to the size of most proteins in E. coli. Considering that the most 
important amidases and peptidases present in this bacterium are multimers of 
monomers with a size of about 60 kDa, the selection of an appropriate membrane cut-
off could allow their separation from peptide deformylase 1. To favor this process even 
more by increasing the differences in enzyme sizes, the use of a smaller version of the 
EcPDF was also investigated. This smaller version (EcPDFshort) was readily obtained by 
introduction of a stop codon in the gene as codon 148, thereby removing residues 148 
to 169 from the C-terminal α-helix of the EcPDF and providing an enzyme of 16.7 kDa. 
It is known that the last 18 residues of EcPDF are disordered in the X-ray structure and 
dispensable for activity 25. 
 Based on the native molecular mass of the EcPDF and the shorter variant, two 
different membrane sizes were tested for PDF retention. Initially EcPDFwt and 
EcPDFshort were loaded on 30 and 50 kDa Centricon filters. For both enzymes a high 
resistance and very low flux was observed and no PDF activity was detected in the 
filtrate. Visualization of the 50 kDa filtrate on SDS-PAGE showed the presence of only a 
very small amount of protein at the position where PDF was expected in view of its 
molecular weight. Further analysis of mass balance and activity showed that all PDF 
was still present in the retentate (Fig. 2). Therefore, we decided to use a higher 
membrane cut-off value. EcPDFwt and EcPDFshort were loaded on a 100 kDa Centricon 
membrane and in this case about 10% of the PDF activity was found in the filtrate. 
Since no significant differences were observed between yields obtained with EcPDFwt 
and its shorter variant, further tests with ultrafiltration were carried out only using 
EcPDFwt. 
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 First, EcPDFwt (4 mg/mL) that had been purified by affinity chromatography was 
loaded on 50 and 100 kDa Centricon filters. This experiment was carried on to evaluate 
the capability of the pure enzyme to pass through the filters and the possibility that 
sedimentation of particles during filtration caused membrane fouling. In the case of the 
100 kDa filters, all deformylation activity appeared in the filtrate, whereas the use of 50 
kDa cutoff membranes led to only 2% yield of PDF in the filtrate. This was improved to 
25% yield when the enzyme was loaded on the 50 kDa filter after 5-fold dilution. Thus 
passage of PDFwt through the filter is heavily influenced both by the size of the pores in 
the membrane and protein concentration.  
To avoid membrane clogging due to sedimentation of particles, Centriprep filters 
were used for subsequent experiments. These filters have a design that allows filtration 
to occur while at the same time fine particles are sedimenting at the bottom of the filter 
instead of on the membrane. Initially, with 50 kDa Centriprep filters and CFE of E. coli 
overexpressing EcPDFwt, no peptide deformylase activity was found in the filtrate. 
Therefore the same test experiment was performed using a 100 kDa membrane, which 
resulted in recovery of 21% of the PDF activity in the filtrate (Table 2). The level of 
contaminating amidase in the purified sample decreased 27-fold compared to CFE. 
  
Figure 2. SDS-PAGE of retentate, filtrate and CFE using 30 and 
50 kDa Centricon filters. 
Lane 1, reference protein ladder; 
Lane 2, retentate using 30 kDa Centricon filters; 
Lane 3, filtrate using 30 kDa Centricon filters; 
Lane 4, retentate using 50 kDa Centricon filters; 
Lane 5, filtrate using 50 kDa Centricon filters; 
Lane 6, CFE of E. coli cells overexpressing EcPDFwt. 
   1    2     3    4    5      6  
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When compared to the results obtained using affinity chromatography (Table 1) 
ultrafiltration appeared an inefficient purification method. PDF recovery was lower and 
the amount of amidases remaining in the sample was much higher with ultrafiltration 
than with affinity chromatography. 
The poor performance of ultrafiltration could possibly be due to the formation of 
protein aggregates that reduce PDF recovery in the filtrate. Different conditions may 
contribute to formation of aggregates, including protein concentration, pH, ionic 
strength, and mechanical stress. During ultrafiltration, the protein concentration in the 
retentate increases, which may cause aggregation and membrane fouling. Moreover, 
the continuous mechanical stress can cause perturbations of the protein structure with 
subsequent exposure of hydrophobic surfaces leading to aggregation 12. The improved 
yield obtained when diluting the enzyme five-fold in dilution buffer before loading it on 
the 50 kDa Centricon filter supported this explanation. 
 One of the methods to prevent the formation of aggregates is the use of additives 
like salt (0.1 and 1M NaCl) or betaine. However, when this was attempted, no increased 
yield was observed compared to when standard buffer was used. Membrane fouling is 
strongly affected by the shear flow causing absorption and/or gel-like depositions on the 
membrane surface, which may be reduced by cross-flow filtration. Stamatakis and Tien 
33 reported that with this technique only a fraction of the particles brought to the 
membrane surface could deposit on the membrane itself.  To test cross-flow filtration, 
we loaded CFE containing overexpressed EcPDFwt on a 100 kDa cutoff filter. One liter 
of cell-free extract containing overexpressed EcPDFwt was worked-up as described in 
   1     2     3     4     5      
Figure 3. SDS-PAGE of retentate, filtrate and CFE 
obtained with 100 kDa Centriprep filters. 
Lane 1, reference proteins; 
Lane 2, filtrate using 100 kDa filters; 
Lane 3, retentate using 100 kDa filters; 
Lane 4, filtrate using 100 kDa filters; 
Lane 5, retentate using 100 kDa filters. 
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Materials and Methods and subsequently loaded onto the filter. A pressure of 1.5 bars 
was applied and the retentate was washed three times with process water or MOPS 
buffer to prevent protein aggregation. Despite this, the amount of PDF that appeared in 
the flow-through was only 2%.   
 



















CFE 1.9 10.2 195 100 1 0.2 975 
Filtrate 0.4 1.3 321 21 1.6 0.012 2.7*104 
a Measured with For-Met-Ala-OH as substrate. 
 
 A possible explanation for the unsatisfactory result of cross-flow filtration is that 
also under these conditions membrane fouling by protein can still occur, depending on 
the nature of the filtered material. An example of this is reported in the literature by 
Bailey and Meagher 5. In their studies concerning the use of cross-flow filtration for 
clarification of E. coli lysates, fouling occurred with some of the membrane materials, 
leading to poor flux and transmission, despite the use of shear flow and additives 4;5. 
 In the case of EcPDF we can also speculate that the fouling and clogging of the 
membranes may be caused by a more specific protein-protein interaction. Bingel-
Erlenmeyer and coworkers provided biochemical evidence that EcPDF interacts directly 
with the ribosomes via its C-terminal α-helix 9. One E. coli cell contains about 15,000 
ribosomes, representing 25% of the total mass of the bacterial cell. The molecular 
weight of ribosomes is about 3,000 kDa. Formation of aggregates of EcPDF and 
ribosomes or with other proteins could therefore partially prevent its purification via 
ultrafiltration even when using high molecular weight membranes. Since the preparation 
of CFE included a centrifugation step (33,300 x g, 60 min), we assume that the lack of 
passage through ultrafiltration membranes is not the result of the presence of the active 
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Purification of PDF via ion-exchange chromatography  
 Ion-exchange chromatography (IEC) represents a cheap and easily scalable 
protein purification method. For industrial application the use of a single step purification 
is preferred, therefore EcPDFwt was purified via an optimized gradient elution IEC as 
described in Materials and Methods. The results of a typical purification experiment 
starting from 1 mL of the clear cell free extract are given in Table 3. 
 



















CFE 1.6 7.8 208 100 1 0.2 1040 
IEC column 0.3 1.6 180 19 0.9 0.08 2250 
 a Activity measured with For-Met-Ala-OH as substrate. 
 
The specific activity of the purified PDFwt as well as the recovery obtained using this 
procedure were unsatisfactory since the yield was only 19%. Moreover, the level of 
contamination due to the presence of amidases in the sample was only reduced by a 
factor of 2, even when the fractions containing the highest levels of PDF activity were 
pooled and tested.  
 These disappointing results of IEC chromatography did not point to clear 
possibilities for improvement. Therefore, the use of protein engineering to improve the 
purification procedure was attempted. Recombinant DNA technology allows the fusion 
of purification tags to the target protein to alter its properties and facilitate the separation 
by IEC. For example, it has been reported  that a polyarginine tag consisting of six 
arginines fused to the C-terminal end of human urogastrone can act as an ion-exchange 
tag 21;29. Other positively and negatively charged tags composed of multiple arginine, 
glutamate or aspartate residues have also been constructed 13;19;36-38. In view of these 
results, we inserted an octaglutamate tag (Etag) in a flexible loop that is present 
between β-strands C and D (residues 61-66) of PDF enzyme as described in Materials 
and Methods. It has been reported that this CD loop has to be flexible but has no role in 
activity and/or substrate binding. Moreover, it is not conserved and its composition and 
length varies in different PDF types 16;39.The point of insertion is after codon TCG 192 
which encodes Glu-64 in the wild-type sequence. The construct was verified by 
sequencing and expressed in E. coli TOP10 yielding the desired EcPDFEtag.  
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 The overexpression of this new PDF variant was similar to what was achieved 
with EcPDFwt (20% of the total protein) and the activity of the EcPDFEtag was only 
slightly affected by the presence of the charged moiety. After purification using Met-Lys-
Sepharose affinity chromatography, the specific activity of EcPDFwt towards the 
substrate For-Met-Ala-OH was 1,800 U/mg while with PDFEtag an activity of 1300 U/mg 
was found.  
 
Table 4. Purification of EcPDFEtag from CFE of E. coli TOP10 containing pBAD-PDFEtag using IEC with a 


















CFE 0.8 4.5 180 100 1 0.16 1,120 
IEC column 0.6 0.6 970 73 5 6*10-4 1.6*106 
a Activity measured with For-Met-Ala-OH as substrate. 
 
 The results of an IEC purification experiment starting from 1 mL of CFE 
containing EcPDFEtag are reported in Table 4. More than 70% of the PDF activity was 
found back after IEC and the amount of amidases in the purified sample was reduced 
by a factor of 1,500. 
 The results show that IEC in combination with the use of an engineered PDF 
carrying a charged octaglutamate tag is a suitable method for the removal of amidases 
and peptidases from EcPDF to be used in peptide deformylation. 
 
PDF catalyzed deprotection of N-formyl-dipeptides  
 In order to prepare sufficient EcPDFEtag for testing the application of the Etag 
modified PDF variant in peptide synthesis, the PDFEtag protein was purified from CFE 
using a HiLoad 26/10 column. This procedure allowed the isolation, in a single step, of 
150 mg of pure EcPDFEtag from only 44 mL cell-free extract (protein content 30 mg/mL). 
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Table 5. Purification of EcPDFEtag from CFE of E. coli TOP10 containing pBAD-PDFEtag using a HiLoad 


















CFE 21 1400 156 100 1 0.19 821 
HiLoad 26/10 
column 14 150 884 64 5.5 8*10
-4 1.1*106 















The purified EcPDFEtag was then used in a reaction containing 1.2 mM N-formyl-
Leu-Phe-NH2. The mixture was incubated under standard reaction conditions (pH 7.2, 
30°C, 8 µg/mL EcPDFEtag). After 4 h, full deformylation of the substrate was obtained 
without any detectable peptide bond hydrolysis. When the deformylation reaction was 
carried out with CFE, extensive peptide bond hydrolysis occurred, most likely due to 
leucine aminopeptidase activity produced by the E. coli host. 
 
Cosolvent stability ofEcPDFwt and EcPDFEtag 
A major problem associated with the application of enzymes for the deprotection 
of N-formyl peptides is the insolubility of protected peptides in water. Polar organic 
solvents, such as dimethyl sulfoxide (DMSO), dimethylformamide (DMF), methanol 
(MeOH), N-methylpyrrolidone (NMP), tetrahydrofuran (THF) and 2-methyl-2-propanol 
Figure 4. SDS-PAGE of purified EcPDFs variants using 
IEC and affinity chromatography. 
Lane 1, reference proteins 
Lane 2, EcPDFwt purified via affinity chromatography; 
Lane 3, EcPDFshort purified via affinity chromatography; 
Lane 4, EcPDFEtag purified via affinity chromatography; 
Lane 5, EcPDFEtag purified via IEC; 
Lane 8, CFE , EcPDFEtag; 
Lane 9, reference proteins. 
  1     2       3      4      5       8      9 
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are often utilized as cosolvents to increase peptides solubility 27. Therefore, the stability 
of PDFwt, PDFshort and PDFEtag purified via affinity chromatography was tested by 
determining activities in the presence of different concentrations of cosolvents. 
Complete inactivation of these PDFs was observed when the enzymes were incubated 
and their activity tested with 10% (vol/vol) NMP and THF. The effect of DMF and DMSO 
was not as detrimental, but remaining activities were very low for all three enzymes, 
































































Figure 5. Effect of organic solvents on PDF activity. 
Panels: A, dimethylformamide; B, DMSO; C, 




When the same test was carried out by incubating the PDFs in different 
concentrations of methanol, the loss of activity was lower. Despite this better stability in 
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methanol, the residual activity was still low; only 20% of the initial activity was left in 
presence of 20% (vol/vol) methanol (Fig. 5). 
The data obtained show that there is only little difference in enzyme stability 
between the EcPDFwt and the two engineered variants. Apparently, neither the insertion 
of the negatively charged polyglutamate tag in the flexible loop nor the removal of the C-
terminal α-helix had a major effect on enzyme stability in presence of cosolvents. 
 
Effect of temperature on enzyme stability 
 The thermal stability of the EcPDF and its variants was determined by measuring 
the remaining activity after preincubation of the purified enzymes for 60 min at 
temperatures between 4 and 60 °C. The wild-type PDF appeared to be more stable 
than the mutants at temperatures up to 50 °C. Nevertheless, also PDFwt suffered from 
considerable thermal deactivation, e.g. 60% of the initial activity was left after 
preincubation at 40 °C. Furthermore, at temperatures up to 20 °C there is no difference 
in activity between the three enzymes (Fig. 6A). 
The temperature optimum was measured with For-Met-Ala as the substrate 
under standard reaction conditions. The maximum activity of the three enzymes 
appeared to be at 30°C. Despite a major activity loss at higher temperatures, a 
stabilizing effect due to the presence of substrate was visible for temperatures close to 











































Figure 6. Effect of temperature on PDF. A) Effect of temperature on enzyme stability; B) Temperature 
optimum with For-Met-Ala-OH as substrate.  Symols: ♦, EcPDFwt; ■,  EcPDFEtag; ▲,  EcPDFshort. 
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 The storage stability of the purified enzymes was also monitored, both at -20 °C 
and 4 °C (Fig. 7). When stored up to 60 days, all PDFs showed a good stability at both 
storage temperatures. Only after 120 days at 4 °C, a decrease in activity was observed 
for the EcPDFEtag and EcPDFshort, while the wild-type enzyme maintained its original 





































Figure 7. Storage stability at 
-20°C (panel A) and 4°C 
(panel B). Symbols:  
♦,  PDFwt; 




Synthesis of the tripeptide N-formyl-Tyr-Leu-Phe-NH2 using E-tagged peptide 
deformylase and thermolysin 
 In order to demonstrate the applicability of the purified EcPDFEtag in chemo-
enzymatic peptide synthesis, we synthesized the tripeptide N-formyl-Tyr-Leu-Phe-NH2 
using two thermolysin-catalyzed coupling steps and one PDF-catalyzed deformylation 
step according to the scheme given in Fig. 8. The formyl group can be conveniently 
introduced on single amino acids and peptides using formic acid and acetic acid 
anhydride. First, a dipeptide was made by coupling the formyl-protected amino acid N-
formyl-Leu with H-Phe-NH2 using thermolysin (Fig. 8, step a). The formylated dipeptide 
precipitated from the reaction mixture and was isolated. Subsequently, it was 
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deprotected with EcPDFEtag (Fig. 8, step b). This resulted in complete removal of the 
formyl group, without any detectable peptide bond hydrolysis. In addition, since PDF is 
highly L-enantioselective, only the correct enantiomer would undergo deformylation, 
allowing a high optical purity of the obtained product. After isolation of H-Leu-Phe-NH2 
with ethyl acetate/H2O at pH 9.5, the purity of the product was >98% with a final yield of 
80%. The deprotected Leu-Phe-NH2 dipeptide was subsequently coupled to N-






Figure 8. Reaction scheme of the synthesis of N-formyl-Tyr-Leu-Phe-NH2 starting from amino acids and 




 A PDF variant carrying a polyglutamate tag of 9 residues inserted into a flexible 
surface loop of the enzyme was successfully overexpressed in E. coli TOP10. The 
activity and stability of the enzyme were checked and it was found that the properties of 
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the engineered variant are comparable to those of the wild-type form, with the exception 
of a reduced thermostability at temperatures above 20 °C. Similar negatively charged 
tags composed of glutamate or aspartate groups have been fused to green fluorescent 
protein, maltose binding protein and firefly luciferase to allow rapid ion-exchange 
purification 21. More general purification tags providing different interaction possibilities 
have also been proposed 7. Earlier it was described that polyarginine tags can increase 
the isolelectric point of human β-urogastrone and facilitate isolation 30.  
 EcPDFEtag was subsequently purified from the overproducing strain by using ion 
exchange chromatography with a 64% recovery and a purification factor of 5. This 
method has the advantage of being industrially applicable, cheap and easily scalable. 
Compared to the wild-type enzyme lacking this tag on the internal flexible loop, the E-
tagged protein was more easily purified. After a single chromatographic step, protein of 
about 80% purity was obtained, lacking most of the amidase activity that was detected 
in cell-free extract and that is detrimental for peptide synthesis applications. The stability 
and activity of the E-tagged enzyme were not significantly different from those of wild-
type enzyme. 
 The enzyme appeared to be suitable for the application in peptide synthesis 
since it allows a mild and selective deprotection of N-formyl peptides without significant 
peptide bond hydrolysis. An additional advantage of the PDF-catalyzed deprotection is 
that N-terminal R-isomers are not deformylated, leading to an increased diastereomeric 




1. Rao, MB, A,M, Tanksale, M.S. Ghatge, V.V. Deshpande. 1998. Molecular and 
biotechnological aspects of microbial proteases. Microbiol. Mol. Biol. Rev. 62: 597-635. 
2. Adams, J. M. 1968. On the release of the formyl group from nascent protein. J. Mol. Biol. 
33:571-574. 
3. Asenjo, J. and B. Andrews. 2008. Protein purification using chromatography: selection of 
type, modelling and optimization of operating conditions. J. Mol. Recognit. 22:65-76. 
4. Bailey, S. M. and M. M. Meagher. 1997. The effect of denaturants on the crossflow 
membrane filtration of Escherichia coli lysates containing inclusion bodies. J. Membr. 
Science 131:29-38. 
5. Bailey, S. and M. Meagher. 1997. Crossflow microfiltration of recombinant Escherichia coli  
lysates after high pressure homogenization. Biotech. Bioeng. 56:304-310. 
Chapter 2              Purification of recombinant E. coli peptide deformylase  
 
    73
6. Becker, A., I. Schlichting, W. Kabsch, S. Schultz, and A. F. Wagner. 1998. Structure of 
peptide deformylase and identification of the substrate binding site. J. Biol. Chem. 
273:11413-11416. 
7. Becker, K., J. Van Alstine, and L. Bnlow. 2008. Multipurpose peptide tags for protein 
isolation. J. Chromatogr. A 1202:40-46. 
8. Ben Bassat, A., K. Bauer, S. Y. Chang, K. Myambo, A. Boosman, and S. Chang. 1987. 
Processing of the initiation methionine from proteins: properties of the Escherichia coli 
methionine aminopeptidase and its gene structure. J. Bacteriol. 169:751-757. 
9. Bingel-Erlenmeyer, R., R. Kohler, G. Kramer, A. Sandikci, S. Antolic, T. Maier, C. 
Schaffitzel, B. Wiedmann, B. Bukau, and N. Ban. 2008. A peptide deformylase-ribosome 
complex reveals mechanism of nascent chain processing. Nature 452:108-111. 
10. Boesten, W.B., P. Raemakers-Franken, T. Sonke, G. Euverink and P. Grijpstra. 2003. 
Polypeptides having alpha-H-alpha amino acide amide racemase activity and nucleic acids 
encoding the same. US Patent 7491520. 
11. Bordusa, F. 2002. Proteases in organic synthesis. Chem. Rev. 102:4817-4868. 
12. Chi, E. Y., S. Krishnan, T. W. Randolph, and J. F. Carpenter. 2003. Physical stability of 
proteins in aqueous solution: mechanism and driving forces in nonnative protein 
aggregation. Pharm. Res. 20:1325-1336. 
13. Dalboge, H., H. H. Dahl, J. Pedersen, J. W. Hansen, and T. Christensen. 1987. A novel 
enzymatic method for production of authentic hGH from an Escherichia coli produced hGH-
Precursor. Nat. Biotech. 5:161-164. 
14. Donnan, S. 1996. Protein Purification Protocols: Second Ed: Human Press Inc..  
15. Escobar-Alvarez, S., Y. Goldgur, G. Yang, O. Ouerfelli, Y. Li, and D. A. Scheinberg. 
2010. Structure and activity of human mitochondrial peptide deformylase, a novel cancer 
target.  Mol. Cell. Biol. 30:5099-5109. 
16. Fieulaine, S., C. Juillan-Binard, A. Serero, F. Dardel, C. Giglione, T. Meinnel, and J. L. 
Ferrer. 2005. The crystal structure of mitochondrial (Type 1A) peptide deformylase provides 
clear guidelines for the design of inhibitors specific for the bacterial forms. J. Biol. Chem. 
280:42315-42324. 
17. Ghosh, R. and Z. F. Cui. 2000. Protein purification by ultrafiltration with pre-treated 
membrane. J. Membr. Science 167:47-53. 
18. Ghosh, R., S. S. Silva, and Z. Cui. 2000. Lysozyme separation by hollow-fibre 
ultrafiltration. Biochem. Eng. J. 6:19-24. 
19. Graslund, T., G. Lundin, M. Uhlen, P. A. Nygren, and S. Hober. 2000. Charge 
engineering of a protein domain to allow efficient ion-exchange recovery. Prot. Eng., Design 
Selection 13:703-709. 
20. Groche, D., A. Becker, I. Schlichting, W. Kabsch, S. Schultz, and A. F. V. Wagner. 
1998. Isolation and crystallization of functionally competent Escherichia coli peptide 
deformylase forms containing either iron or nickel in the active site. Biochem. Biophys. Res. 
Comm. 246:342-346. 
21. Hedhammar, M., T. Graslund, M. Uhlen, and S. Hober. 2004. Negatively charged 
purification tags for selective anion-exchange recovery. Prot. Eng., Design Selection 17:779-
786. 
22. Leeds, J. A. and C. R. Dean. 2006. Peptide deformylase as an antibacterial target: a critical 
assessment. Curr. Opin. Pharmac. 6:445-452. 
Chapter 2              Purification of recombinant E. coli peptide deformylase  
 
    74
23. Mannervik, B., A. Runarsdottir, and S. Kurtovic. 2009. Multi-substrate coactivity space 
and quasi-species in enzyme evolution: Ohno's dilemma, promiscuity and functional 
orthogonality. Biochem. Society Trans. 037:740-744. 
24. Mead, D. A., E. Szczesna-Skorupa, and B. Kemper. 1986. Single-stranded DNA 'blue' T7 
promoter plasmids: a versatile tandem promoter system for cloning and protein engineering. 
Prot. Eng., Design Selection 1:67-74. 
25. Meinnel, T., C. Lazennec, F. Dardel, J. M. Schmitter, and S. Blanquet. 1996. The C-
terminal domain of peptide deformylase is disordered and dispensable for activity. FEBS 
Letters 385:91-95. 
26. Muramatsu, I., M. Murakami, T. Yoneda, and A. Hagitani. 1964. The formylation of amino 
acids with acetic formic anhydride. Bull. Chem. Soc. Jpn. 38:244-246. 
27. Narita, M., S. Honda, H. Umeyama, and S. Obana. 1988. The solubility of peptide 
intermediates in organic solvents. Solubilizing potential of hexafluoro-2-propanol. Bull. 
Chem. Soc. Jpn. 61:281-284. 
28. Rajagopalan, P. T. R., A. Datta, and D. Pei. 1997. Purification, characterization, and 
inhibition of peptide deformylase from Escherichia coli. Biochemistry 36:13910-13918. 
29. Sassenfeld, H. M. and S. J. Brewer. 1984. A polypeptide fusion designed for the 
purification of recombinant proteins. Nat. Biotech. 2:76-81. 
30. Smith, J. C., R. B. Derbyshire, E. Cook, L. Dunthorne, J. Viney, S. J. Brewer, H. M. 
Sassenfeld, and L. D. Bell. 1984. Chemical synthesis and cloning of a poly(arginine)-
coding gene fragment designed to aid polypeptide purification. Gene 32:321-327. 
31. Sonke T. 2008. Novel developments in the chemo-enzymatic synthesis of enantiopure α-
hydrogen-and α,α-disubstituted α-amino acids and derivatives.  PhD thesis, University of 
Amsterdam. 
32. Sonke, T., B. Kaptein, A. F. V. Wagner, P. J. L. M. Quaedflieg, S. Schultz, S. Ernste, A. 
Schepers, J. H. M. Mommers, and Q. B. Broxterman. 2004. Peptide deformylase as 
biocatalyst for the synthesis of enantiomerically pure amino acid derivatives. J. Mol. Catal. 
B: Enzymatic 29:265-277. 
33. Stamatakis, K., and C. Tien. 1992. A simple model of cross-flow filtration based on particle 
adhesion. AIChE Journal 39:1292-1302. 
34. Stoscheck, C. 1990. Quantitation of protein. Methods Enzymol. 182:50-69. 
35. Toyonaka T., F. Kawasaki, and Y and Yokohama Y. 1978. Method of removing formyl 
groups from N-formyl-amino acid and N-formyl-peptide esters having free carboxyl groups. 
US Patent 4071511. 
36. Uhln, M., B. r. Nilsson, B. Guss, M. Lindberg, S. Gatenbeck, and L. Philipson. 1983. 
Gene fusion vectors based on the gene for staphylococcal protein A. Gene 23:369-378. 
37. Zhang, C., R. Love, J. Jilka, and C. Glatz. 2000. Genetic engineering strategies for 
purification of recombinant proteins from canola by anion exchange chromatography: an 
example of  β-glucuronidase. Biotechnology Progress 17: 161. 
38. Zhao, J., C. Ford, C. Glatz, M. Rougvie, and S. Gendel. 1990. Polyelectrolyte precipitation 
of beta-galactosidase fusions containing poly-aspartic acid tails. J. Biotech. 14:273-284. 
39. Zhou, Z., X. Song, Y. Li, and W. Gong. 2004. Unique structural characteristics of peptide 
deformylase from pathogenic bacterium Leptospira interrogans. J. Mol. Biol. 339:207-215. 
 
 
      
 















Peptide deformylases are widely studied for their potential as chemotherapeutic 
targets, but their use in biocatalytic applications has been hardly explored. To find 
peptide deformylases that show suitable characteristics for industrially relevant biotrans-
formations, peptide deformylase sequences were retrieved from the genomes of a 
variety of organisms. Using multiple sequence alignments it was found that these 
enzymes can be classified in 8 phylogenetic groups. To enable determination of the 
substrate profile, temperature optimum, thermostability, and tolerance to organic 
solvents, eight bacterial peptide deformylase genes from different phylogenetic groups 
were cloned and expressed in Escherichia coli. The results showed good 
overexpression of peptide deformylases in active form and revealed that the enzymes 
had very similar substrate specificities. Temperature optima, on the other hand, varied 
from 25 to 50°C. 
 
Introduction 
In eubacteria, mitochondria and chloroplasts protein synthesis is a complex 
process that requires the removal of an N-formyl group that is present at the N-terminus 
of the nascent polypeptide chain by a peptide deformylase (PDF) 24;26. This step is 
crucial for the subsequent removal of methionine by methionine aminopeptidase and 
the maturation of the polypeptide 14. For many years, the N-terminal deformylation of 
peptides after translation was considered a unique feature of bacterial cells, but more 
recently, DNA  sequences similar to the genes encoding peptide deformylase (def) in 
bacteria were found in unicellular eukaryotes, plants and mammals 14;23. The eukaryotic 
PDFs were proven to be active in vivo and in vitro but their biological role is still not 
completely clarified 5;11;28.  
The central role of PDF in bacterial protein synthesis triggered efforts to discover 
antibiotics that can selectively target this enzyme 20. This is now complicated by the 
discovery of active human forms of PDF (HsPDF). A key step in the design of inhibitors, 
which should not be toxic to mammalian cells, is the elucidation of structures of bacterial 
and human PDFs 11. Crystal structures of several peptide deformylases are now 
available and inhibitors can be designed on the basis of structural differences, for 
example, by targeting the active-site entrance 11 
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Despite the vast amount of research on PDFs driven by the desire to develop 
effective antibacterial chemotherapeutic agents, data on the use of PDF for other 
applications are extremely limited. The first application in biocatalysis was explored by 
Sonke and coworkers who described the enzyme-catalyzed stereoselective hydrolysis 
of racemic N-formylated molecules, the use of PDF in the stereoselective formylation of 
racemic amino acid derivatives, and the selective deprotection of N-formyl protected 
peptides 36. The enzyme showed a high L-stereoselectivity for N-formyl amino acid 
derivatives, but the activities strongly depended on the substrate. Very low activity was 
found in case of bulky substrates, such as N-formyl-tert-leucine amide, as well as with 
α,α-disubstituted amino acid amides, i.e. N-formyl-(α-methyl)phenylglycine amide 36. 
Moreover, in the case of deprotection of N-formyl peptides, major limitations were the 
low activity of E. coli PDF (EcPDF) towards formylated dipeptides with most amino 
acids in the first position 32 and the lack of an industrially applicable purification method.  
From an industrial point of view, the application of Fe2+-containing peptide defor-
mylases in biocatalytic transformations is also limited by their intrinsic instability, which 
is mainly caused by the oxidation of the Fe2+ to Fe3+. This can be efficiently prevented 
by the use of reducing agents (e.g. tris(2-carboxyethyl)phosphine (TCEP)) and 
hydrogen peroxide scavengers (catalase), or by substituting the Fe2+  metal cofactor 
with an ion (e.g. Ni2+) that is less prone to oxidation 3;33. Although the instability of the 
PDF can in principle be solved this way, the use of a scavenger and/or the replacement 
of the metal cofactor add to the cost of enzyme production and the complexity of the 
biocatalytic process. Therefore, the availability of PDF variants that are highly active 
and stable under aerobic conditions would be of great advantage to reduce costs and 
facilitate their industrial use. In any case, properties such as stability, kinetic 
parameters, and enantioselectivity have to be evaluated for such variants in order to 
decide if a new biological catalyst can be competitive with a chemocatalytic route or the 
use of an existing enzyme variant. 
The question then is: how to find enzymes with ideal characteristics for a given 
biocatalytic process? The search for a new enzyme with specific properties is usually 
done either by the use of protein engineering to improve a known enzyme, or through 
the search for a better enzyme from the natural biodiversity. The choice for one or the 
other method is based on the specific characteristics that the biocatalyst should 
possess and the availability of a suitable starting enzyme. In fact, although natural 
diversity can provide a vast number of novel genes and activities relevant for industrial 
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applications 12, evolutionary selection in Nature never occurred to provide an optimal 
biocatalysts for an industrial application, making it unlikely that a natural enzyme is in 
any way optimal for a practical process. Therefore, the two aforementioned methods for 
obtaining improved enzyme variants are complementary, rather than alternatives. A new 
enzyme isolated from Nature will often need to be improved in the laboratory before it 
can be applied industrially. 
Natural diversity can be searched in different ways: via the exploration of known 
cultures; through the use of enrichment cultures; by construction and screening of 
metagenomic libraries; or by database mining of genome sequences. The first three 
methods are time consuming and and costly. Furthermore, it is sometimes difficult to 
find a link between the enzymatic conversion of interest and bacterial growth. Since 
genome mining is a quick way to obtain a variety of cloned enzymes variants, we 
started with the selection and partial biochemical characterization of a smaller set of 
peptide deformylases encoded by genes from organisms available in culture collections. 
The respective PDF sequences can be recovered from genome sequence databases by 
homology searches. This approach is rapidly gaining potential in view of the vast 
amount of sequence data becoming available through next generation sequencing 
technologies. Accordingly, this Chapter describes the screening of genomic databases 
for peptide deformylase encoding genes and their phylogenetic analysis. Eight bacterial 
peptide deformylases were selected and their genes were cloned and expressed in E. 
coli, followed by assessing their properties with the aim to find a PDF with better activity, 
enantioselectivity and stability as compared to PDF from E. coli (EcPDF). 
Another important issue addressed in this Chapter is the stability of PDF in the 
presence of cosolvents. In fact, the poor substrate solubility in water and the low activity 
of EcPDF in non-aqueous solvents are limiting its use in industrial processes. Since 
thermostability and solvent stability may be correlated, we selected the peptide 
deformylases from the termophile Bacillus stearothermophilus (BsPDF) for exploring its 
biocatalytic potential. 
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Materials and methods 
Phylogenetic analysis of peptide deformylase genes 
To obtain putative PDF sequences we performed BLAST searches using the E. 
coli PDF sequence as a query and the databases from the NCBI website 
(http://www.ncbi.nlm.nih.gov) and the Pedant database (http://pedant.gsf.de/). 
A selection of 260 sequences resulting from BLAST hits (cutoff 20% identity) 
were aligned using ClustalW and the resulting phylogenetic tree was displayed using 
TreeView and edited. 
 
PDF cloning and cultivation conditions 
For all plasmid constructs described in this study, E. coli TOP10 was used as the 
host organism. It was routinely grown on LB medium supplemented with 100 mg/L of 
carbenicillin (Carb) at 20, 28 or 37°C. When protein expression was required from the 
araBAD promoter, L-arabinose was added at a concentration of 0.002, 0.02 or 0.2 wt % 
when the OD620 of the culture reached 0.5-0.8. 
The peptide deformylase genes from H. influenzae (U32745), P. aeruginosa 
(AE004441), H. pylori (AE000591), E. coli (AE00407), B. subtilis, Synechocystis sp. 
(D90906), C. jejuni (AL139074) and B. stearothermophilus (O31410) were amplified by 
PCR using specific primers and inserted in pDONR221 as per Gateway Cloning 
Technology protocols (Invitrogen, Breda, the Netherlands). The peptide deformylase 
genes were subsequently recombined to expression vector pBAD/Myc-His-DEST in a 
standard LR recombination reaction (Invitrogen) with a molar ratio destination to entry 
vector of 1:2.4 (150:300 ng). After transformation of E. coli TOP 10, recombinants were 
selected by plating on LB-plus-Carb (100 mg/L) medium, followed by overnight 
incubation at 28°C. Finally a correct clone for each gene, as established by plasmid 
DNA isolation and restriction analysis, was selected for further use. The expressed 
proteins do not contain a His-tag. 
 
Protein determination and electrophoresis 
Protein concentrations were determined by the Bradford method 6 with bovine 
serum albumin (Pierce, Rockford, Il) as the standard. 
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Protein electrophoresis was performed using sodium dodecyl sulfate-polyacryl-
amide (4 to 12%) Bis-Tris gels (NuPAGE, Invitrogen) under reducing conditions with 
MOPS-SDS running buffer (Invitrogen). 
 
Determination of peptide deformylase activities 
Deformylase activities of PDF prepations were routinely measured at 30°C in a 
total volume of 500 µL with N-formyl-Met-Ala-OH as the substrate. Amounts of 50 µL of 
different dilutions of PDF in a buffer containing 20 mM MOPS/NaOH (pH 7.7), 100 mM 
NaCl, 10 µg/mL bovine liver catalase, and 2 mM TCEP, were mixed with 450 µL of 
substrate solution containing 5.5 mM N-formyl-Met-Ala-OH in 110 mM MOPS/NaOH 
buffer (pH 7.2), 300 mM NaCl, and 0.1 mg/mL bovine liver catalase. The amount of PDF 
added was chosen such that in 15 min about 10% of the substrate was converted. After 
starting the reaction by addition of the PDF, samples of 100 µL were withdrawn from the 
reaction mixture with 5 min intervals and mixed with 100 µL of 1 M phosphate buffer 
(H3PO4-NaOH, pH 2.66) to stop the reaction. Substrate and product concentrations 
were measured using the HPLC as described below. To obtain an enzymatic blank, 500 
µL of the same phosphate stopping buffer and 50 µL of diluted PDF were mixed prior to 
the addition of 450 µL of the substrate solution. 
For determination of the substrate specificity of PDFs, incubations were done 
similarly. Samples of 50 µL of different dilutions of PDF (see above) were mixed with 
450 µL of a 13 mM substrate solution in 110 mM MOPS/NaOH buffer (pH 7.2) 
containing 300 mM NaCl and 0.1 mg/mL of bovine liver catalase. After starting the 
reaction by adding PDF, 100 µL aliquots were withdrawn from the reaction mixture with 
5 min time intervals, added to 400 µL of 50% ethanol in water, and analyzed by HPLC. 
 
HPLC analyses  
 HPLC was carried out using a stainless-steel analytical column (250 mm length, 
4.6 mm ID) packed with Inertsil ODS-3 material, 5 µm particle size, from Alltech Applied 
Science (Breda, The Netherlands). The flow rate was 1 mL/min. Detection was 
performed at 40°C at a wavelength of 210 nm. The injection volume was 5 µL.  
 For PDF deformylation activity measurements, For-Met-Ala-OH and H-Met-Ala-
OH were separated using the following gradient of acetonitrile in 10 mM H3PO4: t=0-4 
min, 0.1 % (v/v) acetonitrile isocratic; t=4-15 min, 0.1%-50% acetonitrile linear increase; 
t=15-15.1 min, 50%-0.1% linear decrease; t=15.1-20 min, 0.1% acetonitrile isocratic.   
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Quantification of formic acid was performed using pre-column derivatization of 
carbonic acids with 4-nitrophenylhydrazine (NPH) and 1-ethyl-3-[3-dimethylamino-
propyl]carbodiimide (EDC) followed by HPLC. Separation was achieved on a reverse 
phase column with a gradient of acetonitrile and derivates were monitored at 400 nm 30.  
For peptidase activity measurements, the production of Phe was analyzed using 
the following gradient of acetonitrile in 10 mM H3PO4: t=0-15 min, 0-30% acetonitrile 
linear gradient; t=15-15.1, 30-0% acetonitrile decrease; t=15.1-20, 0 % acetonitrile 
isocratic. 
 
Temperature stability and optimum of PDF 
The temperature stability of the enzymes was analyzed by preincubation of 0.05 
mg/mL of cell-free extract containing an overexpressed PDF enzyme for 1 h at 
temperatures between 0 and 60°C. Subsequently, 50 µL samples of the pretreated 
enzyme solutions were used to determine the remaining activity according to the 
standard PDF assay at 30°C. 
For the determination of the temperature optimum, the standard protocol for 
activity assays was applied at a temperature range from 20 to 60°C. 
 
Influence of organic cosolvents on enzyme activity 
The effect on enzyme stability of several water-miscible organic solvents 
[methanol, tetrahydrofuran (THF), dimethylformamide (DMF), tert-butanol, dimethyl 
sulfoxide (DMSO) and N-methyl-2-pyrrolidone (NMP)] (v/v) concentration was 
measured as follows. At 30°C, 50 μl samples of EcPDF and other PDF variants, pre-
diluted in a solution containing 20 mM MOPS/NaOH (pH 7.7), 100 mM NaCl, 10 µg/mL 
bovine liver catalase, and 2 mM TCEP, was mixed with 450 µL of substrate solution 
composed of 110 mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 0.1 mg/mL bovine 
liver catalase, 5.5 mM of the substrate N-formyl-Met-Ala-OH and a final concentration of 
cosolvent of 10, 20 or 40%. Samples were periodically withdrawn from the incubation 
mixture to measure the amount of deformylated peptide formed. The residual specific 
activity is reported as a percentage of the specific activity of the enzyme that was found 
when no cosolvent was added to the reaction mixture.  
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Results and discussion 
Phylogenetic analysis 
The widespread distribution of phylogenetically related peptide deformylases in 
prokaryotic and eukaryotic organisms is evident from the detection of E. coli peptide 
deformylase (EcPDF) homologs in essentially all sequenced genomes. To identify 
bacterial peptide deformylases of varying origin that may possess enhanced stability 
and different substrate selectivity as compared to the EcPDF, we screened various 
databases for the presence of peptide deformylase-encoding sequences. In total, 260 
annotated peptide deformylase sequences from different organisms were retrieved, 
using the sequence of EcPDF as a query. These sequences were subsequently aligned 
and a phylogenetic tree was generated using the program TreeView. This analysis 
clustered the sequences into 9 groups (Fig. 1).  
The relatively long nodes as compared to the branches of the phylogenetic tree 
indicate low overall identity, even within a group. This is in agreement with the notion 
that only a few residues are crucial for proper deformylase activity allowing significant 
sequence variation. Despite the low sequence identity, the presence and topology of the 
amino acids involved in catalysis are well conserved, suggesting that the variants 
possess identical catalytic mechanisms and similar selectivities. This is also in 
agreement with the fact that the amino acid sequences of the peptide deformylases 
from E. coli PDF and S. aureus PDF are only 23% identical, but an examination of their 
structures in the vicinity of the metal ion in the active site revealed no significant 
differences 2.  
PDFs are often divided in two different groups: type I and type II enzymes 13;16;18. 
Type I enzymes would generally occur in Gram-negative bacteria whereas group II 
enzymes would occur in Gram-positive bacteria (red line in Fig. 1, 13 However, there is 
no strict correlation between the type of PDF that is present in a certain organism and 
its classification (i.e by Gram reactivity) and some bacteria have both a type I and a 
type II enzyme. An analysis of genome databases shows that bacteria can contain one 
(e.g E. coli), two (B. stearotermophilus, E. faecium, E. faecalis), or up to four (S. 
coelicolor) PDF gene sequences (Fig. 1). In general, gram-negative organisms have a 
single PDF gene, while gram-positive bacteria, including S. aureus, typically carry two, 
although one of them often encodes an inactive protein 16. 
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Specific structural features distinguish the type I and type II bacterial PDFs. Type 
II enzymes are characterised by the presence of two sequence insertions in the N-
terminal part of the enzyme and by the presence at the C-terminus of a long loop which 
ends with a small β-strand that folds back in the direction of the second β-sheet of the 
enzyme. In type I enzymes, the N-terminal part is shorter and an α-helix is present at 
the C-terminus 16. Despite the differences in secondary structure between enzymes of 
the two groups, the conformation of the active site and the catalytic properties are very 
similar. 
The enzymes of groups I and II cluster in phylogenetically different subgroups. As 
mentioned, type I PDFs are generally present in Gram-negative bacteria (proteo-
bacteria, cyanobacteria, Chlamydiae, Spirochaetales) and in eukaryotes (see Fig. 1), 
whereas type II enzymes appear in two clusters, one formed by PDFs from Firmicutes 
and the other by PDFs from Actinobacteria. An exception to this classification is for 
example the PDF from M. tuberculosis (MtPDF). MtPDF has features similar to type I 
PDFs, with an extended C-terminal portion but the enzyme also has several insertions 
typical of type II enzymes 31. 
Type I PDFs can be divided in two subclasses: PDFIA and PDFIB. The first 
subclass corresponds to animal- and plant-mitochondrial enzymes, while the PDF1B 
enzymes occur in gram-negative bacteria, some gram-positive bacteria and plants 35. 
PDFs from eukaryotes, including plant mitochondrial and chloroplast PDFs, as well as 
PDFs from protozoa, are classified as type I PDFs since they do not have the two 
typical insertions of type II enzymes and occur in a separate subgroup. While PDFIB is 
similar in its 3D structure and biochemical properties to type II bacterial PDFs, PDFIA 
has as main difference the nature of the metal cofactor. Arabidopsis thaliana PDF 
(AtPDF) uses Zn2+ as cofactor, probably reflecting the need to be active in the highly 
oxidative environment of plant mitochondria 34. Human mitochondrial PDF (HsPDF) is a 
dimer and has a tetrahedrally coordinated Co2+ 11. It possesses about 30% sequence 
identity with bacterial and plants PDFs and the degree of similarity is about 50%, which 
is reflected in a conserved α/β-fold. The overall fold resembles the one of EcPDF (a 
type IB PDF), although it possesses a more accessible entrance to the active site due 
to a different set of residues that in EcPDF occlude the entrance site 11. The in vivo role 
of the type I eukaryotic PDFs is not completely clear although in recent years an 
enzymatic machinery for the formylation and deformylation of proteins was found both 
in mammals and in plants 5;10;34. Animal PDFs are similar to the enzymes found in 
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Actinobacteria, even though mitochondrial genes are believed to originate from 
Rickettsiae 19. Therefore, a possible hypothesis of their origin is horizontal gene 
transfer from an actinobacterium to an ancestor eukaryotic cell 35. 
 
 
Figure 1. Phylogenetic tree of peptide deformylases. Symbols: squares, PDFs from T. thermophilus, B. 
burgdorferi and L. plantarum; triangles, PDFs from H. influenzae, P. aeruginosa, H. pylori, E. coli, B. 
stearothermophilus, Synechocystis sp., B. subtilis, and C. jejuni. 
 
 Eukaryotic PDFs are also characterized by an extension at the N-terminus and a 
longer CD-loop between strands β2 and β3. This loop can extent close to the active site 
and may have a role in changing its conformation, as reported for AtPDF and the 
Plasmodium falciparum enzyme (PfPDF) 9;28. Studies conducted on animal PDFs 
showed a marked difference compared to all other PDFs by the presence of conserved 
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substitutions in the vicinity of the active site. In fact, the first Gly and the second Ala in 
conserved motif 1 (sequence  GIGLAATQV in EcPDF) and Leu in motif 2 (EGCLS in 
EcPDF) are replaced by other residues and this is responsible for the low activity of the 






B     
                     motif 1     motif 2             motif 3 
                    #########    #####            #######  
    GXGXXAXQX    EGCLS   QHEXDHL  
E. coli           GIGLAATQVDIHQRIIV 59 IEEGCLSIP-EQ 96 IQHEMDHLVG 139 
H. influenza     GIGLAAPQVDILQRIIT 60 IEEGCLSIP-GF 97 IQHEIDHLNG 140 
P.  aeruginosa    GIGLAATQVNVHKRIVV 60 YQEGCLSVP-GF 98 IQHECDHLNG 141 
H. pylori          GIGLAAIQVGLPLRMLI 59 YKEGCLSVP-GF 101 IQHEIDHLNG 144 
B. subtilis DEF1   GVGLAAPQIGILKRAAV 60 GIEGCLSFP-NV 96 VQHEMDHLDG 139 
B. subtilis DEF2  GVGLAAPQINIKKRMIA 74 SGEGCLSVDEAI 117 FQHEIDHLNG 160 
B. cereus   GIGLAAPQIGVSKKMIA 75 GGEGCLSVDREV 118 FQHEIDHLNG 161 
B. stearothermoph  GIGLAAPQINVSKRMIA 74 TGEGCLSVDRDV 117 FQHEIDHLNG 160 
Synechocystis   GIGLAAPQVGINKQLLV 73 VEEGCLSVP-NV 113 IQHEMDHLNG 156 
Thermotoga    GVGLAAPQVGISQRFFV 70 AEEGCLSFP-EI 105 FQHEFDHLNG 148 
Plasmodium      GIGLSAPQVNISKRIIV 59 LIEGCLSFP-GI 100 FQHEFDHLNG 143 
Arabidopsis PDF1A  GVGLAAPQIGVPLRIIV 140 FFEGCLSVD-GF 194 LQHECDHLDG 237 
L. brevis    GVGLAAPQVDVSKQMSA 74 EGEGCLSVDREV 119 CQHEIDHLNG 162 
Borrelia     GVGLAAPQVGLDLALFV 64 YKEGCLSIP-GV 101 IQHEMDHLNG 144 
S. pneumoniae    GVGLAAPQLDISKRIIA 86 EGEGCLSVDRNV 137 VQHEIDHING 180 
C. jejeuni    GVGLAAIQVDIPLRVLL 55  CTEGCLSVP-DF 102 IQHENDHLNG 145 
Leptospira   GVGLAAPQIGILKQIVV 62 FWEGCLSVP-GM 107 YQHECDHLQG 150 
M. tuberculosis   GVGLAANQIGCSLRLFV 65 DDEGCLSVP-GE 113 LQHETGHLDG 155 
Trypan. brucei TbPDF1  CISFSAPKGHWDAAIVL 98 MWENCISCGACT 143 LMHELDHLSG 185 
Trypan. brucei TbPDF2  YPSLCAPKIGWNVQMMF 127 AWEPCASCCFLL 86 ALHELDHLNG 229 
Homo sapiens mitoch  CVGLSAPQLGVPRQVLA 124 FPEGCESVA-GF 179 IQHEMDHLQG 221 
Mus musculus mitoch  CVGLSAPQLGVPLQVLA 102 FPEGCESVAGFL 166   IQHEMDHLQG 109 
 
Figure 2:  Comparison of PDF sequences. A, Sequence alignment of N-terminal region of selected PDFs. 
The insertion present in the AB loop of type II PDFs is indicated with a box. B, Conserved sequence motifs in 
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 In the last decade a third class of PDFs was identified in trypanosomes and 
Archaea. These PDFs are placed in a cluster from which originate also PDFs of 
Cyanobacteria, Spirochaetales and some eukaryotes, including protists and amoeboids 
(light green in Fig. 1). Studies on these PDF sequences revealed that they have 
mutations in another highly conserved motif, motif 3 (e.g. lacking the Q that is present 
in E. coli QHEMDHL), suggesting that these PDFs may have different catalytic 
properties (Fig. 2). Moreover, the phylogenetic tree highlights two groups which are 
more distant at the sequence level. The organisms with these PDFs are Gram-positive 
bacteria belonging to the Firmicutes and Gram-negative β-proteobacteria (yellow in 
Fig. 1).  
 
The iron-free PDFs from bacteria growing under strict iron limitation (L. plantarum, 
Borrelia) do not appear in a separate cluster, but are similar to PDFs of phylogenetically 




Overexpression and purification of peptide deformylases 
 Eight peptide deformylases-encoding genes from different phylogenetic groups 
were selected for cloning and overexpression in E. coli (Table 1). The genes were 
amplified from chromosomal DNA and cloned into a pBAD-derived expression vector as 
described under Materials and Methods. Expression levels were tested by activity 
measurement and SDS-polyacrylamide gel electrophoresis (Fig. 4-6). From the 




Sp. Act. purified enzyme 
 (U/mg) 
H. influenzae HiPDF 120 2.1 * 103 
P. aeruginosa PaPDF 155 4.3* 103 
H. pylori HpPDF 60 1.3 * 103 
E. coli EcPDF 370 4 * 103 
B. stearothermophilus BstPDF 20 130 
Synechocystis sp. SyPDF 70 650 
B. subtilis BsPDF 25 270 
C. jejuni CjPDF 20 200 
a Measured with For-Met-Ala-OH as substrate.
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sequence similarity studies, H. influenzae (HiPDF), P. aeruginosa (PaPDF) and H. 
pylori (HpPDF) deformylase genes showed the highest sequence similarity with the 
EcPDF def gene (triangles in Fig. 1) and this was clearly reflected by the best heterolo-
gous expression in E. coli. The BsPDF, SyPDF, PaPDF, HiPDF and HpPDF were 
present at a level of 10-30% of the total soluble protein (Fig. 3) while expression of 




Analysis of the CFE prepared from an expression culture of the BsPDF in E. coli TOP10 
showed that good overexpression occurred, even though the specific activity was rather 
low (Fig. 3-5). 
Figure 4. SDS-PAGE of CFE from induced and non- 
induced cells  
Lane 1, reference protein ladder; 
Lane 2, not induced SyPDF; 
Lane 3, induced SyPDF, 
Lane 4, not induced PaPDF; 
Lane 5, induced PaPDF, 
Lane 6, not induced HpPDF, 
Lane 7, induced HpPDF, 
Lane 8, reference protein ladder, 
Lane 9, not induced HiPDF, 
Lane 10, induced HiPDF. 
1     2    3      4     5     6     7     8    9    10 
Figure 3. SDS-PAGE of CFE from induced and non- 
induced cells. 
Lane 1, reference protein ladder; 
Lane 2, not induced EcPDF; 
Lane 3, induced EcPDF 
Lane 4, not induced CjPDF; 
Lane 5, induced CjPDF, 
Lane 6, not induced BsPDF, 
Lane 7, induced BsPDF, 
Lane 8, not induced BstPDF, 
Lane 9, induced BstPDF. 
1     2     3     4     5     6     7      8     9 
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To isolate and characterize the overexpressed enzymes, affinity column 
chromatography as described by Sonke and coworkers was used 36. The use of this 
chromatographic method is based on the Met-Lys-Sepharose affinity matrix and gives 
pure protein in a single step. Other attractive features of this method are the fact that 
native proteins can be isolated (affinity tags are not necessary) and that it can be 
universally applied. The PDF enzyme binds to the Met-Lys-Sepharose affinity matrix in 
the presence of fluoride ions, which dramatically increase the affinity of the enzyme for 
small peptides, most likely because fluoride mimics formate. Switching to a chloride-
containing buffer decreases the affinity of PDFs for the ligand causing the elution of the 
desired enzyme. In addition, this affinity method allows the purification only of the active 
form of the peptide deformylase.  
 
 
Figure 5. SDS-PAGE of CFE and purified PDFs 
obtained with Met-Lys-Sepharose affinity column 
chromatography. 
Lane 1, reference protein ladder; 
Lane 2, purified. EcPDF; 
Lane 3, EcPDF CFE 
Lane 4, purified CjPDF; 
Lane 5, CjPDF CFE, 
Lane 6, purified BsPDF, 
Lane 7, BsPDF CFE, 
Lane 8, purified BstPDF, 
Lane 9, BstPDF CFE. 
1     2    3     4    5    6    7     8    9 





The affinity purification method was successfully applied to all PDFs that were 
overexpressed, which resulted in an increase of specific activities by a factor 10 to 30 
(see Table 1). Thus, eight different PDFs were isolated in a single purification step, and 
all were catalytically active. 
 
Effect of temperature on enzyme stability 
The thermal stability of the purified PDFs was determined by measuring the 
remaining activity after preincubation of the purified enzyme at a concentration of 3 
µg/mL for 60 min at temperatures between 20 and 80 °C. The activity of all PDFs 
decreased dramatically with the increase of temperature, with a loss of 50% after 
incubation at temperatures ranging between 30 and 50°C. These unexpected results 
might be explained by the fact that PDFs were diluted to concentrations <50 µg/mL to 
mimic process conditions. It is known that peptide deformylase is highly unstable at low 
concentrations 15. This explanation was confirmed by repeating the thermostability test 
for EcPDF at higher concentrations, i.e. 500 µg/mL instead of 3 µg/mL (Fig. 7). The 
undiluted sample of EcPDF appeared to be stable at 30°C whereas a decrease of 50% 
was observed when the diluted enzyme was preincubated at30°C (Figure 7). 
 
1     2     3     4      5     6     7      8     9 Figure 6. SDS-PAGE of CFE and purified PDFs 
obtained with Met-Lys-Sepharose affinity column 
chromatography. 
Lane 1, reference protein ladder; 
Lane 2, SyPDF CFE; 
Lane 3, purified SyPDF  
Lane 4, PaPDF CFE; 
Lane 5, purified PaPDF, 
Lane 6, purified HpPDF, 
Lane 7, HpPDF CFE, 
Lane 8, purified HiPDF, 
Lane 9, HiPDF CFE. 






















Figure 7.  EcPDF 
thermostability; relative 
activity after 60 min pre-
incubation at increasing 
temperatures. Effect of 
PDF concentration. 
Symbols:  
♦ EcPDF (3 µg/mL) 




Temperature optimum  
A higher temperature will increase the reaction rate but may also enhance 
enzyme inactivation. Therefore a proper evaluation of enzyme performance under 
process conditions requires measurement of the temperature optimum and stability. 
Activity measurements were performed with all purified peptide deformylases at 
temperatures between 20 and 70°C. BstPDF and HiPDF showed a higher temperature 
optimum (45 to 50°C) while CjPDF, HpPDF and SyPDF showed highest activities at 




































































Figure 8. Temperature optimum of BstPDF (A), HiPDF (B) and EcPDF (C).. 
 
Effect of pH on enzyme activity 
Enzyme activities were determined between pH 4.0 and 11.5 with a universal 
Britton-Robinson buffer, because the use of different buffers over a large pH range led 
to buffer-dependent effects. The purified enzymes were active towards For-Met-Ala-OH 
in the whole range of tested pH values (Fig. 9). The pH optimum varied among 
enzymes from different species: BstPDF and BsPDF showed maximum activity at pH 9 
while EcPDF and SyPDF performed better at pH around 7.  
Overall, the PDFs showed near maximum activity over a broad pH range, from 
about pH 7 to 10, probably due to the absence of ionisable groups in the oxyanion hole 
4. At pH values of about 5 and 11, however,, the peptide deformylases had only about 

















































































































































Figure 9. Effect of pH on activity of different PDFs. Enzymes: BsPDF (A), CjPDF (B), HiPDF (C), HpPDF 
(D), PaPDF (E), SyPDF (F), EcPDF (G), BstPDF (H). See text for details.  
 
Effect of organic cosolvents on enzyme stability 
As described in Chapter 2, the insolubility of peptide intermediates and protected 
peptides in water is a major problem for peptide synthesis. Polar organic solvents such 
as dimethyl sulfoxide (DMSO), dimethylformamide (DMF), methanol (MeOH), N-
methylpyrrolidone (NMP), tetrahydrofuran (THF) and 2-methyl-2-propanol are often 
used as cosolvents to increase peptide solubility 27. Unfortunately, previous data 
showed that EcPDF was quite unstable in the presence of organic cosolvents (Results 
and Discussion, Chapter 2). We tested BstPDF in the presence of different 
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concentrations of cosolvents since it has been demonstrated that a clear correlation 
exists between thermostable enzymes as derived from thermopiles and resistance to 
denaturation by the presence of cosolvents 29 8. In addition, thermophilic enzymes have 
longer storage stability and possess the ability to perform reactions at elevated 
temperatures. They also may be more stable under process conditions 1.  
Unfortunately, the effect of MeOH and DMSO on BstPDF stability was similar to 
what was observed for EcPDF, with only about 50% activity remaining even when the 








































Figure 10. Effect of cosolvents on the activity of BstPDF. 
 
 
Substrate specificity of peptide deformylases 
The substrate specificity of the purified peptide deformylases was tested towards 
a range of racemic N-formylated amines and amino acid derivatives. All the reactions 
were performed with the standard assay at pH 7.2 and conversions were followed by 
measuring formic acid production as described in Materials and Methods. The 
advantage of this method is that it can be generally applied for every substrate of 
interest. Because of the low solubility of the substrates used, substrate stock solutions 
were prepared in dimethyl sulfoxide (DMSO) before addition to the reaction mixture. 
This cosolvent was chosen despite the stability issues mentioned in the previous 
paragraph, but the final concentration in the assays was kept below 10%. 
The results in Table 2 show that the activity of the PDFs strongly varies for the 
different substrates. First it appears that with all enzymes the most reactive substrate 
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was the dipeptide N-formyl-Met-Ala-OH having a methionine in position P1. 
Furthermore, N-acetyl-phenylalanine nitrile was not hydrolyzed by any of the PDFs 
whereas N-formyl-phenylalanine nitrile was readily converted, confirming the previously 
reported observation that the enzyme is active only on N-formylated derivatives 25;36. 
Inspection of the structure of EcPDF (PDB 1BS6) shows that the additional methyl 
group would overlap with the side chain of Leu-91 and Leu-46 and with the carbonyl 
oxygen of Gly-45 7. Two other substrates for which none of the PDFs tested displayed 
activity are N-formyl-α-methyl-benzyl amine and N-formyl-sec-butyl amine. This is 
probably due to the absence of hydrogen bond donors or acceptors in these molecules 
because a hydrogen bond between the substrate’s formulated nitrogen and the carbonyl 
oxygen of Gly-45, as well as a hydrogen bond to O1 of Gly-89 are important for activity 
and can not be formed (Fig. 11B). 
There are also differences between the activity for N-formyl-phenylalanine, N- 
formyl-phenylalanine-NH2 and for N-formyl-phenylalanine nitrile. Also in this case, the 
lower activity towards N-formyl-phenylalanine could be caused by the inability of 
hydrogen bond formation between the substrate and Gly-89. Becker and coworkers 
proposed that this hydrogen bond, donated by the amide nitrogen of the second amino 
acid of the substrate (P2), is communicated to the metal ligand Cys-90, thereby 
reducing the energy of the transition state and providing a sort of substrate-assisted 
catalysis (Fig. 11B) 4. 
Comparing the hydrolysis of the two N-formyl α-aminonitriles confirmed the 
importance of the side chain of the amino acid which has to fit into the hydrophobic 
methionine-binding pocket. The higher activity observed with N-formyl-phenylalanine 
nitrile is in line with previous observations, reporting a kcat/Km value that is 10-fold higher 
with N-formyl-Phe-Xaa(NH2) compared to N-formyl-Leu-Xaa(NH2) 32. 
These experiments were performed with the aim to explore the substrate 
specificity of PDFs belonging to different phylogenetic classes and harvested from 
various microbial sources. The results showed that the substrate specificities of the 
tested PDFs are very similar, even though they originate from very different organisms 
















































































































Organism          
CiPDF + ++ ++ ++ - + - - ++++ 
EcPDF + ++ +++ +++ - ++ - - ++++ 
HiPDF ++ ++ +++ ndb - + - - ++++ 
HpPDF + ++ +++ nd - ++ - - ++++ 
PaPDF + +++ +++ nd - ++ - - ++++ 
SyPDF + +++ +++ nd - + - - ++++ 
a  Activities were scored as follows: -, ≤ 10 U/g; +, 10-100 U/g; ++, 100-1000 U/g; +++, 1000-6000 U/g; 
++++, ≥ 200 U/mg. 
b nd, not determined. 
 
Considering the importance of N-formyl methionine deformylation during 
ribosomal protein synthesis, it is not surprising that peptide deformylase optimally act on 
peptides having the sequence N-formyl-Met-X 17. Structurally, the high specificity of the 
enzyme is due to the deep burial of the P1’ side chain residue (methionine) in a 
hydrophobic cleft situated close to the active site (Fig. 11A). This interaction contributes 
to the affinity of PDF for its substrate and facilitates the initial nucleophilic attack on the 
formyl group by a water molecule that is bound to the metal ion in the PDF active site. 
Although other amino acid side-chains can enter the hydrophobic pocket, such 
substrates display a relatively low affinity (high Km values) and the hydrolysis rates (kcat 
values) can be very low. This is likely due to non-optimal positioning of the formyl 
moiety as a result of the forced insertion of a P1’ side chain in the hydrophobic pocket17. 




 Knowledge about substrate recognition and selectivity of PDFs is still limited. 
Extensive studies were only reported by Meinnel and coworkers, who showed the effect 
of the first and second amino acid residue in formylated dipeptide substrates on the 
activity of EcPDF 32. Their results indicated that the presence of the hydrophobic pocket 
allows efficient deformylation of methionine only. The effect on the activity with amino 
acid derivatives has, to our knowledge, not been explored earlier, most studies focusing 
on inhibition of the enzyme by various complex molecules.  
It is commonly assumed that enzymes evolve towards acquiring a higher catalytic 
efficiency to better accomplish their biological function. The substrate turnover rate and 
specificity of enzymes control the flux through interconnected metabolic pathways. 
Whether or not a stringent selectivity is required depends on the physiological function 
of an enzyme 22. For example, enzymes involved in catabolism may have a broad 
substrate range, while enzymes playing a role in central metabolism and anabolism 
must be specific in order to discriminate among metabolic intermediates having only 
small structural differences. Consequently, peptide deformylase and methionine 















Figure 11. Active site pocket of EcPDF. Figures were generated using pdb structure 1BS6. Left: structure 
of the active site pocket shown in surface display, H-Met-Ala-Ser-OH in ball and sticks (green). Right: 
close up of the active site with H-Met-Ala-Ser-OH and Ni2+ binding interactions. Picture made with Pymol 
software. 
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catalytic activity for their natural substrates. The substrate recognition sites of the 
different PDFs are structurally conserved and restricted, thus providing a similar 
stringent substrate specificity to enzyme variants even when these have a low 
sequence similarity and occur in phylogenetically very different organisms 21;37. In view 
of these considerations and the results obtained, the chances to find natural peptide 
deformylase variants with broader substrate specificity can be regarded as very low.   
 
Conclusions 
A potential way to obtain peptide deformylases with higher stabilities and better 
catalytic properties than that of EcPDF is through mining of sequenced genomes. In this 
chapter we report the cloning and overexpression in E. coli of eight peptide 
deformylases from phylogenetically different organisms. The enzymes could be 
expressed in E. coli and were easily purified using the Met-Lys-Sepharose affinity 
chromatography method developed for the E. coli enzyme. The characterization of 
these enzymes revealed different temperature optima, with BstPDF and HiPDF having 
an optimum temperature at 40-50 °C and somewhat higher temperature stability. A 
major factor influencing the temperature stability was the concentration of the purified 
enzyme, which is in line with early studies of Groche and colleagues who showed that 
when stored at high concentrations EcPDF can remain active for several weeks 15. The 
substrate specificity of the recombinant PDFs was also tested, but despite the choice of 
enzymes from very different organisms, no major differences in substrate range were 
discovered. In view of these results and the biological function of PDFs the chance to 
find in nature PDFs with a broader substrate range than that of the E. coli enzyme is 
regarded as small. An alternative method for obtaining improved peptide deformylases 




1. Cabral J.S. (Ed) 2000. Applied biocatalysis. European Federation of Biotechnology. 
Working Party on Applied Biocatalysis. Harwood Academic Publishers. 
 2.  Baldwin, E. T., M. S. Harris, A. W. Yem, C. L. Wolfe, A. F. Vosters, K. A. Curry, R. W. 
Murray, J. H. Bock, V. P. Marshall, J. I. Cialdella, M. H. Merchant, G. Choi, and M. R. 
Deibel, Jr. 2002. Crystal structure of type II peptide deformylase from Staphylococcus 
aureus. J. Biol. Chem. 277:31163-31171. 
Chapter 3                               Exploring bacterial genomes for novel PDFs 
 
  98
 3.  Becker, A., I. Schlichting, W. Kabsch, S. Schultz, and A. F. Wagner. 1998. Structure of 
peptide deformylase and identification of the substrate binding site. J. Biol. Chem. 
273:11413-11416. 
 4.  Becker, A., I. Schlichting, W. Kabsch, D. Groche, S. Schultz, and A. F. V. Wagner. 
1998. Iron center, substrate recognition and mechanism of peptide deformylase. Nat. 
Struct. Mol. Biol.  5:1053-1058. 
 5.  Bracchi-Ricard, V., K. T. Nguyen, Y. Zhou, P. T. R. Rajagopalan, D. Chakrabarti, and 
D. Pei. 2001. Characterization of an eukaryotic peptide deformylase from Plasmodium 
falciparum. Arch. Biochem. Biophys. 396:162-170. 
 6.  Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-
254. 
 7.  Chan, M. K., W. Gong, P. T. R. Rajagopalan, B. Hao, C. M. Tsai, and D. Pei. 1997. 
Crystal structure of the Escherichia coli peptide deformylase. Biochemistry 36:13904-
13909. 
 8.  Cowan, D. A. 1997. Thermophilic proteins: stability and function in aqueous and organic 
solvents. Comp. Biochem. Physiol. A 118:429-438. 
 9.  Dirk, L. M. A., J. J. Schmidt, Y. Cai, J. C. Barnes, K. M. Hanger, N. R. Nayak, M. A. 
Williams, R. B. Grossman, R. L. Houtz, and D. W. Rodgers. 2008. Insights into the 
substrate specificity of plant peptide deformylase, an essential enzyme with potential for 
the development of novel biotechnology applications in agriculture. Biochem. J. 413:417-
427. 
 10.  Dirk, L. M. A., M. A. Williams, and R. L. Houtz. 2001. Eukaryotic peptide deformylases. 
Nuclear-encoded and chloroplast-targeted enzymes in arabidopsis. Plant Physiol. 127:97-
107. 
 11.  Escobar-Alvarez, S., Y. Goldgur, G. Yang, O. Ouerfelli, Y. Li, and D. A. Scheinberg.  
2010. Structure and activity of human mitochondrial peptide deformylase, a novel cancer 
Target. Mol. Cell. Biol. 30:5099-5109 
 12.  Ferrer, M., F. Martnez-Abarca, and P. N. Golyshin. 2005. Mining genomes and 
`metagenomes' for novel catalysts. Curr. Opin. Biotechnol. 16:588-593. 
 13.  Giglione C, . 2000. Peptide deformylase as a target for new generation, broad spectrum 
antimicrobial agents. Mol. Microbiol. 36:1197-1205. 
 14.  Giglione, C.  2000. Identification of eukaryotic peptide deformylases reveals universitality 
of N-terminal protein processing mechanisms. EMBO J. 19:5916-5929. 
 15.  Groche, D., A. Becker, I. Schlichting, W. Kabsch, S. Schultz, and A. F. V. Wagner. 
1998. Isolation and crystallization of functionally competent Escherichia coli peptide 
deformylase forms containing either iron or nickel in the active site. Biochem. Biophys. 
Res. Comm. 246:342-346. 
 16.  Guilloteau, J. P., M. Mathieu, C. Giglione, V. Blanc, A. Dupuy, M. Chevrier, P. Gil, A. 
Famechon, T. Meinnel, and V. Mikol. 2002. The crystal structures of four peptide 
deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the 
structure-based design of antibacterial agents. J. Mol. Biol. 320:951-962. 
 17.  Hu, Y. J., Y. Wei, Y. Zhou, P. T. R. Rajagopalan, and D. Pei. 1999. Determination of 
substrate specificity for peptide deformylase through the screening of a combinatorial 
peptide library. Biochemistry 38:643-650. 
 18.  Kreusch, A., G. Spraggon, C. C. Lee, H. Klock, D. McMullan, K. Ng, T. Shin, J. 
Vincent, I. Warner, C. Ericson, and S. A. Lesley. 2003. Structure analysis of peptide 
Chapter 3                               Exploring bacterial genomes for novel PDFs 
 
  99
deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga 
maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide 
deformylase. J. Mol. Biol. 330:309-321. 
 19.  Lang, B. F., M. W. Gray, and G. Burger. 1999. Mitochondrial genome evolution and the 
origin of eukaryotes. Annu. Rev. Genet. 33:351-397. 
 20.  Leeds, J. A. and C. R. Dean. 2006. Peptide deformylase as an antibacterial target: a 
critical assessment. Curr. Opin. Pharmac. 6:445-452. 
 21.  Li, J. Y., Y. M. Cui, L. L. Chen, M. Gu, J. Li, F. J. Nan, and Q. Z. Ye. 2004. Mutations at 
the S1 sites of methionine aminopeptidases from Escherichia coli and Homo sapiens 
reveal the residues critical for substrate specificity. J. Biol. Chem. 279:21128-21134. 
 22.  Mannervik, B., A. Runarsdottir, and S. Kurtovic. 2009. Multi-substratecoactivity space 
and quasi-species in enzyme evolution: Ohno's dilemma, promiscuity and functional 
orthogonality. Biochem. Society Transactions 037:740-744. 
 23.  Margolis, P., C. Hackbarth, S. Lopez, M. Maniar, W. Wang, Z. Yuan, R. White, and J. 
Trias. 2001. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to 
mutations in defB. Antimicrob. Agents Chemother. 45:2432-2435. 
 24.  Mazel, D., S. Pochets, and P. Marliere. 1994. Genetic characterization of polypeptide 
deformylase, a distinctive enzyme of eubacterial translation. EMBO 13:914-923. 
 25.  Meinnel, T. and S. Blanquet. 1995. Enzymatic properties of Escherichia coli peptide 
deformylase. J. Bacteriol. 177:1883-1887. 
 26.  Meinnel, T., Y. Mechulam, and S. Blanquet. 1993. Methionine as translation start signal: 
a review of the enzymes of the pathway in Escherichia coli. Biochimie 75:1061-1075. 
 27.  Narita, M., S. Honda, H. Umeyama, and S. Obana. 1988. The solubility of peptide 
intermediates in organic solvents. Solubilizing potential of hexafluoro-2-propanol. Bull. 
Chem. Soc. Jpn. 61:281-284. 
 28.  Nguyen, K. T., X. Hu, C. Colton, R. Chakrabarti, M. X. Zhu, and D. Pei. 2003. 
Characterization of a human peptide deformylase: implications for antibacterial drug 
design. Biochemistry 42:9952-9958. 
 29.  Owusu, R. K. and D. A. Cowan. 1989. Correlation between microbial protein 
thermostability and resistance to denaturation in aqueous: organic solvent two-phase 
systems. Enzyme Microbial. Technol. 11:568-574. 
 30.  Peters, R., J. Hellenbrand, Y. Mengerink, and S. Van der Wal. 2004. On-line 
determination of carboxylic acids, aldehydes and ketones by high-performance liquid 
chromatography-diode array detection-atmospheric pressure chemical ionisation mass 
spectrometry after derivatization with 2-nitrophenylhydrazine. J. Chromatogr. 1031:35-50. 
 31.  Pichota, A., J. Duraiswamy, Z. Yin, T. H. Keller, J. Alam, S. Liung, G. Lee, M. Ding, G. 
Wang, W. L. Chan, M. Schreiber, I. Ma, D. Beer, X. Ngew, K. Mukherjee, M. 
Nanjundappa, J. W. P. Teo, P. Thayalan, A. Yap, T. Dick, W. Meng, M. Xu, J. Koehn, 
S. H. Pan, K. Clark, X. Xie, C. Shoen, and M. Cynamon. 2008. Peptide deformylase 
inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and 
biological results. Bioorg. Med. Chem. 18:6568-6572. 
 32.  Ragusa, S., P. Mouchet, C. Lazennec, V. Dive, and T. Meinnel. 1999. Substrate 
recognition and selectivity of peptide deformylase. similarities and differences with 
metzincins and thermolysin. J. Mol. Biol.289:1445-1457. 
 33.  Rajagopalan, P. T. and D. Pei. 1998. Oxygen-mediated inactivation of peptide 
deformylase. J. Biol. Chem. 273:22305-22310. 
Chapter 3                               Exploring bacterial genomes for novel PDFs 
 
  100
 34.  Serero, A., C. Giglione, and T. Meinnel. 2001. Distinctive features of the two classes of 
eukaryotic peptide deformylases. J. Mol. Biol. 314:695-708. 
 35.  Serero, A., C. Giglione, A. Sardini, J. Martinez-Sanz, and T. Meinnel. 2003. An unusual 
peptide deformylase features in the human mitochondrial N-terminal methionine excision 
pathway. J. Biol. Chem. 278:52953-52963. 
 36.  Sonke, T., B. Kaptein, A. F. V. Wagner, P. J. L. M. Quaedflieg, S. Schultz, S. Ernste, 
A. Schepers, J. H. M. Mommers, and Q. B. Broxterman. 2004. Peptide deformylase as 
biocatalyst for the synthesis of enantiomerically pure amino acid derivatives. J. Mol. Catal. 
B: Enzymatic 29:265-277. 









Screening and selection methods for 
deformylase activity




 Several screening and selection methods were tested for their application in the 
screening of directed evolution libraries of E. coli peptide deformylase. In microtiter plate 
format, activity could be detected using a pH indicator that changes color due to formic 
acid formation. For selection assays, we optimized a protocol based on 
complementation of L-leucine auxotrophy of host cells due to peptide deformylase 
mediated production of a deformylated precursor of L-leucine. The method was used to 
select active clones on synthetic medium containing arabinose for induction and 




 The last decade has seen an increasing number of applications of enzymes in 
various industrial sectors, especially because of the high selectivity and activity of many 
enzymes under mild reaction conditions. On the other hand, many enzymes are not 
ideal process catalysts 14. Over the last two decades, the growing understanding of 
structure-function relationship in proteins and the development of efficient molecular 
biology protocols have increased the possibilities for studying and engineering enzyme 
properties. Thus, protein engineering has become a powerful tool for improving the 
fitness of enzymes for various practical applications 7 1;39. If directed evolution is used, a 
success will not only require the choice of a good method for library construction, but 
also the availability of a reliable way to indentify and isolate the desired variants from 
large collections of mutant enzymes 19;40. Indeed, the development of analytical tools for 
finding the improved variants (sometimes compared to searching for a needle in the 
haystack) often is the bottleneck during the improvement of an industrial enzyme by 
directed evolution 29.  
 For retrieving the best enzyme variants from a mutant library, it is essential that 
the desired feature is linked to the gene encoding this particular variant. This 
phenytype-genotype linkage can be achieved in various ways, such as phage or 
ribosome display 11;27;32, cell surface display 3, whole-cell methods, or through in vitro 
compartmentalization 13.  
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 Identification of the best variants (phenotypes) in a mutant library can be 
achieved in two fundamentally different ways: screening or selection. Although the two 
terms are often confused in the literature, an important difference is that in case of 
screening the mutants composing the library are tested individually via a suitable 
analytical method, whereas selection is based on physical (affinity-based panning) or 
biological (using a specific growth advantage) purification or enrichment of the desired 
variants from the mutant library. For the latter, the genotype-coupled improved enzyme 
must make the system selectable, e.g. by enhancing the affinity for a specific ligand or 
by providing to the host the capacity to survive or multiply 34;38. During the design of a 
screening or selection protocol, it should be kept in mind that “you get what you screen 
for”. This means that it is highly desirable to use screening or selection conditions that 
are as closely as possible related to the enzyme property that needs to be improved for 
a real application 41. Consequently, cost effective, reproducible, and rapid high-
throughput techniques are of major importance.  
A range of screening and selection strategies have been described 9;10;21;22;26;34 
and choosing the best one is not always an easy task. Often, a two-round procedure is 
used, in which a first round of screening or selection is designed to discard all 
deleterious mutants, and a second round, which is carried out under more stringent 
conditions with the real substrate, is used to recover the best variants for a specific task 
5. The initial screening round is often simplified by coupling the formation of the product 
of the desired reaction to a follow-up transformation that results in a visible signal, or by 
employing artificial substrates that lead to a coloured or fluorescent product that can 
easily be detected 31 12;41. However the use of artificial substrates bears the inherent risk 
that a biocatalyst identified does not have the required features in the real conversion 34.  
The advantage of screening is that it is based on the separate examination of 
each variant in the library for the desired characteristic (e.g. increased activity) via an 
analytical technique like liquid chromatography, mass spectrometry, or NMR. This 
allows a direct measurement of product and substrate, providing quantitative data, and 
conditions may be chosen that reflect, in miniaturized form, the real application 36. 
Clearly, depending on the size of the library, screening can become very laborious and 
expensive, also because many mutants are tested that are not active or not properly 
folded. Costs can also increase since the design of appropriate small-volume assays 
often involves robotics (colony pickers, automatic liquid handlers) and sophisticated 
analytical equipment like MS or NMR instruments equipped with flow injection, or 
Chapter 4          Screening and selection methods for deformylase activity  
  
  104
fluorescence-activated cell sorting (FACS) 5;34;36. Furthermore, even at microtiter plate 
scale large numbers of assays may add to the cost of the procedure when expensive 
chemicals such as cofactors are needed. 
 
 
These drawbacks of screening stand in strong contrast to the use of growth 
selection strategies, which are much less labour intensive and allow analysis of much 
larger numbers of variants at the same time. Library sizes of up to 1010-1013 variants 
can be handled by selection, compared to some 10,000, which is often considered the 
upper limit for most microtiter plate-based screenings 8. Careful design of a selection 
assay is crucial to prevent false positives that could appear, for example as a result of 
chromosomal mutations that influence the selected phenotype.  
The objective of this study was to develop a method for the isolation of peptide 
deformylase (PDF) variants with increased activity toward selected formylated 
dipeptides, starting from a library composed of about 106 variants that was obtained by 
simultaneous saturation of 4 positions in the enzyme sequence (Chapter 5). We 
describe various screening methods that were investigated as well as the development 
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Results and discussion 
Formate dehydrogenase assay 
The most commonly used assay for PDF is the one developed by the group of 
Meinnel 20, which is based on coupling the production of formate to the reduction of 
NAD+ by formate dehydrogenase (FDH). The deformylation rate is directly proportional 
to the rate of production of NADH from NAD+, which can be monitored at 340 nm. 
Unfortunately, the low specificity constant of FDH for formate can easily make formate 
conversion the rate-limiting step in this assay, corrupting a correct evaluation of PDF 
activity. Moreover, the high background absorbance at 340 nm before the addition of 
substrate to the reaction mixture containing cell-free extract will also interfere with a 
correct assessment of the deformylation activity.  
We did some tests but it appeared that the assay indeed was too insensitive to 
reliably distinguish clones converting N-formyl-Met-Ala-OH from background (cell free 
extract not overexpressing EcPDF). The results did not match those obtained with the 
standard HPLC test, and the formate dehydrogenase-based assay for library screening 























    formate
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Figure 2. Reaction scheme of the formate dehydrogenase assay for peptide deformylase with N-formyl-
Met-Ala-OH as substrate. 
 
Ninhydrin method 
The ninhydrin method is based on a chromogenic reaction that detects the 
primary amine group of methionine which becomes unmasked in the deformylation 
reaction. First, the unspecific background reaction of ninhydrin with free amines present 
in the E. coli crude extracts was determined. Different dilutions of this extract were 
incubated with a ninhydrin solution at 90°C for 5 and 10 min. The results showed that 
only at total protein concentrations below 1 mg/mL the samples did not show the typical 
Ruhemann’s purple colour. Subsequently, extracts prepared from E. coli cells 
overexpressing peptide deformylase from plasmid pBAD-PDFEtag (Chapter 2) were 
diluted to a total protein concentrations of about 0.1 mg/mL and incubated with 10 mM 
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N-formyl-Met-Ala-OH or N-formyl-Phe-Phe-OH. From assays with extracts containing 
different levels of PDF, it became apparent that very precise dilutions of cell-free extract 
and exact incubation times were required to allow discrimination between the wild-type 
enzyme and improved mutants. Furthermore, it was judged difficult to sufficiently control 
these variables when the assay was done in high-throughput format. Moreover, 
peptides with a primary amino group, e.g. N-formyl-Lys-Phe-OH, can react with 
ninhydrin in the absence of deformylation, disturbing the assay. These facts, especially 
the low sensitivity and high background signals, indicated that a more robust method 
was needed for library screening. 
 
p-(Dimethylamino)benzaldehyde (DMBA) method 
A second colorimetric assay that was tested is based on p-(dimethyl-
amino)benzaldehyde (DMBA). DMBA reacts rapidly with primary amines to form a 
complex with a maximum absorbance at 450 nm which is easily detectable by spectro-
photometry (Fig.3). A linear relation between absorbance and peptide concentration 
was obtained in the range of 0.3-10 mM H-Met-Ala-OH. Furthermore, it was possible to 
detect the difference in deformylase activity between a clone overexpressing EcPDFEtag 
and one in which only the genomic copy of the PDF-encoding gene was present. The 
activities on N-formyl-Met-Ala-OH that were measured with the DMBA assay correlated 
well to the ones obtained via HPLC analysis. Thus the DBMA assay seems applicable 



















Figure 3. Reaction of DMBA with H-Met-Ala-OH, thereaction product of the PDF-catalyzed deformylation 
of N-formyl-Met-Ala-OH. 
 
Despite the positive results obtained, it was decided not to use this method for 
primary screening of PDF variants. The robotics needed for the processing a library 
composed of 106 clones makes the method too expensive.  
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pH shift method 
Aiming at a screening method that would allow an easy and fast examination of a 
large number of colonies, we attempted the use of pH indicators. Advantages are easy 
detection of colour change without the need for a chromogenic moiety present on the 
substrate, and the possibility to use an indicator directly on agar plates 6;34.  
During the deformylation reaction catalyzed by PDF, formic acid (pKa=3.75) and 
a free N-terminal amino group (pKa=8.0) are formed. The initial pH will decrease during 
progress of the reaction, which can be detected by a pH indicator incorporated in an 
agar plate or added to a microtiter plate. First, we investigated the decrease in pH 
associated with the deformylation reaction by incubating about 50 mg of E. coli cells that 
did or did not overexpress EcPDFEtag with a buffered substrate solution containing N-
formyl-Met-Ala-OH (2.5 mM) and phenol red. The pH of the solution was 7.2. When 
using a phosphate buffer concentration of 20 mM, the pH decreased 1.2 units in 5 min, 






















Figure 4. Effect of pH indicator on 
the activity of EcPDFEtag with N-
formyl-Met-Ala-OH. Symbols:  ●, 
reaction without phenol red; ■, 
reaction in the presence of phenol 
red. 
 
Subsequently, the effect of the pH indicator on the activity of EcPDFEtag was 
tested. The decrease of pH was followed in a similar reaction mixture with and without 
addition of phenol red. This yielded a pH decrease of 1.6 units in 5 min in both cases. 
However, when the amount of N-formyl-Met-Ala-OH and H-Met-Ala-OH were analyzed 
using the standard HPLC assay, 70 % substrate conversion appeared to have been 
reached when no phenol red was added to the reaction mixture, while only 40 % 
conversion was observed under the same conditions in the presence of the indicator 
(Fig. 4). Apparently, this difference in conversion caused only a marginal effect on the in 
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pH shift. Even though the inhibitory effect of the indicator was only small when using N-
formyl-Met-Ala-OH as the substrate, it was decided not to continue the development of 
this pH indicator based method. Careful tuning of the buffer concentration for each 
specific screening substrate (especially for the poorly converted ones), and of reaction 
time and amount of PDF to be used in the screening assay would have been needed to 
make this screening method sufficiently sensitive and discriminating. 
 
Growth selection  
Because of the very high throughput and the minimal equipment needed, 
selection methods were explored. To allow a link between the growth of E. coli and the 
deformylase activity, we used leucine-containing N-formylated dipeptides as sole source 
of leucine to complement the leucine auxotrophy of E. coli strains like MC1061 and  
TOP10. The following requirements hold for such a selection method: (1), E. coli 
auxotrophic strains should be able to grow on a minimal medium containing leucine; (2), 
the cells need to take up the leucine-containing formylated peptide from the medium; 
(3), the desired EcPDF variants have to deformylate the N-formylated dipeptide; (4), 
cell-born peptidases and/or amidases need to hydrolyze the deformylated dipeptide, 
and not the formylated one, liberating leucine; and (5), leucine, that is produced this way 
should sustain growth.  
A selection assay was explored by Mazel et al. 24 to identify and isolate the 
deformylase gene of E. coli. The selection was based on the ability of methionine and 
leucine auxotrophic cells, transformed with indigenous E. coli genes, to hydrolyse N-
formyl-Leu-Met-OH. This compound can not be degraded by wild-type E. coli cells but 
cell growth was achieved through overexpression of E. coli DNA fragments, cloned into 
a high-copy-number plasmid, conferring to the cell the ability to use the deformylase 
substrate as a source of methionine and leucine. This method shows that plate 
selection of PDF variants is possible. A similar strategy was explored by us for the 
selection of PDF mutants with altered P1 specificity, using a leucine auxotrophic E. coli 
strain as a host, overexpression of EcPDF, and selecting of variants on a medium 
containing N-formylated leucine dipeptides as sole source of leucine.  
For a successful selection assay, the medium has to be designed in such a way 
that non specific-growth (by false-positives) is avoided. The choice of a suitable minimal 
medium started by testing the ability of E. coli MC1061 and TOP10 cells transformed 
with pBAD-PDFEtag to grow on M9 minimal medium containing glycerol as carbon 
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source. This medium also contained thiamine, carbenicillin, 0.002% (w/v) L-arabinose to 
induce the PDF expression, and when needed a source of leucine (as described in 
Materials and Methods). Growth tests showed that the presence of L-leucine promoted 
the formation of colonies after 3 days, whereas without leucine no colonies appeared. 
The same experiment was carried out using the dipeptide N-formyl-Asp-Leu-OH as sole 
leucine source, but in this case colonies were not visible after 5-15 days of incubation at 
37°C. To demonstrate that this result was not caused by toxicity of the substrate, the 
viability of the cells was checked by applying small filter paper discs (diameter ca. 0.5 
cm) with a 300 µM L-leucine solution to the agar plates. The formation of colonies 
around the filter after 1-2 days of incubation confirmed that cells were still viable. After 
incubation for 15 days at 37°C on the selection medium the E. coli cells thus are still 
viable and unable to utilize N-formyl-Asp-Leu-OH as leucine source, indicating that the 
selection medium is sufficiently stringent to prevent false positives. The lack of growth 
with N-formyl-Asp-Leu-OH is in agreement with the very low activity of EcPDF towards 
formylated dipeptides with aspartic acid in position P1’ 30. The test revealed that, under 
the applied conditions, discrimination between wild-type EcPDF and a mutant with 
increased activity towards N-formyl-Asp-Leu-OH should be possible. 
After showing that wild-type cells were not able to grow on selection medium, a 
positive control demonstrating the uptake and metabolism of formylated dipeptides was 
necessary. Four shake flasks containing liquid M9 minimal medium, with glycerol and 
arabinose, and with N-formyl-Asp-Leu-OH, H-Asp-Leu-OH, N-formyl-Leu-Phe-NH2 or H-
Leu-Phe-NH2 as sole leucine source, were inoculated with E. coli MC1061 containing 
pBAD-PDFEtag. Growth rate and dipeptide concentration were monitored to demonstrate 
uptake and subsequent peptide bond hydrolysis (Fig. 5). Both non-formylated 
dipeptides supported growth of the cells, which coincided with dipeptide consumption. 
The two formylated dipeptides, on the other hand, were not consumed at all, and did not 
enable the growth of E. coli cells. The lack of growth with the formylated dipeptides 
confirms the low activity of peptide deformylase with the substrates used in these 
experiments. Next, we tested N-formyl-Met-Leu-OH, which is a good PDF substrate, 
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Figure 5. Growth and dipeptide uptake by E. coli MC1061 cells containing pBAD-PDFEtag. (A) 
Consumption of dipeptides. (B) Growth in the presence of different dipeptides as L-leucine source. 
Symbols: ▲, N-formyl-Leu-Phe-NH2; ♦, N-formyl-Asp-Leu-OH; ●, H-Leu-Phe-NH2; ■, H-Asp-Leu-OH. 
 
as source of leucine. Ragusa and coworkers observed that the best substrates for PDF 
are formylated dipeptides with methionine in position P1’ 30. We tested the growth of E. 
coli strains MC1061 and TOP10 on M9 minimal medium plates supplied with N-formyl-
Met-Leu-OH, in the absence of L-arabinose. Colonies appeared after 2 days at 37°C, 
showing that the cells were able to take up and metabolize the substrate via 
deformylation by their genome encoded peptide deformylase and subsequent peptide 
bond hydrolysis by endogenic peptidases. The negative control in which no peptide was 
added to the minimal medium showed no growth. The experiment was repeated with 
recombinant cells overexpressing EcPDFEtag from a pBAD plasmid and induced with 
increasing concentrations of L-arabinose (0.002 to 0.2% w/v). Interestingly, we noticed 
a decrease of the number and the size of colonies, which was proportional to the 
inducer concentration. Using M9 medium with 0.02% L-arabinose, the number of CFU 
decreased to 4% of a control on M9 medium with no inducer. At concentrations higher 
than 0.02 % (w/v) L-arabinose, no growth was visible even after several days. When the 
same strains were plated on LB medium with varying concentrations of arabinose, we 
found that growth was not influenced by induction.  
 Tao and coworkers 37 showed that gene expression is different in E. coli cells 
growing in LB medium compared to cells cultivated in minimal media. In the latter case, 
the need for building blocks switches on biosynthetic pathways, including regulators of 
metabolism and stress response factors.  Cell growth is slower and metabolites (e.g. 
acetate) accumulate in the cells. A study showing that the expression of proteins from 
vectors containing the pBAD promoter varies in different media was published by 
Guzman and colleagues15. Their results showed more efficient expression of 
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heterologous genes in glycerol containing minimal medium compared to rich medium, 
which could be explained by partial catabolite repression or specific repression by 
components present in the rich medium. From these observations we expected that 
growth on glycerol-containing minimal medium would be associated with strongly 
induced peptide deformylase expression, which could cause a level of stress to the cells 
that is not compatible with healthy growth. To check this, E. coli MC1061 and TOP10 
empty strains (expressing no PDF) were plated on minimal medium containing different 
L-arabinose concentrations. The ability to grow even at 0.2 % (w/v) L-arabinose 
confirmed that induced overexpression, likely in combination with activation of 
biosynthetic pathways, negatively influenced growth on synthetic medium.  
We therefore decided to test if the activity of PDF or the PDF protein itself 
impaired growth. Inactive PDF mutants were created by site-directed mutagenesis of 
three conserved residues reported to be involved in the catalytic cycle 25. Two mutants 
of EcPDFEtag were constructed: (i) C138A/H141A and (ii) E142A. Overexpression and 
activity tests resulted in two soluble mutant proteins lacking deformylase activity. Both 
mutant plasmids were transformed to E. coli MC1061 and TOP10. After plating on 
glycerol minimal medium supplemented with 0.002 or 0.2 % (v/w) L-arabinose, visible 
colonies only appeared on plates containing the lower concentration of inducer, clearly 
showing that the negative effect of induction on growth is not caused by an excess of 
deformylase activity in the cells but by the high activity of the transcription/translation 
machinery under the strongly inducing conditions, or by the PDF protein itself. Note that 
peptide deformylase is not just an ordinary cytoplasmic enzyme. Recently Bingel-
Erlenmeyer and coworkers 4 showed that there is a specific interaction of EcPDF with 
the ribosome. This association, mediated by the C-terminal helix, is important in vivo to 
ensure efficient processing of newly synthesised peptides. Since ribosomal peptide 
synthesis is highly organized and concerted, it is conceivable that an unbalance in the 
relative levels of ribosome and PDF in the cells negatively effects translation under 
conditions of stress imposed by minimal medium and high overexpression. 
To find a minimal medium that could support growth at high L-arabinose 
concentrations, we tested the addition of nutrients to minimal medium. We first tested 
casamino acids, which is a peptide mixture produced by hydrolysis of casein. Separate 
samples containing equal numbers of colony forming units (CFU) of E. coli 
TOP10(pBAD-PDFEtag) or MC1061(pBAD-PDFEtag) were plated and incubated on rich 
medium (LB) and minimal medium (supplemented with glycerol, thiamine, MgSO4, 
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CaCl2 and casamino acids). In both cases increasing concentrations of L-arabinose 
were tested (0 - 0.002 - 0.02 or 0.2 %). The number of appearing CFU was higher when 
casamino acids were present in the minimal medium, but growth was still not visible at 
0.2-0.02% (w/v) L-arabinose. Also when trace elements (TEs) were added to the 
minimal medium, the growth inhibiting effect of the inducer was still occurring. Only 
when both casamino acids and TEs were added, colonies appeared (in limited number) 
after incubation at 37°C for 5 days, and 90% of the plated CFUs formed colonies on 
synthetic medium containing casamino acids and TEs at 0.002% L-arabinose.  
Another parameter that is crucial for growth and gene expression is the carbon 
source. The growth rate of E. coli is about 2-fold higher in glucose minimal medium than 
with glycerol, but the total level of gene transcription is higher in case of a carbon 
source that is more rapidly utilized 23;28. The cells not only upregulate genes involved in 
the metabolism of the given carbon source, but also activate pathways linked to 
unavailable compounds. This broader transcription program, although requiring more 
energy, ensures the cells a faster stress response in nutrient-poor environments 2;16;23.  
To further decrease the stress applied on the cells, glycerol as carbon source in 
the minimal medium was replaced by glucose 42. The expression system used in this 
study (pBAD vector) is based on the L-arabinose operon. This system is characterized 
by the possibility to modulate expression rates by increasing or decreasing the inducer 
concentration, and a very low level of uninduced expression, which can be reduced to 
zero by addition of glucose The influence of glucose is mediated by cAMP, which binds 
CRP (cAMP receptor protein), which together with AraC is necessary for induction 17;33. 
Moreover glucose can inhibit L-arabinose uptake by repressing the synthesis of L-
arabinose permease 18. The use of glucose in combination with TEs and casamino 
acids efficiently minimized the influence of the L-arabinose inducer concentration on cell 
growth. CFU counts were comparable in LB and M9 medium containing TEs, casamino 
acids and glucose even at 0.2% (w/v) L-arabinose. 
These observations show that a combination of TEs, casamino acids and 
glucose could overcome the growth-inhibitory effect of PDF induction. However, since 
the casamino acid mixture contains a source of leucine, it can not be used in the current 
selection procedure. Therefore, a mixture of amino acids in which leucine was not 
included was prepared as described in the Experimental section. Even though a 
selection method using this medium containing both glucose and L-arabinose seems 
contra-intuitive, overexpression of PDF under these conditions was observed on SDS-
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polyacrylamide gels using CFE prepared from cells grown on glucose medium. 
Although clone to clone variations on the same plate were observed at L-arabinose 
concentrations of 0.2-0.02%, a clear expression of peptide deformylase was detected, 
confirming that the presence of glucose is not leading to complete inhibition of PDF 
expression. 
Finally, different concentrations of dipeptides (H-Leu-Phe-OH, H-Asp-Leu-OH 
and H-Phe-Leu-OH) were added as leucine source to the glucose medium containing 
TEs and amino acids to determine the optimal dipeptide concentration for growth of E. 
coli when the N-formylated dipeptides mentioned below would be used as selection 
substrates. This was found to be 1 mM. In addition no chemical hydrolysis was detected 
by HPLC analysis after 2 weeks of incubation at 37°C in minimal medium for none of 
the tested substrates (N-formyl-Phe-Leu-OH, N-formyl-Leu-Phe-NH2, N-formyl-Asp-Leu-
OH). Thus, it was expected that PDF variants with suitably altered specificity in the P1’ 
pocket can be isolated by growth selection on glucose-containing mimimal medium 
supplemented with a mixture of amino acids and 1 mM of a leucine-containing 
formylated di- or tripeptide as sole source of leucine. Because of these positive results 
and the ease of use, with no background growth, growth selection on agar plates was 
concluded to be the most attractive method for the identification of PDF mutants with 
increased activity towards synthetic peptide substrates. 
 
Conclusions 
 The development of robust and cost effective methods for assaying enzyme 
activity is extremely important for the identification of desired enzyme variants by protein 
engineering. In this study several screening methods were compared and a selective 
growth method was fine-tuned for the selection of modified peptide deformylases in E. 
coli leucine auxotrophic cells. The use of glucose as carbon source allowed growth of 
PDF overexpressing variants, providing a tool for selection of PDFs with modified 









All standard chemicals were of the highest grade obtainable. N-formyl-Met-Ala-
OH, H-Met-Ala-OH, N-formyl-Met-Lys-OH, N-formyl-Leu-Phe-NH2, H-Leu-Phe-OH, H-
Phe-Leu-OH, H-Asp-Leu-OH, were purchased from Bachem (Bubendorf, Switzerland). 
Bovine liver catalase (10,000-40.000 U/mg) was obtained from Sigma-Aldrich (Saint 
Louis, USA); tris-(2-carboxyethyl)-phosphine (TCEP) was obtained from Fluka (Buchs, 
Switzerland). Formylated amino acid derivatives were obtained from Chiralix (Nijmegen, 
NL). Amino acids were purchased from Sigma-Aldrich. 
 Restriction enzymes, T4 DNA ligase and T4 DNA polymerase were obtained 
from New England Biolabs. Adenosine triphosphate and deoxynucleoside triphosphates 
were purchased from Roche (Mannheim, Germany). Synthesis of oligonucleotides for 
site-directed mutagenesis and DNA sequencing were performed at Life Technologies 
GIBCO (Carlsbad, USA). 
 
Microorganism, plasmids and cultivation conditions in growth assays 
Plasmid-free E. coli TOP10 (mcrA, Δ(mrr-hsdRMS-mcrBC), ΔlacX74, deoR, 
recA1, araD139Δ(ara-leu)7697, galK, rpsL, endA1, nupG) and MC1061 (araD139 
Δ(araA-leu)7697 ΔlacX74 galK16 galE15(GalS) λ- e14- mcrA0 relA1 rpsL150(strR) 
spoT1 mcrB1 hsdR2) were propagated in Luria Bertani (LB) medium at 37°C. When 
cells were transformed with pBAD-PDFwt or pBAD-PDFEtag, 100 mg/L carbenicillin 
was added to the medium. For the growth tests, E. coli cells were plated on different M9 
based minimal media and incubated at 37°C. 
The M9 minimal medium (pH 7.3) contained per liter: 6 g Na2HPO4, 3 g KH2PO4, 
0.5 g NaCl, 1 g NH4Cl, 240 mg MgSO4 and 11 mg CaCl2. When necessary 10 mg/L 
thiamine, and/or 100 mg/l of cabenicillin were added. Glucose (0.2 % w/v) or glycerol 
(0.2 % w/v)) were added as carbon source. Solid medium contained 20 g/l agarose. 
When positive control tests were run, 0.4 mM leucine was added while if the substrate 
used was a formylated dipeptide, its final concentration was 1 mM. L-arabinose 
concentrations varied form 0 to 0.2% (v/w).  
Casamino acids M9 medium was prepared by addition of casamino acids 
(Becton Dickinson, USA) to M9 medium at a final concentration of 10 mg/L. In this case 
no L-Leu was added.  
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When required, amino acids (50 mg L-alanine, 50 mg L-arginine, 500 mg L-
aspartic acid, 500 mg L-glutamic acid, 50 mg glycine, 50 mg L-histidine, 50 mg L-
isoleucine, 50 mg L-lysine, 50 mg L-methionine, 50 mg L-phenylalanine, 50 mg L-
proline, 50 mg L-serine, 50 mg L-threonine, 20 mg L-tryptophan, 20 mg L-tyrosine and 
50 mg L-valine), and 5 mL of  a trace element stock solution were added to M9 medium 
(1 liter). Trace elements were prepared as a 1 L stock containing the following: 780 mg 
Ca(NO3)2·4H2O, 200 mg FeSO4·7H2O, 10 mg ZnSO4·7H2O, 10 mg H3BO3, 10 mg 
CoCl2·6H2O, 10 mg CuSO4·5H2O, 4 mg MnSO4·H2O, 3 mg Na2MoO4·2H2O and 2 mg 
NiCl2·6H2O.  
 
Electroporation of E. coli MC1061 cells  
 E. coli MC1061 cells were made electrocompetent by inoculating a single colony 
into 5 mL LB medium, followed by overnight growth at 28°C. Next, 2.5 mL of this culture 
was transferred to 500 mL LB medium and grown at 37°C to an OD620 of ca. 0.5. Cells 
were then harvested by centrifugation for 20 min at 4,400x g in a Beckman JLA 8.1000 
rotor and kept at 4°C for subsequent steps. The pellet was resuspended in 500 mL ice-
cold water and centrifuged again. This procedure was repeated twice. The pellet volume 
was estimated and an equal volume of ice-cold water was added to resuspend cells. 
This yielded electrocompetent cells that could be stored at -20°C. 
 For electroporation, 0.2 ng of plasmid DNA was added to 50 L of 
electrocompetent cells followed by application of a pulse in an electroporation cuvette 
(400 ohms, 2.5 kV, 25 µF). After addition of 1 mL of SOC medium, the cells were 
incubated at 37°C for one h before plating appropriate dilutions on LB plates 
supplemented with 100 mg/L carbenicillin. 
 
Protein analysis 
Protein concentrations were determined using the Bradford method with bovine 
serum albumin (BSA, Sigma) as standard protein. 35 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
routinely performed in NuPAGE 4 to 12% Bis-Tris gels (Invitrogen) under reducing 
conditions with MOPS-SDS running buffer. The gels were stained with the SimplyBlue 
SafeStain (Invitrogen). 
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Formate dehydrogenase assay for peptide deformylase 
The FDH method is based on the use of Candida boidinii formate 
dehydrogenase. In a quartz cuvette (1 cm optical path), 450 µL reaction mixture 
containing 110 mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 0.1 mg/mL bovine liver 
catalase, 10 mM NAD+ solution, 1 mM N-formyl-Met-Ala-OH and 1U FDH (Sigma) were 
incubated. The reaction was started by adding 50 µL of a diluted EcPDF solution in 20 
mM MOPS/NaOH, pH 7.7, 100 mM NaCl, 10 µg/mL bovine liver catalase, and 2 mM 
TCEP to the mixture. The reaction was monitored at 30°C using a Perkin-Elmer UV-Vis 
spectrophotometer at 340 nm. 
 
Ninhydrin assay 
The ninhydrin assay for the detection of deformylase activity was carried out at 
30°C in a total volume of 200 µL. An amount of 100 µL of a suitable dilution of PDF in a 
buffer containing 20 mM MOPS/NaOH, 10 µg/mL bovine liver catalase, 100 mM NaCl, 
pH 7.7, and 2 mM TCEP was mixed with 100 µL of substrate solution composed of 110 
mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 0.1 mg/mL bovine liver catalase 
(Sigma) and 10 mM of the substrate (N-formyl-Met-Ala-OH or N-formyl-Phe-Phe-OH). 
The PDF dilutions were chosen such that approximately 10% of the substrate was 
converted in 15 min. Reactions were stopped by addition of 100 µL of a ninhydrin 
solution (1% in H2O) followed by incubation at 90°C for 5 min. 
 
DMBA assay 
The p-dimethylaminobenzaldehyde (DMBA) reagent was prepared by dissolving 
2 g DMBA in a citric acid solution in ethanol (315.5 g citric acid/L ethanol). The 
deformylase reaction was conducted in the same buffer as the ninhydrin assay, at 30°C 
in a total volume of 5 mL. The reaction was started by addition of 0.5 mL of PDF in 
dilution solution to 4.5 mL of solution containing 5.5 mM N-formyl-Met-Ala-OH as the 
substrate. The, 800 µL aliquots were withdrawn from the reaction mixture every 5 min 
and added to 400 µL of DMBA reagent. After 20 min at room temperature, the 
absorbance was measured at 415 nm.  
 
Site-directed mutagenesis 
For the mutagenesis work, the pBAD-PDFEtag construct was used as a template. 
A single mutant (E142A) and a double mutant (C138A/H141A) were constructed using 
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the QuikChange Site-Directed Mutagenesis Kit of Stratagene, following the protocol 
provided by the manufacturer. E142 was mutated to A with primer 5’-GCCATATGTATT-
CAGCATGCGATGGATCACCTGG-3’ and its complementary primer.  The double 
mutant was prepared by mutating C138 to A and H141 to A with the primer 5’-
GGTCTGTTAGCGATCGCGATTCAGGCGGAGATGGATCACC-3’ and its complemen-
tary primer. The mutated nucleotides are indicated in bold. In order to check the efficacy 
of the mutagenesis, a silent mutation was created in each primer to introduce a 
restriction site. The recognition sites of PvuI (double mutant primer) and NdeI (single 
mutant primer) are underlined. The resulting plasmids were transformed in E. coli 
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Saturated mutagenesis of EcPDF to broaden 
its substrate range 





The application of peptide deformylase in biocatalysis is restricted by its narrow 
substrate specificity. In this Chapter, a site-saturation mutagenesis approach was 
followed to broaden the substrate range of the EcPDFEtag, which is a modified version of 
E. coli peptide deformylase. The changes were directed toward four non-conserved 
residues known to be involved in substrate binding. The library was obtained by 
combinatorial randomization of these residues. The application of a growth selection 
method (described in Chapter 4) using N-formyl-Phe-Leu-OH as substrate yielded a 
mutant with 2.5-fold increased activity. Following the same approach, the activity of 
EcPDFEtag towards N-formyl-Leu-Phe-NH2 could be increased by two-fold. Sequencing 
of the mutants revealed the presence in both cases of a single mutation at the position 
of Cys-138, revealing the importance of this residue in substrate recognition. 
Subsequently, the activities of 20 different E. coli transformants expressing EcPDFEtag 
variants, covering all possible proteinogenic amino acids at position 138, was 
determined and five new substitutions at this position leading to active mutants were 




 Over the last decades, peptide deformylase (PDF) has been recognized as an 
interesting target for the development of antibacterial and anticancer drugs. Several 
crystal structures of PDFs of bacterial origin were solved with the aim to assist the 
design of new inhibitors for the enzyme, and a nmber of publications on this topic have 
appeared 9;17 15 2 21 8. Data on the use of PDF for other applications are very limited. 
Only one publication describes the use of E. coli PDF for the resolution of racemates of 
N-formylated α- and β-amino acids, α-amino acid amides and α-aminonitriles, which are 
interesting building blocks for organic synthesis 23. An important observation was that 
PDF has good regio- and enantioselectivity 19;23.  
 Substrate recognition and selectivity of PDF from E. coli were comprehensively 
studied by Ragusa and coworkers 20, who identified a set of enzyme-substrate 
interactions which are responsible for its tight specificity. The presence of a hydrophobic 
pocket at the S1’ site for methionine side-chain binding allows efficient deformylation of 




peptides with a formylated methionine only. N-formylated peptides with phenylalanine, 
leucine, tyrosine and isoleucine in position P1' are accepted but with a catalytic 
efficiency that is nearly two orders of magnitude lower (Table 1) 20. Consequently, for 
developing new applications, PDF needs to be changed from a highly specific enzyme 
into an enzyme with relaxed substrate specificity that will effectively deformylate N-
formylated peptides with other P1’side chains than methionine. 
 The hydrophobic S1' pocket of E. coli PDF (Figure 1) is built of three subparts 20: 
1) a ceiling, framed by the side chains of residues Glu-88 and His-132; b) the floor, 
characterized by Ile-44 and Cys-129; c) the back, lined by the side chains of Ile-86, Leu-
125 and Ile-128.  
 
Table 1. Effect of the nature of the first amino acid residue (P1’)on the hydrolysis of a 
combinatorial peptide library by PDF from E. coli 20 
Formylated N-terminal amino acid  kcat/Km (M-1s-1x103) Relative kcat/Km 
Methionine 131±11 100 
Phenylalanine 37±4 28 
Leucine 3.0±0.3 2.3 
Tyrosine 2.4±0.3 1.8 
Isoleucine 1.8±0.08 1.4 
Glutamine 1.8 ±0.02 1.4 
Alanine 0.84±0.08 0.6 
Valine 0.19±0.02 0.14 
Histidine 0.07±0.01 0.05 
Lysine 0.05±0.01 0.04 
Serine 0.04±0.01 0.03 
Threonine 0.034±0.004 0.026 
Glutamic acid 0.018±0.002 0.014 
Glycine 0.017±0.002 0.013 
Arginine 0.015±0.002 0.011 
Asparagine 0.011±0.001 0.008 
Aspartic acid 0.0009±0.00001 0.0007 
Proline «0.00003 «0.00002 
Tryptophan NS NS 
NS, no substrate 
 
Only two of these residues (Glu-88 and His-132) are involved in the hydrogen bonding 
network that is crucial for correct three-dimensional folding and for binding of the metal 
ion that is essential for catalysis and these are highly conserved among PDFs of 
different origins. The other residues that shape the S1' pocket are not conserved 




although the selectivity of different peptide deformylase is identical 14;16(see Chapter 3). 
Therefore, the high specificity is not primarily due to specific interactions with side 
chains of single amino acids but  
 
 
Figure 1. Representations of the active site of EcPDFwt with H-Met-Ala-Ser-OH as the ligand in the active 
site.. (A) Residues forming the hydrophobic pocket are shown as sticks. Ni2+ is coordinated by three 
conserved residues (His-132, His-136, Cys-90). (B) Structure of the pocket shown in surface display 
mode. The figures were generated with VMD software using pdb file 1BS6. 
 
should be attributed to the overall size and hydrophobicity of the crevice. Based on this 
assumption and on published work on substrate recognition and docking experiments, 
as well as on the design of inhibitors for peptide deformylase 6;10;14;15;20;22, we decided to 
target the amino acids Ile-86, Leu-125, Ile-128 and Cys-129 for expanding the substrate 
range.  
 Different tools are available to alter enzyme specificity and to create enzyme 
variants that are able to accept a larger range of substrates 18. Site-directed 
mutagenesis has successfully been used for redesigning substrate specificity in 
different classes of enzymes 11-13;24. This approach is based on detailed knowledge of 
the enzyme structure and mechanism 18. Use of a more random approach followed by 
different rounds of selection is an alternative approach. In this case, knowledge about 
the structure of the enzyme and interactions in the active site is not required, and 














in contact with the substrate. A drawback of this technique is the need to establish a 
selection or screening method that is suitable for evaluating the large numbers of 
mutants that are typically needed for finding the desired variants in random directed 
evolution libraries1.  
 In this Chapter, we report the use of a hybrid approach for the development of 
PDF variants with altered substrate specificity. In this method, four of the residues 
forming the hydrophobic S1’ pocket in E. coli PDF, i.e. Ile-95, Leu-134, Ile-137 and Cys-
138, were simultaneously randomized by saturated mutagenesis (Chapter 2). These 
correspond to Ile-86, Leu-125, Ile-128 and Cys-129 in the wild-type form of E. coli PDF. 
The choice for simultaneous randomization was supported by the synergistic effects 
that could possibly occur and that can not be reliably predicted for mutations applied to 
individual positions 3;5;25. Furthermore, the mutagenesis only targets positions which on 
the basis of the structure are expected to influence the selectivity of the enzyme. A gene 
library comprising about 220,000 mutants was generated and clones exhibiting the 
desired phenotype were identified by a growth selection assay. Analysis of the positive 
clones revealed a dominant role of the residue at position Cys-138 in determining the 
substrate specificity of PDF.  
 
Materials and methods 
Microorganisms, plasmids and cultivation conditions 
 Three different Escherichia coli strains were used as host for the propagation and 
expression of plasmid pBAD-PDFEtag and its mutants. Plasmid-containing E. coli 
ElectroMAX DH5α-ETM cells (Invitrogen), E. coli TOP10 (Invitrogen) and E. coli MC1061 
[hsdR2 hsdM+ hsdS+ araD139 Δ(ara-leu)7697 Δ(lac)X74 galE15 galK16 rpsL (StrR) 
mcrA mcrB1] were cultivated at  28, 30 or 37°C in LB medium supplemented with 100 
mg/L carbenicillin (LB-carb) for 16-18 h. The expression of the def gene, which encodes 
PDF, and its mutants, was induced in TOP10 and MC1061 cells by addition of 0.002 % 
(w/v) arabinose when the OD620 of the culture reached 0.5-1.0.  
 During the selection assays, strain E. coli MC1061 was cultivated on minimal 
medium plates (pH 7.3) that contained per liter: 6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 
1 g NH4Cl, 240 mg MgSO4, 11 mg CaCl2, 50 mg L-alanine, 50 mg L-arginine, 500 mg L-
aspartic acid, 500 mg L-glutamic acid, 50 mg glycine, 50 mg L-histidine, 50 mg L-
isoleucine, 50 mg L-lysine, 50 mg L-methionine, 50 mg L-phenylalanine, 50 mg L-




proline, 50 mg L-serine, 50 mg L-threonine, 20 mg L-tryptophan, 20 mg L-tyrosine, 50 
mg L-valine, 2 g glucose, 40 mg thiamine, 100 mg of carbenicillin, 5 mL of a trace 
elements solution and 20 g agarose. The trace elements solution contained per liter 780 
mg Ca(NO3)2·4H2O, 200 mg FeSO4·7H2O, 10 mg ZnSO4·7H2O, 10 mg H3BO3, 10 mg 
CoCl2·6H2O, 10 mg CuSO4·5H2O, 4 mg MnSO4·H2O, 3 mg Na2MoO4·2H2O and 2 mg 
NiCl2·6H2O. For control tests 50 mg/L L-leucine was added to the medium. The L-
arabinose concentration for PDF expression in growth selection experiments varied 
from 0.002 to 0.2 % (w/v). 
 
Electroporation of E. coli MC1061 cells  
 E. coli MC1061 cells were made electrocompetent by inoculating a single colony 
into 5 mL LB medium, followed by overnight growth at 28°C. Next, 2.5 mL of this culture 
was transferred to 500 mL LB medium and grown at 37°C to an OD620 of about 0.5. 
Cells were then harvested by centrifugation for 20 min at 4,400x g in Beckman JLA 
8.1000 and kept at 4°C during subsequent steps. The pellet was washed three times in 
ice-cold water suspended in volume of ice-cold water equal to the pellet volume. This 
yielded electrocompetent cells that were stored at -20°C. 
 For electroporation, 0.2 ng of plasmid DNA was added to 50 µL of 
electrocompetent cells followed by application of a pulse in an electroporation cuvette 
(400 ohms, 2.5 kV, 25 µF). After addition of 1 mL of SOC medium (containing per liter: 
2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 2.5 mM MgCl2, 10 mM 
MgSO4, 20 mM glucose) the cells were incubated at 37°C for one h before plating 
appropriate dilutions on LB plates supplemented with 100 mg/L carbenicillin. 
 
Construction of a four site saturated expression library 
 Forward and reverse primers with random codons (NNN) at the target positions 
were designed to recombine and randomize the codons for each of the four amino acid 
residues that were expected to influence the substrate specificity of PDF (Ile-95, Leu-
134, Ile-137 and Cys-138) (Table 2). 
Two separate PCR reactions (50 µL each) were performed for each of the four 
codons using Herculase II Fusion Enzyme (0.5 µl, Stratagene) and accompanying 
buffer, 30 ng pBAD-PDFEtag template, 1 mM dNTPs and either a codon-specific 
saturated (NNN) forward primer in combination with the reverse external primer or a 




codon-specific saturated (NNN) reverse primer in combination with the forward external 
primer (all primers: 250 nM)(Figure 2). All 8 reactions (4 residues x 2 reactions per  
 
Table 2. Synthetic oligonucleotides used for site saturated mutagenesis. Boldface – codon to be 
saturated. 
Primer  Codon Nucleotide sequence (5’  3’) 
PDFMUT 1for ATT GCGGCGAAACAGGCNNNGAAGAAGGTTGCC 
PDFMUT 2for CTG GAACTGGAAGCAGACGGTNNNTTAGCCATC 
PDFMUT 3for ATC GACGGTCTGTTAGCCNNNTGTATTCAGC 
PDFMUT 4for TGT CGGTCTGTTAGCCATCNNNATTCAGCATGAG 
PDFMUT 1rev AAT GCAACCTTCTTCNNNGCCTGTTTCGCCG 
PDFMUT 2rev CAG GATGCCTAANNNACCGTCTGCTTCCAGTTC 
PDFMUT 3rev GAT CATGCTGAATACANNNGGCTAACAGACCGTCT 
PDFMUT 4rev ACA TCTCATGCTGAATNNNGATGGCTAACAGACCG 
PDFex 1for  TCGCAACTCTCTACTGTTTCTCCATACCC 
PDFex1rev  CCTGGCAGGTTCCCTACTCTCGCATGG 
att-Primer forward  AGGAGGAATTAACCATGTCCGTGCTTCAAGTGTTACATATTCC 
att-Primer reverse  TTAAGCCCGGGCTTTCAGACGATCCAGTTTTTC  
 
residue) were started with an initial denaturation for 2 min at 95°C, followed by 30 
cycles of 20 s at 95°C, 20 s at 55°C, and 30 s at 72°C, and ended with an additional 
incubation of 3 min at 72°C.  After checking with agarose gel electrophoresis whether a 
single product was formed, the 8 amplification products were purified using the 
QIAquick PCR Purification Kit (Qiagen) and the final concentration of each single 
fragment was determined with the Qubit fluorometer in combination with Quant-iT 
dsDNA HS Assay Kit (Invitrogen). After this, an equimolar mixture of all fragments was 
added to a solution containing Herculase II Fusion Enzyme (0.5 µL), 1 mM dNTPs and 
accompanying buffer (50 µL). No additional primers or DNA template were added in this 
step. After an initial denaturation for 2 min at 95°C, the fusion PCR was performed by 
30 cycles of 20 s at 95°C, 20 s at 55°C, and 30 s at 72°C, followed by a final extension 
of 3 min at 72°C. The product of this fusion PCR was purified via preparative gel 
electrophoresis followed by extraction of the fragment from the gel with the QIAquick 
Gel Extraction Kit (Qiagen). Subsequently, the product was amplified (200 ng) in a new 
PCR reaction (50 µL) containing Herculase II Fusion Enzyme (0.5 µl) and 
accompanying buffer, 1 mM dNTPs, 250 nM att-Primer forward and 250 nM att-Primer 




reverse, using the same amplification conditions as above in order to add the 
recombination sites needed for cloning. The resulting product of 605 nt was then 
purified using the Qiaquick PCR Purification Kit (Qiagen) and cloned into pDONR/Zeo 
according to standard Gateway technology protocols. The resulting plasmid collection 
was transformed into E. coli ElectroMAX DH5α-E by electroporation. Transformants 
were selected by plating on LB plates containing zeomycin with incubation at 28°C for 
16-18 h, resulting in a library of about 400,000 clones. All colonies from this entry library 
were collected in LB liquid medium, after which plasmid DNA was isolated from 150 µL 
aliquots of the cell suspension using QiaPrep Spin Miniprep kit (Qiagen). The resulting 
plasmid preparations were stored and used as the mutant library. 
 After checking the quality of this entry library by sequencing of 14 randomly 
picked clones, a standard LR recombination reaction (a recombination reaction between 
attL and attR sites in standard Gateway cloning vectors) was applied to transfer the 
gene library from pDONR/Zeo to pBAD/Myc-His-DEST (see Materials and Methods, 
Chapter 2) with a molar ratio of destination vector to entry vector of 1:2 (150:300 ng). 
After electroporation of E. coli MC1061, transformants were selected by plating on LB 
medium containing 100 μg/ml carbenicillin, followed by overnight incubation at 28°C.  
 
Selection of active mutants and screening for increased activity 
 Active mutants were selected for their ability to allow the host (E. coli MC1061, 
leucine auxotrophic strain) to grow at 37°C on 1 mM N-formyl-Leu-Phe-NH2, N-formyl-
Phe-Leu-OH or N-formyl-Asp-Leu-OH as the sole source of leucine using a minimal 
solid medium supplemented with L-arabinose (0.02 or 0.2 % w/v) and glucose (0.2% 
w/v). After 5 days of growth, single colonies were transferred from the agar plates to 96-
well microtiter plates (MTPs) filled with 200 µL LB-carb medium per well. After overnight 
incubation at 28°C with 200 rpm orbital shaking, 100 µL samples of the cultures were 
transferred to new 96-well plates followed by addition of glycerol (8% w/v) and storage 
at -80°C as master plate. Cells of the remaining part of the cultures were collected by 
centrifugation, resuspended in 100 µL physiological salt solution (0.91% w/v of NaCl) 
containing 8% glycerol and stored at -80°C. For re-testing, a sample from the master 
plate was thawed and plated on minimal medium under the same conditions as applied 
in the first selection, and cells were grown at 37°C for 2 days.  




Plasmids were isolated from growing colonies by the QiaPrep Spin Miniprep kit 
(Qiagen) and subsequently reintroduced into E. coli MC1061 according to the protocols 
described above.  
Positive hits, obtained via selection for auxotrophic complementation on minimal 
medium, were further investigated by determination of the PDF activity. In order to do 
so, the colonies growing on minimal medium were transferred to 30 mL LB-carb. 
Expression of the PDFE-tag variant was induced by adding 0.002% L-arabinose when the 
OD620 reached 0.6. Cells were harvested after overnight incubation at 28°C by 
centrifugation at 5,000 x g for 15 min and 4°C. To prepare a cell-free extract (CFE), 
cells were resuspended in 1 mL lysis buffer composed of 50 mM MOPS pH 7.5, 0.1 
mg/mL DNAse I grade II (Roche), 2 mg/mL lysozyme (Bachem), 1.23 mg/mL 
MgSO4·7H2O, 10 µg/mL catalase from bovine liver (Sigma) and 1 mM TCEP and stored 
overnight at -20°C. Then the cell suspension was thawed, incubated for one hour at 
room temperature and subsequently CFE was obtained by centrifugation at 33,300 x g 
for 1 h at 4°C. Expression levels of the PDF mutant enzymes was checked by SDS-
PAGE as described below.  
Deformylase activity was measured at 30°C in a total volume of 500 µL with 50 
µL of different dilutions of PDF (CFE or whole cells) as described under the paragraph 
Activity assays. The incubation time was varied based on the expected activity of the 
mutant clones on the different substrates. Analysis of substrate and product was 
performed using the HPLC method described below. 
 
Single-site saturation mutagenesis of Cys-138 
 Construction of a site-saturation library of amino acid Cys-138 in EcPDFE-tag was 
performed by Sloning Biotechnology. The 17 variants (two mutants were available 
already, see Results) were cloned into pBAD/Myc-His-DEST. Transformation of E. coli 
TOP10 and plating on LB-carb plates, followed by overnight incubation at 28°C, yielded 
the desired transformants. 
 
Protein electrophoresis 
 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
routinely performed in NuPAGE 4 to 12% Bis-Tris gels (Invitrogen) under reducing 




conditions with MOPS-SDS running buffer. The gels were stained with the SimplyBlue 
SafeStain (Invitrogen).  
 
Enzyme purification 
 E. coli TOP10 cells carrying plasmid pBAD-PDFEtag and its variants were 
cultivated at 28-30°C in LB medium supplemented with 100 mg/L carbenicillin for 16-18 
h. The expression of the def gene and its variants was induced when the OD620 reached 
0.5-1.0 by the addition of 0.002 % arabinose. Cells were harvested by centrifugation 
and about 2 g (wet weight) of cell paste was suspended in 10 ml buffer (20 mM 
HEPES/KOH, 100 mM KCl, pH 7.7 supplemented with 10 µg/mL catalase from bovine 
liver). After disintegration by sonication (Branson B12, 10 min) at 0°C, cell-free extract 
was obtained by centrifugation at 33,300 x g for 1 h at 4°C. CFE was subsequently used 
for enzyme purification. 
Purification of all PDF mutants was executed using an ÄKTA explorer system 
(GE Healthcare) equipped with a Mono Q HR 5/5 column (GE Healthcare). The 
procedure is described in Chapter 2. 
 
Activity assays 
 The activity of the PDF variants was assayed towards several substrates in 450 
µL reaction mixtures containing 110 mM MOPS/NaOH buffer (pH 7.2), 300 mM NaCl, 
0.1 mg/mL bovine liver catalase and 0.6 mM of the desired substrate. To this substrate 
solution was added 50 µL of an appropriate dilution of PDF in 20 mM MOPS/NaOH, pH 
7.7, 100 mM NaCl, 10 µg/mL bovine liver catalase, and 2 mM TCEP. After starting the 
reaction by the addition of the PDF, 100 µL aliquots were withdrawn from the reaction 
mixture and added to 100 µL of 1 M phosphate buffer (H3PO4-NaOH), pH 2.66, to stop 
the reaction. Sampling times were adjusted in accordance with the activity of the PDFs 
for the substrate ensuring activity measurements in the initial linear part of the progress 
curve. The substrates that were used for the activity tests were: N-formyl-Leu-Phe-NH2; 
N-formyl-Phe-Leu-OH; N-formyl-Val-Val-OH; N-formyl-Tyr-Leu-Phe-NH2; N-formyl-Met-
Ala-OH; N-formyl-Lys-Phe-NH2; N-formyl-Phe-Phe-NH2 provided by Chiralix (Nijmegen, 
the Netherlands). Samples were analyzed using the HPLC method described below. 
 
 





 HPLC analysis was carried out using a stainless-steel analytical column (50 mm 
length, 4.6 mm ID) packed with Inertsil ODS-3 material, 3 µm particle size (Alltech 
Applied Science). The flow was 2 mL/min. Detection was performed at 40°C at a 
wavelength of 210 nm. For HPLC detection of N-formyl-Met-Ala-OH (2.21 min), H-Met-
Ala-OH (0.63 min), N-formyl-Val-Val-OH (1.86 min), H-Val-Val-OH (0.51 min), N-formy-
Tyr-Leu-Phe-NH2 (2.53 min), the injection volume was 10 µL and the following gradient 
of acetonitrile in 10 mM H3PO4 was used: t=0-0.5 min, 0.5 % (v/v) acetonitrile isocratic; 
t=0.5-3 min, 0.5%-50% acetonitrile linear increase; t=3-3.1 min, 50%-0.5% acetonitrile 
linear decrease. For HPLC analysis of N-formyl-Phe-Leu-OH (2.59 min), H-Phe-Leu-OH 
(1.56 min), N-formyl-Lys-Phe-NH2 (0.91 min), H-Lys-Phe-NH2, N-formyl-Leu-Phe-NH2 
(2.34 min), H-Leu-Phe-NH2 (1.26 min), N-formyl-Asp-Leu-OH (1.73 min), H-Asp-Leu-
OH (0.8 min) the injection volume was 5 µL and the following gradient of acetonitrile in 
10 mM H3PO4 was used: t=0-3 min, 5-65% (v/v) acetonitrile linear increase; t= 3-3.1 
min, 65-5% acetonitrile linear decrease. 
 
Modeling of C138A and C138V mutants 
 In order to evaluate the effects of the mutations C138A and C138V on the active 
site architecture, their amino acid sequences were used to build three-dimensional 
models with the SWISS-MODEL server (http://swissmodel.expasy.org//SWISS-
MODEL.html). 
 
Results and discussion 
Structure-inspired saturated mutagenesis 
 In order to change the substrate specificity of the EcPDFEtag, residues potentially 
involved in substrate recognition were identified by inspecting PDF crystal structures 
and the reaction mechanism. The substrate binding site of PDFs is formed by 7 
residues 14;20, and of these, four residues were chosen as targets for the structure-
guided saturated mutagenesis. The importance of residues His-132 and Glu-88, which 
together delineate the ceiling of the pocket in EcPDF, was demonstrated by Meinnel 
and coworkers 6. These residues are strictly conserved in PDFs and are involved in the 
correct folding of the 3D structure of the enzyme via a complex hydrogen bonding 
network. His-132 also serves as a ligand for the metal ion (Figure 1) and Glu-88 is 




involved in a series of hydrogen bonds which reinforce the enzyme structure in the 
vicinity of the metal ion. Therefore they were omitted from the set of target positions for 
mutagenesis. Another residue that is part of the S1' pocket is Ile-53, which appears to 
be a hydrogen bond donor to the second carbonyl of the substrate and most likely plays 
no important role in the recognition of the P1' side chain. Therefore, the sites that were 
selected as mutagenesis targets in the PDFEtag were Ile-95, Leu-134, Ile-137 and Cys-
138. 
 An interesting feature of these residues is that they are not conserved, although 
the substrate specificity of peptide deformylases originating from different organisms is 
strictly identical 20 and Chapter 3. For this reason it was decided to simultaneously 
mutate these four sites, creating a mutant library of high sequence diversity. The 
advantage of mutating in a combinatorial way instead of preparing single mutants is 
reported in various papers showing that mutants having multiple amino acid 
substitutions have larger differences in substrate specificity compared to single mutants. 
The effects of individual mutations on substrate selectivity can be influenced by the 
identity of other residues that are near to the targeted region due to combined effects on 
binding site geometry and substrate orientation 1;25. In fact, we expected that the 
substrate specificity of PDF will be influenced by the overall size and hydrophobic 
character of the crevice more than by the identity of single amino acid side chains. Only 
hydrophobic interactions are responsible for formation of the hydrophobic pocket that 
nicely accommodates the methionine side chain (His-141, Cys-138, Ile-137, Leu-134, 
Ile-95, Glu-97, Ile-53). Hydrogen bonds are formed only between atoms of the peptide 
backbone of the substrate and Gly-53, Ile-53, Gly-98 and Arg-106. This is consistent 
with the low sequence specificity of the enzyme for the P2’ and further amino acid 
residues of the nascent polypeptide chain. 






Figure 2. Schematic representation of the mutagenesis procedure used in this study. In the first step two 
separate PCR reactions were performed for each of the four codons using a random codon in the target 
position of the mutagenic primer and an universal external primer. After purification of the amplicons, an 
equimolar mixture of all fragments was added to a solution containing polymerase. The resulting product was 
then purified, multiplied with recombination sites containing primer, and cloned into pDONR/Zeo. 
 
The mutant library was constructed with the Saturated Mutation Primer PCR (SMPP) 
Recombination method 4 applying the EcPDFEtag gene as template and using saturated 
mutagenic forward and reverse primers for simultaneous randomization of the four 
target amino acid residues. This enabled the exploration of all possible combinations 
and permutations of interesting amino acid residues at the 4 target sites, thereby 
including possible synergetic interactions which may be caused by compensating 
geometric effects that may be required for fitting different P1’ side chains. Cloning of the 
obtained fragments into vector pBAD/Myc-His-DEST via in vitro recombination resulted 
in a mutant library of about 400,000 colonies. The quality of the library was checked via 
sequencing of the PDF genes of 42 randomly picked colonies. In total 11 of these genes 
revealed the wild-type sequence, 22 carried a single mutation, 7 carried two mutations 
Universal 5’-primer 
and saturated primer 
Universal 3’-primer 













and 2 were triple mutants. Despite the presence of wild-type PDF genes, the library was 
sufficiently rich in molecular diversity. Furthermore the use of a growth selection method 
for the identification of the best mutants allows an extremely high-throughput with the 
exclusive survival of desired variants and removal of wild-type enzymes before further 
analysis. 
  
Selection of mutants with altered substrate specificity 
 The development of a selection method for PDF variants with increased activity 
toward a formylated dipeptide containing leucine is described in Chapter 4. This 
approach is based on the complementation of E. coli MC1061 leucine auxotrophy. For 
this purpose, cells are grown on a medium containing leucine in a form of a formylated 
dipeptide. The successful utilization of this substrate can be achieved only if it is 
unmasked to the dipeptide by a peptide deformylase because this is required for 
subsequent hydrolysis into the free amino acids by cellular peptidases. The substrates 
used in the selection procedure were N-formyl-Phe-Leu-OH, N-formyl-Leu-Phe-NH2 and 
N-formyl-Asp-Leu-OH (Figure 3). These substrates were chosen because a study by 
Ragusa et al. 20 showed that the catalytic efficiencies [kcat/KM] of EcPDFwt for these 
substrates differ by more than 4 orders of magnitude 20. 
 The first selection was conducted on agar plates containing N-formyl-Phe-Leu-
OH as the only source of leucine and 0.2% L-arabinose to induce protein expression. A 
total of about 400,000 colony forming units (CFUs) were plated on this. After 5 days at 
37°C, 15 of these actually formed colonies. Re-streaking of these positive colonies 
showed that 10 of them were still able to grow on the selective plates, while the 
remaining 5 were false positives. Subsequently, plasmid borne activity was proven for 3 
of these 10 hits by isolation of the plasmid from these primary hits followed by 
reintroduction into E. coli MC1061 and a second selection round on the same medium. 
This procedure allowed us to discriminate among the clones that were able to grow due 
to a mutation carried on the plasmid and the ones favouring growth due to chromosomal 
mutations that might theoretically appear due to such diverse effects as better uptake of 
the substrate, increased PDF overexpression, or higher peptidase activity leading to 
more leucine formation from formylated dipeptides.  


































reference substrate  
Figure 3. Reference substrate for PDF and selection substrates used in this study. 
 
 
Determination of the specific activity of these 3 hits toward N-formyl-Phe-Leu-OH was 
carried out using CFE (see Materials and Methods) and revealed a 2.5-fold 
improvement compared to the EcPDFEtag wild type. Sequencing disclosed that all three 
carried asingle mutation C138V, each encoded by a different codon. 
 The same selection method was applied to identify mutants with activity towards 
N-formyl-Leu-Phe-NH2. In this case, however, the negative control (non-mutated 
EcPDFEtag in E. coli MC1061) already demonstrated significant growth, precluding 
identification of improved mutants. A reduction of the L-arabinose concentration from 
0.2 to 0.02 wt. % significantly reduced the wild-type growth and thus allowed 
discrimination between wild-type and improved mutants. Plating of about 350,000 CFUs 
on this medium resulted in the appearance of 44 colonies. The positive colonies were 
retested for their ability to grow on selective medium and 25 of them were confirmed. 
Subsequently, plasmid-encoded activity was proven for 4 of these, using a second 
selection round on the same selective medium containing N-formyl-Leu-Phe-NH2 as 
only source of leucine. An increase in activity of about 2-fold toward the selection 
substrate was determined after preparation of the CFE from these clones. All 4 mutants 
appeared to contain the C138A mutation, encoded by the triplets GCC and GCG. 






































Figure 4. The hydrophobic S1’ pockets of EcPDF 
variants. (A) Mutant EcPDFEtagC138A. (B) Mutant 
EcPDFEtagC138V. (C) EcPDFwt and H-Met-Ala-Ser-
OH (in grey) in the active site pocket. The Met side 
chain points downward into the S1’ site. Residues 
forming the hydrophobic pocket are shown in sticks. 
 
 
 As described above, the selection for E. coli clones that express a PDF variant 
that has acquired activity with N-formyl-Phe-Leu-OH or N-formyl-Leu-Phe-NH2 was 
done on plates containing 0.2 and 0.02 % L-arabinose, respectively. The lower 
concentration of inducer was needed to suppress the growth of the non-mutated 
EcPDFEtag when using the latter substrate. This was surprising since the specific activity 



















Phe-NH2. To further study why the EcPDFEtag allowed better growth with N-formyl-Leu-
Phe-NH2 than with N-formyl-Phe-Leu-OH (despite the higher catalytic efficiency of 
EcPDFfor the latter substrate) the activity of intact E. coli cells expressing EcPDFEtag 
wild type was determined with both formylated peptides and compared to that of the 
same cells towards the deformylated dipeptides. The results made clear that whole cells 
metabolize N-formyl-Leu-Phe-NH2 faster than the other formylated substrate (Table 3). 
For example, 0.045 mg/l of E. coli MC1061 cells (wet weight) expressing PDFE-tag 
converted in 15 min 96% of a 1 mM N-formyl-Leu-Phe-NH2 solution, whereas under the 
same conditions only 13% conversion was obtained with 1 mM N-formyl-Phe-Leu-OH. 
Both substrates were effectively split into separate amino acids after deformylation. 
Thus, the relative deformylation activity of whole cells for these two substrates is 
inverted as compared to that of free enzyme. Moreover the deformylated peptides are 
converted faster than the formylated ones. We can therefore conclude that the 
unexpected better growth on minimal medium with N-formyl-Leu-Phe-NH2 as sole 
source of leucine can be traced back to a higher rate of substrate uptake by the E. coli 
cells. 
 
Table 3. Degradation of N-formyl-Leu-Phe-NH2 and N-formyl-Phe-Leu-OH by whole cells 
of E. coli  MC1061 expressing PDFEtag. 
 Relative amount (area %)b 
Substrate 0.9 ga 0.09 ga 
Exp 1 :   
 N-formyl-Leu-Phe-NH2 4 60 
 H-Phe-OH 73 26 
 H-Phe-NH2 22 10 
 H-Leu-Phe-NH2 1 4 
Exp 2:   
 N-formyl-Phe-Leu-OH 87 93 
 H-Phe-OH 12 7 
 H-Phe-Leu-OH 2 1 
a   Amount of wet cells used for activity determination (in 20 ml reaction volume).Cells 
were mixed with substrates (N-formyl-Leu-Phe-NH2 or N-formyl-Phe-Leu-OH) and 
concentration of substrate was and reaction products were measured after 15 min.     
b  Percentage of substrate remaining and reaction products formed after incubation of 
whole cells with the substrate indicated (1 mM). 
 




The third substrate used in the selection assay was N-formyl-Asp-Leu-OH. 
Despite the use of different L-arabinose concentrations for induction and a prolonged 
incubation time of the selection plates (up to 25 days), no colonies were observed. An 
explanation for this may be the very low catalytic efficiency of EcPDF wild-type for 
formylated dipeptides with an aspartic acid residue in position P1'. Since the catalytic 
efficiency for this substrate is more than 100,000-fold lower than for a formylated 
peptide with an N-terminal methionine residue (see Table 1), we can speculate that the 
increase in activity needed for growth was just too high to be obtained in a single round 
of mutagenesis. 
 
Partial characterization of Cys-138 EcPDFEtag mutants 
 Based on the observations in the primary screening that only mutations at 
position Cys-138 gave an increased activity towards the selection substrates, our 
interest shifted to a deeper understanding of the role Cys-138 plays in substrate 
recognition. This residue is positioned at the floor of the cavity and it is interacting with 
the methionine side chain of the substrate (Figure 4). We constructed all possible 
mutants at this position and tested the expression and activity of E. coli cells harboring 
these EcPDFEtag variants using gel electrophoresis and the activity assay described in 
Materials and Methods. The results of these experiments are presented in a qualitative 
mode in Table 3, and the gels are shown in Figure 5. 
In total six substitutions at position Cys-138 (C138I, C138L, C138T, C138V, 
C138A and C138Y) led to expression of active enzyme. Using CFE, a first evaluation of 
their activity on several substrates showed that the variants posses a remarkable 
difference in substrate specificity. The nonpolar aliphatic side chains of alanine, valine 
and isoleucine at position 138 allow activity on several substrates, whereas the polar 
side chains of tyrosine and threonine give a lower activity as compared to the EcPDF 
wild-type towards all tested substrates. 
The six active mutants were all overexpressed in E. coli TOP 10 and appeared 
stable. They were subsequently purified via ion exchange chromatography in order to 
determine, in a quantitative way, the substrate specificity towards a series of N-
formylated peptides (Figure 5). Overexpression was high: about 10-20% of the total 
protein in cell-free extract of mutants C138I, C138L, C138T and C138V consisted of 
PDF, while in the case of C138Y and C138A the expression level was less than 10%.   




 After purification all mutants (Figure 6) showed a lower activity for N-formyl-Met-
Ala-OH compared to EcPDF wild-type (Table 5). The activities found with pure enzyme 
confirmed the results of the growth selection. In fact, the C138V mutant, which was 
found with N-formyl-Phe-Leu-OH as selection substrate, showed the highest activity 
towards this substrate, with a 2.4-fold improvement as compared to the wild-type 
enzyme. The mutant was also highly active towards another substrate with a 
phenylalanine in position P1’: N-formyl-Phe-Phe-NH2, attesting the correlation between 
the mutation and the acceptance of the phenylalanine side chain in the modified S1’ 
pocket. Moreover, the fact that mutant C138I was not found during the selection assay 








Figure 5. SDS-PAGE of the EcPDFE-tag mutants. Upper panel: whole cells. Lower panel: SDS soluble 
fraction. Letters indicate the C138 substitution introduced at position C138 in E. coli PDFE-tag. Ma: marker 
proteins, Ni, non-induced. 
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 A similar evaluation was done considering N-formyl-Leu-Phe-NH2 as substrate. 
In this case, the only mutant with a significantly increased activity towards the dipeptide 
is C138A. Again, the result of the activity assays and the growth selection matched. 
Furthermore the outcome of the retest demonstrated the strength of the growth 
selection assay. Thanks to a careful tuning of the conditions chosen for the selection 
using N-formyl-Leu-Phe-NH2 we were able to discriminate between C138A and wild-
type, having only 1.5-fold difference in activity (Table 5). 
 The largest improvement in substrate specificity was reached for the substrate N-
formyl-Phe-Phe-NH2. Clones C138V and C138I showed respectively a 7.7- and a 7.5-
fold increased activity as compared to the wild type (Table 5). Despite the good results 
obtained, the activity towards the tested substrates still appeared much lower than the 
one measured with the natural substrate mimic, N-formyl-Met-Ala-OH.  
 We conclude that because of the prominent role played by residue Cys-138 in 
substrate recognition, most mutations at this position are extremely detrimental for the 
activity of EcPDFEtag with the natural substrate. Analysis of the production of the PDFs 
mutated at position 138 revealed formations of inclusion bodies in the cells, which were 
visible upon SDS-PAGE of pellets obtained by centrifugation of total cell lysates (data 
not shown). Inclusion body formation coincided with a low level of PDF in the soluble 











lane 1, Protein standard 
lane 2, CFE C138I  
lane 3, C138I purified  
lane 4, CFE C138L 
lane 5, C138L purified 
lane 6, CFE C138T 
lane 7, C138T purified 
lane 8, CFE C138Y 
lane 9, C138Y purified 
lane 10, CFE C138A 
lane 11, C138A purified 
lane 12, CFE C138V 
lane 13, C138V purified 
Figure 6. SDS-PAGE of the EcPDFEtag mutants before and after purification via ion exchange 
chromatography; Lanes were loaded with 25 µg protein. 
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substitution of Cys-138 with isoleucine, alanine or valine. The aggregation of insoluble 
misfolded protein reveals the importance of position 138 for correct folding of 
EcPDFEtag. According to previous studies conducted by Meinnel and coworkers 20, the 
substitution of Cys-129 in EcPDFwt (corresponding to Cys-138 in EcPDFEtag) had very 
different effects on the catalytic efficiency. It was shown that C129W resulted in a 
reduction of hydrolysis rate by four orders of magnitude while with C129A the 
deformylation rate was identical to that of the wild-type enzyme. In contrast substitution 
of Ile-86, Ile-128 and of Leu-125 caused a decrease of catalytic efficiency in all cases 
although the remaining rate varied of up to one order of magnitude 20 
 It is likely that for further enhancement of the activity of PDF towards different N-
formylated dipeptides, more mutagenesis rounds that include other sites than Cys-138 
would be needed. Future mutagenesis studies can identify other crucial residues for 
substrate recognition and simultaneous mutagenesis of these hotspots could lead to an 
altered substrate binding pockets with more dramatic effects on the substrate specificity 
of the enzyme. 
 
Table 5.  Peptide deformylase activity of EcPDFEtag and different C138 mutants purified via ion 
exchange chromatography. 
 Sp. Activity (U/mg) of: 
Compound EcPDFEtag C138I C138L C138T C138Y C138A C138V 
N-formyl-Met-Ala-OH 970 140 30 140 0 420 770 
N-formyl-Val-Val-OH 0.4 0.2 0 0 0.2 0.4 0.8 
N-formyl-Phe-Leu-OH 12 13 3 2 0 5 30 
N-formyl-Lys-Phe-NH2 0.03 0 0 0.04 0 0.01 0.01 
N-formyl-Leu-Phe-NH2 4 0 0 2 0 6 2 
N-formyl-Phe-Phe-NH2 4 30 5 1 2 2 31 
N-formyl-Tyr-Leu-Phe-NH2 4 10 3 1 0 1 12 
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Figure 7. Alignment of the EcPDFwt with the sequences of twenty-nine other peptide deformylases from 
different organisms. The alignment was generated with ClustalW2 at the server of the European 
Bioinformatics Institute. The enzyme codes refer to their accession numbers. The residues highlighted by 
the boxes indicate the sites mutated in this study. The residues marked with a circle line the S1’ pocket of 
BsPDF and TtPDF. 
 
Mutation of the S1’ pocket 
Comparisons of structures and sequences of S1’ pockets of PDFs from different 
organisms using alignment programs and visualization software revealed that the 
variable residues found in the S1’ cleft modify its overall shape only slightly, while 
retaining the hydrophobic character that is responsible for the affinity to and anchoring 
of the substrate Results of alignments show that among the non-conserved residues, at 
least two are changed simultaneously as compared to the E. coli PDF, suggesting a 
change in the pocket shape while maintaining the hydrophobic character, which will 
allow the methionine side chain still to fit when it adopts a different conformation 9.. The 
alignment showed that the S1’ pocket of B. stearothermophilus (BsPDF) is formed by 
Glu-108 and His-153 delineating the ceiling, Val-150 and Ile-59 at the floor and Ile-149, 
Thr-106 and Leu-146 framing the back. In the case of T. thermophilus (TtPDF) the 
residues are Glu-100 and His-145 for the ceiling, Val-43 and Val-142 for the floor and 
Arg-141, Tyr-138 and Gly-98 composing the back (Figure 7). Our attention was 
therefore pointed at the presence of valine instead of cysteine at a position that 
corresponds to Cys-138 of E. coli PDFEtag. 
 Because of the important role played by Cys-138 in defining the substrate 
specificity of EcPDF, the activity of BsPDF and TtPDF, which carry a valine at the 
corresponding position in the S1’ cleft, was tested against N-formyl-Phe-Leu-OH. The 
results showed no elevated activity of these PDFs (Table 6). From a structural analysis 
of the hydrophobic pockets of BsPDF and TtPDF, we noticed that several residues are 
different compared to EcPDFEtag. For example, in TtPDF Arg-141, orienting its side 
chain towards the back of the pocket is present instead of the Ile-137 of EcPDFEtag, and 
Tyr-138 is closing the bottom of the pocket. In the case of BsPDF, Thr-106 is replacing 
Ile-95 of EcPDFEtag while the other residues of the pocket are conserved. Despite this, 
the orientation of their side chains is different compared to EcPDF (Figure 7), probably 
leading to a different orientation of the N-formylated peptide in the active site compared 
to EcPDF, which still allows high catalytic efficiency when methionine is present in 
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position P1 but does not cause an increased activity towards other hydrophobic amino 
acid residues. 
 
Table 6. Peptide deformylase activity in E. coli TOP10 CFE overexpressing EcPDFEtag, 
                 B. stearothermophilus PDF (BsPDF) and T. thermophilus PDF (TtPDF). 
 Sp. Activity (U/mg)  
Compound EcPDFEtag  BsPDF  TtPDF  
N-formyl-Met-Ala-OH 12 17 14 






Figure 7. Representations of the hydrophobic pockets of BsPDF (A) and TtPDFEtag (B). Residues forming the 
hydrophobic pocket are shown in sticks. 
 
Previous studies on E. coli PDF showed this enzyme to have a relatively high 
affinity for hydrophobic amino acid residues other than methionine (as indicated by their 
low KM value) but also a very low hydrolysis rate (kcat). This is possibly due to a wrong 
orientation of the N-formyl group in the catalytic site 7. 
From the mutagenesis work on the EcPDFEtag it appears that very few mutations 
are allowed in order to maintain activity. This is in contrast with the fact that PDF from 
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other organisms present a different set of amino acids around the S1’ pocket and yet are 
highly active towards the natural substrate. We can therefore conclude that it is not just 
the change of one amino acid that can strongly influence the substrate specificity, but a 
combination of substitutions that enables a change of the overall architecture of the 
cleft. 
 Based on the marked substrate specificity of peptide deformylases and on the 
obtained results, it is tempting to assume that Cys-138 in combination with the other 
residues delineating the pocket is evolutionary the best residue for activity towards the 
natural substrate. In fact, a synergy among the variable residues delineating the S1’ 




The mutagenesis data presented here show that very few mutations are tolerated 
in the hydrophobic S1’ pocket that binds the methionine side chain of E. coli PDF. From 
a library that is randomized at four non-conserved positions that surround this pocket, 
few active variants were discovered and they all carried mutations only at residue Cys-
138. These variants showed elevated activity with target N-formyl-peptides that were 
used for selection, demonstrating that it is indeed possible to increase the activity of a 
PDF using the approach described here.  
The analysis of a library of mutants at position 138 confirmed that only a few 
mutations are allowed, with most substitutions giving either unfolded (aggregated) 
enzyme or enzyme with very low activity. Thus, it appears difficult to change the 
selectivity while maintaining activity of E. coli PDF by mutating residues around the S1’ 
pocket only. The fact that the mutated residues are not conserved in the sequence of 
homologous PDFs suggest that compensating mutations are required in residues that 
do not directly surround the active site, but instead occupy positions in the second shell 
around the active site. A strategy to maintain activity while changing substrate specificity 
could thus be to modify a larger number of second shell residues simultaneously with 
the amino acids that surround the S1’ pocket. 
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Peptides built of α-, β- or γ-amino acids can have very different biological 
functions. For example, they can act as hormones, neuropeptides, antibiotics, toxins or 
they may be involved in immune protection. Due to these diverse effects on 
physiological processes peptides are recognized as having high potential in medical 
applications. Peptides are also increasingly important as health- and taste-enhancing 
food ingredients and they may improve nutritional value. The growing interest in the 
physiological role of peptides and their emerging applications in foods and medicine 
contribute to an increased demand for cost-efficient and versatile methodologies for 
peptide synthesis, as well as better procedures for their isolation and analysis. 
 Three main approaches are available for the preparation of small peptides: 
chemical synthesis, production by fermentatation, and chemo-enzymatic peptide 
synthesis. Despite the widespread use of fermentative production for large peptides and 
proteins and the availability of good methods for chemical synthesis of short peptides, 
the chemo-enzymatic approach is considered of growing importance, especially for the 
production of peptides shorter than 10 amino acids. The key step in this process, i.e. the 
coupling of amino acids to form peptide bonds, is based on enzymatic catalysis. It has 
the advantage of mild reaction conditions that prevent undesired racemisation. 
Moreover the selectivity of enzymes allows a limited need for protection/deprotection of 
amino acid side chains, which reduces costs 17;26.  
The most useful enzymes for peptide bond synthesis are proteases that can be 
used in thermodynamically or kinetically controlled coupling reactions. In both cases a 
proper strategy for the introduction and removal of activating or protecting groups needs 
to be employed during the synthesis of complex molecules 2. Despite the existence of 
hundreds of different protecting groups, the search for cheap and easily cleavable ones 
is still ongoing. An attractive solution would be the application of biocatalysis to carry out 
highly chemo- and regioselective deprotection. A cheap, enzymatically cleavable group 
like formyl (For) is industrially attractive since it can easily be introduced in a cost-
effective manner at the N-terminus of peptides and it can be removed enzymatically. 
Formylation can be done using formic acid and acetic acid anhydride 18. The work 
described in this thesis is focused on the application of peptide deformylase as 
biocatalyst for the removal of the formyl group.  
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In eubacteria, ribosome-mediated protein synthesis starts with the N-formylation 
of the methionyl moiety, that will become the first amino acid building block of a newly 
synthesised peptide 22. After peptide synthesis, the formyl group is cleaved off from the 
growing peptide by the action of peptide deformylase. Next, methionyl aminopeptidase 
may remove the N-terminal methionine leading to a mature protein 5. PDF activity is 
essential for the survival of eubacteria, but it is also important in eukaryotes because 
protein synthesis in eukaryotic organelles such as mitochondria also starts with N-formyl 
methionine 8;9;11;24. Its importance for bacterial and mitochondrial protein synthesis and 
growth has stimulated extensive research on the possibility to use PDFs as a target for 
antibacterial and antiparasitic agents 9;15. However, at the start of this work, data on 
biocatalytic applications of PDFs were scarce. Only one publication described the 
application of the enzyme in stereoselective synthesis of amines and amino acid 





















Figure 1. Peptide deformylase reaction with For-Met-Ala-OH. 
 
The formyl moiety can be used as a protecting group that prevents a nucleophilic 
reaction of the N-terminal amino group of an amino acid or peptide that acts as the acyl 
donor in peptide-coupling reactions. If the formyl group is applied for this, it should be 
removed after the coupling step and prior to the next elongation step by a mild method 
that keeps the synthesized peptide bond intact and does not cause racemisation is 
needed for removal of the formyl group after completion of the coupling and prior to the 
next step. Acid-mediated chemical hydrolysis is the conventional method for the 
removal of formyl group from the N-terminus of peptides, but these harsh conditions 
lead to significant concomitant peptide bond hydrolysis.  
The use of a bacterial peptide deformylase offers a milder way for this 
deprotection step. However, adequate purification steps are required for obtaining PDF 
preparations that are suitable for peptide deformylation, since extracts of a production 
organism like E. coli contain amidases and peptidases that cause extensive peptide 
bond hydrolysis. The work detailed in Chapter 2 explores the development of two simple 
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and industrially applicable purification methods for the PDF from E. coli (EcPDF). 
Because of the small size of EcPDF (molecular mass 19 kDa)3 compared to the 
average size of E. coli amidases and peptidase 1, we first tested ultrafiltration as a 
simple and cost-effective way to separate EcPDF from amidases and peptidases 
present in the cell-free extract (CFE). In order to enhance the difference in size, we 
included testing of shortened version of EcPDF obtained by removal of its C-terminal α-
helix at the gene level. The purification of both versions of EcPDF was attempted using 
membranes with different cut-off values (50 and 100 KDa) and filtration conditions. The 
passage of PDF through the membrane was heavily influenced by the size of the pores 
but also by protein concentration, pH, ionic strength and mechanical stress. The best 
purification results, leading to a recovery of 21% of the EcPDF activity in the filtrate, 
were obtained with a 100 kDa filter. The level of contaminating amidases in the purified 
sample decreased by 27-fold compared to the CFE, which was judged as being 
insufficient. A possible cause for this moderate performance is membrane fouling and 
clogging leading to poor flux and aspecific size discrimination. These phenomena can 
possibly be reduced by using tangential flow filtration since in this technique the shear 
flow reduces gel-like depositions on the membrane surface. Nevertheless when 
applying tangential flow for PDF purification, similar unsatisfactory results were 
obtained. Furthermore, the poor separation with filters with smaller pore sizes suggests 
formation of larger supramolecular complexes or aggregates including the EcPDF.  
In parallel, a different purification approach was explored using ion-exchange 
chromatography in combination with the introduction of a negatively charged tag that 
was fused into a flexible and exposed loop of E. coli PDF. The tag was expected to 
enhance the binding of the engineered PDF to an ion-exchange column, increasing 
separation from background E. coli proteins, and providing a separation method that 
does not require expensive affinity material such as those used for hexahistidine- or 
glutathione transferase affinity tags. The overexpression of the octaglutamic acid-
tagged PDF variant (EcPDFEtag) was similar to that of the wild-type enzyme, while its 
specific activity was only slightly affected by the presence of the acidic tag. As a result, 
EcPDFEtag was purified from an overexpressing E coli strain by ion-exchange 
chromatography with 64% recovery of activity and a 1,300-fold decrease of the level of 
contaminating amidases.  
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Figure 2. Structure of E-tag E.coli  peptide deformylase. E-tag: place of insertion of the octaglutamate E-
tag. Truncation: siteof proline, which with the C-terminal helix is removed in the short PDF variant. The 
methionine side chain and methionine amino group of the ligand H-Met-Ala-Ser-OH are also shown. 
 
 The purified octaglutamic acid-tagged enzyme appeared to hydrolyse N-formyl 
dipeptides without significant concomitant peptide bond hydrolysis. It was used for the 
chemo-enzymatic synthesis of the tripeptide N-formyl-Tyr-Leu-Phe-NH2. Following the 
coupling of N-formyl-Leu with Phe-NH2, the purified dipeptide was deprotected with 
EcPDFEtag resulting in the deformylated products in 80% isolated yield. The deprotected 
dipeptide was subsequently coupled to N-formylated tyrosine yielding the expected 
tripeptide. Thus, the enzyme equipped with the purification tag can be rapidly purified 
and used in biocatalytic conversions of industrial interest. 
 Important properties for judging the applicability of peptide deformylase in 
industrial biocatalysis are the stability and substrate specificity of the enzyme. 
Especially the requirement of a methionine or other hydrophobic group at the formylated 
N-terminal position of the peptide substrate is a serious limitation. A possible way to 
obtain a peptide deformylase with a relaxed substrate specificity is to explore natural 
biodiversity by genome mining. By overexpressing in E. coli peptide deformylase genes 
from different organisms, and subsequently characterize their properties,, we aimed at 
discovering more stable enzymes with more relaxed substrate specificities. 
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 Various databases were screened for the presence of peptide deformylase-
encoding sequences, using the sequence of EcPDF as a query. In total, 260 annotated 
PDF sequences were aligned on a phylogenetic tree, resulting in nine different 
phylogenetic groups. Long nodes compared to branches pointed to a low overall identity 
of peptide deformylases, which is in agreement with the knowledge that only few 
residues are essential for activity 7;21. Despite this low sequence identity and the 
differences in secondary structure reported among PDFs, their overall 3D structure and 
catalytic properties are conserved. Exceptions are the mitochondrial PDF enzymes. 
Human and animal peptide deformylases contain mutations in the vicinity of the active 
site which are responsible for their low activity 25. Mutations in regions that are highly 
conserved in bacterial PDF sequences have also been reported in Trypanosomes and 
Archeae, resulting in a low activity of these enzymes, which were found dispensable for 
growth 6;25. We therefore focused on eubacterial PDFs. 
 In order to test the biocatalytic potential of different peptide deformylases, the 
genes from eight of these enzymes were cloned and overexpressed in E. coli (Chapter 
3). Genes from H. influenzae, P. aeruginosa and H. pylori, with higher similarity to 
EcPDF, were best expressed. The eight different enzymes were purified using affinity 
column chromatography and all appeared to be catalytically active. Of the enzymes 
tested only the PDF from B. stearothermophilus and H. influenzae showed a better 
stability at high temperatures. Activity tests were also performed in presence of co-
solvents and at different pH values but, unfortunately, the activities of the various PDFs 
were comparable with that of EcPDF, giving little hope to obtain peptide deformylases 
with higher stabilities through genome mining. 
 The purified peptide deformylases were also tested for their activity towards a 
range of racemic N-formylated amines and amino acid derivatives with the aim of 
exploring their substrate specificity. From the results obtained it was clear that the 
substrate specificities of the PDFs were very similar despite these enzymes belonging 
to different phylogenetic classes. All enzymes showed a high specificity for formylated 
peptides having methionine as first amino acid. The narrow substrate specificity is 
actually not surprising given the central role of peptide deformylase in ribosomal peptide 
synthesis and the conserved structure of their active site. In view of the results obtained, 
the chances to find a natural peptide deformylase with broader substrate specificity 
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seem very low, and therefore a protein engineering approach was explored to change 
enzyme properties. 
 The substrate specificity of the EcPDF was altered by simultaneous site-
saturation mutagenesis at multiple positions. This approach is based on the detailed 
knowledge of the structure and mechanism of an enzyme and can be applied to peptide 
deformylase since several crystal structures of PDFs have been solved 10;12;19 and the 
substrate recognition and the selectivity were comprehensively studied 21. Ragusa and 
co-workers reported efficient deformylation of peptides with methionine in position P1 
only. In line with this, N-formylated peptides with phenylalanine or leucine in the P1 
position gave an activity that was two orders of magnitude lower, and deformylation 
rates with formylated charged amino acids can be up to seven orders of magnitude 









Figure 3. Active-site close-up of E. coli PDF with the positions of the residues targeted in the directed 
evolution library indicated. The ligand H-met-Ala-Ser-OH is shown in green. 
 
 By making use of the available structural information we were able to point at a 
set of amino acids delineating a hydrophobic pocket that lodges the methionine side 
chain in position P1 of the nascent polypeptide. Of the seven amino acids composing 
this pocket only two residues were found to be highly conserved among PDFs from 
different organisms. These conserved residues are involved in the hydrogen bond 
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network that contributes to the correct 3D folding of the enzyme and in the binding of 
the metal ion responsible for catalysis, and thus they are crucial for enzyme function. 
The other residues of the pocket are much more variable among PDFs, although the 
selectivity of the enzymes remains identical. This information suggests that the overall 
shape and hydrophobic character of the pocket is responsible for the high specificity. 
Based on these data and on the crystal structure of EcPDF wild type, four amino acid 
residues in the hydrophobic pocket of EcPDFEtag (Ile-86, Leu-125, Ile-128 and Cys-129) 
were selected as promising targets for simultaneous saturation mutagenesis, generating 
a library of ~220,000 mutants (Chapter 5). By simultaneously saturating these sites, a 
library of high diversity targeting the hydrophobic S1 position was created. At the same 
time, the combinatorial nature of the engineering approach chosen allows synergistic 
effects that can not be explored when mutating individual positions. 
 To be able to identify the improved variants in such a large mutant library, a 
prerequisite is to find a way to link the desired feature of a variant with the gene 
encoding it. This can be achieved by screening or selection methods. In Chapter 4 we 
investigated both approaches and describe the development of a selection method 
based on the complementation of E. coli leucine auxotrophy which was finally used for 
the library analysis. When large numbers of mutants need to be handled, a selection 
strategy that only enriches variants possessing the desired function, is preferable. 
Selection methods have the advantage of being less labour intensive than screenings 
since selection is based on a direct link between the desired property of the mutant and 
the survival capacity of the cell expressing this mutant 27;29. In the case of peptide 
deformylase this link was created by making use of leucine-containing N-formylated 
dipeptides as sole source of leucine for the complementation of E. coli leucine 
auxotrophic strains. The design of a minimal medium that supports cell growth by 
expression of the enzyme variants of interest turned out to be quite difficult since 
several aspects needed to be taken into account. First the M9 minimal medium chosen 
needed to be supplemented with thiamine, amino acids and other trace elements in 
order to counterbalance the level of stress applied on the cells by the simultaneous 
growth and overexpression of peptide deformylase. Also the choice of the carbon 
source appeared crucial for obtaining good overproduction of PDF without negative 
effects on growth.  
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In the directed evolution studies we used an expression system based on the L-
arabinose operon (pBAD vector). Glycerol is generally the preferred carbon source 
when this system is used since glucose inhibits protein production by catabolite 
repression 13;14;23. However, when cells were grown in media containing glycerol, the 
growth-inhibiting effects of the induction were still present. Therefore, to further 
decrease the stress applied on the cells, glucose was used as carbon source 30. In fact 
it is known that the E. coli growth rate is 2-fold higher in presence of glucose, while the 
total rate of gene transcription is higher when a carbon source of lower quality is used 
due to the activation of pathways linked to stress response in nutrient-poor 
environments 16;20. During medium optimization the level of L-arabinose as inducer was 
increased to an optimal concentration for growth of E. coli in glucose containing medium 
and overexpression of peptide deformylase. 
From the four-site randomization library, a total of about 400,000 CFU were 
plated on minimal medium containing N-formyl-Phe-Leu-OH as sole leucine source. 
Three mutants were found that grew faster on the selection medium, and they produced 
a PDF variant with a 2.5-fold increased activity as compared to EcPDFEtag. All of them 
carried the same single mutation C138V, but encoded by 3 different codons reflecting 
the high quality of the mutant library. The same selection method allowed us to find four 
mutants that produced a PDF variant with a 2-fold increased activity towards N-formyl-
Leu-Phe-NH2, which was used as leucine source during selection. In this case the 
genes appeared to contain the mutation C138A. 














Figure 4. Substrates used for selection of PDF variants 
 
 The observation that the screening of this extensively mutated PDF library (4 
positions randomized, 220,000 mutants) with two different selection substrates only 
gave mutants in which Cys-138 was replaced, triggered us to further explore the role of 
this cysteine in substrate recognition. By mutating Cys-138 in EcPDFEtag to all other 19 
amino acids, seven mutants with remarkably different activities compared to wild-type 
were obtained. These results confirmed the key role of Cys-138 and the efficacy of the 
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selection method. At the same time the fact that very few mutations yielded active 
variants showed that the targeted residues form a delicate binding site that is very 
sensitive to deleterious effects of individual mutations. This makes it difficult to modify 
the substrate specificity of the enzyme while maintaining its activity. In view of the large 
sequence diversity of bacterial PDFs, this lack of resilience to mutations that alter the 
specificity of the enzyme is somewhat unexpected and suggests that individual PDFs 
have been well-optimized for selective methionine deformylation.  
 The development of peptide deformylase mutants with altered substrate 
specificity may require mutagenesis of Cys-138 in combination with a larger number of 
residues, which may possibly lead to more drastic redesign of the methionine side-chain 
binding pocket. It remains to be seen if this is possible without destroying the 
interactions required for catalysis. One way to prevent accumulation of negative 
mutations in such libraries may be computational analysis of enzyme stability and active 
site geometry, which may help to reduce library size and increase the frequency of 
positives. Further sequence and activity analysis of libraries such as those described in 
this thesis will help to identify deleterious mutations, which then can be omitted from 
future mutant collections. The beneficial mutations described here may be explored in 
combination with second shell mutations. Also a better understanding of the stubborn 
behaviour of E. coli PDF with respect to accepting mutations that provide it with an 
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Peptiden zijn polymere ketens die zijn samengesteld uit aminozuren die aan 
elkaar zijn gekoppeld via peptide-bindingen. Veel natuurlijke en synthetische peptiden 
hebben een biologische werking, bijvoorbeeld katalytische aktiviteit (enzymen), 
antibacteriële werking (antibiotica), of aktiviteit als hormoon (b.v. insuline). Vanwege 
hun effecten op tal van fysiologische processen kunnen peptiden medisch toegepast 
worden, zoals bij de regeling van de bloedruk of de bloedsuikerspiegel. Ook zijn er 
peptiden die de vruchtbaarheid beinvloeden. Daarnaast zijn peptiden van toenemend 
belang in voeding, vooral vanwege smaak- en gezondheidseffecten. In de meeste 
gevallen gat het om kleine peptiden, bv. van 2-50 aminozuren in lengte. Peptiden die 
veel langer zijn worden meestal eiwitten genoemd. 
De toenemende interesse in het gebruik van peptiden in medische produkten en 
voedingsmiddelen leidt tot een groeiende behoefte aan methoden waarmee deze 
stoffen op een goedkope en veilige wijze gesynthetiseerd kunnen worden. Ook is er 
behoefte aan betere isolatie- en analyse-technieken voor peptiden. Er zijn drie 
principieel verschillende methoden voor de synthese van kleine peptiden: chemische 
synthese, produktie door fermentatie, en chemo-enzymatische synthese. Fermentatie is 
vooraal geschikt voor grotere peptiden en eiwitten. Korte peptiden kunnen redelijk 
efficiënt  geproduceerd worden door chemische synthese. Chemo-enymatische peptide-
synthese is vooral van aantrekkelijk voor de produktie van middelgrote peptiden, b.v. 
van 5-20 aminozuren. Daarbij worden enzymen gebruikt voor het aan elkaar koppelen 
van individuele aminozuren of van kleine peptiden die eerst chemisch zijn 
gesynthetiseerd. De enzymatische vorming van de peptide-bindingen vereist gewoonlijk 
dat de te koppelen carboxyl-groepen vooraf geaktiveerd worden (b.v. als een ester). 
Daarnaast is het nodig carboxyl-groepen en amine-groepen die niet moeten reageren te 
beschermen met een zgn. beschermgroep. De meeste beschermgroepen zijn duur in 
gebruik, en hebben vaak nadelen die industrieel gebruik uitsluiten. 
Een potentieel aantrekkelijke beschermgroep voor de vrije N-terminale amine 
van een peptide of aminozuur is de formyl-groep (For). Deze is aantrekkelijk omdat de 
formyl-groep (-C(O)H) goedkoop is, en in principe enzymatisch verwijderd kan worden. 
Dat laatste is van belang omdat milde condities voorkomen dat het peptide racemiseert 
of anderszins beschadigd raakt tijdens de synthese. Dit proefschrift beschrijft een 
onderzoek naar de enzymatische verwijdering van de formyl-groep met het enzym 
peptide deformylase.  
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Het belang van peptiden, verschillende aspecten van de produktie van peptiden, 
en de eigenschappen van peptide deformylase zijn beschreven in Hoofdstuk 1. 
Peptide deformylase (PDF) is in staat een formyl-groep af te splitsen zonder de interne 
peptide-binding te splitsen. Deze selectiviteit vindt zijn oorsprong in de biologische 
functie van het enzym: bacteriële ribosomen (en eukaryote organellen) synthetiseren 
eiwitten die als N-terminus een N-formylmethionine hebben. Na de synthese van het 
peptide wordt de N-formylgroep afgesplitst door peptide deformylase, dat dus specifiek 




















Peptide deformylase reactie met een peptide dat begint met de sequentie For-Met-Ala. 
 
Toepassing van peptide deformylase bij industriele produktie van peptiden 
vereist dat het enzym een bredere specificiteit heeft, dus niet alleen een N-formyl-groep 
kan afsplitsen van een peptide dat begint met N-formylmethionine, maar ook met 
peptiden die een ander geformyleerd N-terminaal aminozuur hebben. Ook is het nodig 
PDF op een goedkope manier in grote hoeveelheden te producere en te zuiveren. 
Daarbij is vooral van belang dat industriële preparaten geen peptidasen als 
verontreiniging bevatten die de te synthetiseren polypeptides zouden kunnen afbreken. 
Wanneer het gastheer-organisme waarin enzym-produktie plaatsvindt peptidasen 
bevat, moeten deze tijdens de zuivering dus efficiënt gescheiden worden van het 
peptide deformylase.  
De ontwikkeling van een methode voor de snelle zuivering van peptide 
deformylase van de bacterie E. coli is beschreven in Hoofdstuk 2 van dit proefschrift. 
Om de kosten laag te houden is vooral gekeken naar ultrafiltratie (UF) en anionen-
wisseling-chromatografie (IEC). PDF is een klein eiwit (168 aminozuren). Om zuivering 
met ultrafiltratie te verbeteren is een nog kortere (kleinere) variant van het PDF 
gemaakt. Deze variant, die een C-terminale alpha-helix mist, leverde wel een betere 
zuivering en scheiding van amidasen op dan met het oorspronkelijke enzyme, maar de 
opbrengst bij zuivering was nog steeds slechts 21%, en de scheiding van peptidasen en 
PDF was nog onvoldoende. Daarom is een ook een andere aanpak gevolgd: op gen-
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niveau is er een polyglutamaat-tag aangebracht in een flexibel gedeelte van het PDF. 
De extra negatieve lading die hiermee geintroduceerd is, maakte het mogelijk een 
goede scheiding met IEC te bereiken. Zowel de opbrengst (61%) als de verwijdering 
van peptidasen (1300 maal minder dan in celvrij extract) waren beter dan met de UF 
methode. 
 Belangrijke eigenschappen voor industriële toepassing zijn stabiliteit en 
katalytische aktiviteit. Een manier om een PDF in handen te krijgen met een verhoogde 
stabiliteit is beschreven in Hoofdstuk 3. Als bron voor PDFs is gekozen voor microbiële 
genoomsequenties. Door in databases genen te zoeken die verwant zijn aan PDF van 
E. coli is een 8-tal varianten geidentificeerd, die vervolgens tot overexpreesie zijn 
gebracht in E. coli en gezuiverd m.b.v. affiniteitschromatografie. Na gedeeltelijke 
zuivering bleken de enzymen te verschillen wat betreft temperatuur-stabiliteit, maar de 
nieuwe varianten waren nauwelijks beter wat betreft resistentie tegen organische 
oplosmiddelen en substraatbereik. Resistentie tegen oplosmiddelen is van belang 
omdat veel peptiden slecht oplosbaar zijn in water; toevoeging van een oplosmiddel kan 
de oplosbaarheid verhogen. De specificiteit van de gezuiverde enzymen is getest en het 
bleek dat alle PDFs een sterke voorkeur hadden voor N-formyl-peptiden met methionine 
als eerste aminozuur. Dit is niet verrassend omdat alle ribosomaal-gesynthetiseerde 
eiwitten, die de natuurlijke substraten zijn, ook altijd aan de N-terminus een N-
geformyleerde metionine bezitten. 
Een andere aanpak voor het in handen krijgen van een PDF met een breder 
substraatbereik is protein engineering. Dit kan op een gerichte manier, door mutaties te 
maken op grond van de bekende kristalstruktuur van PDF, of met een random aanpak 
(directed evolution). In dit proefschrift is een hybride aanpak gevolgd: het random 
maken van een beperkt aantal posities rond de active site van PDF. Zo'n aanpak vereist 
een selectie- of screening-methode waarmee snel de gewenste varianten kunnen 
worden geidentificeerd in een collectie van een zeer groot aantal gemuteerde enzymen. 
In Hoofdstuk 4 beschrijft het proefschrift de ontwikkeling van dergelijke selectie-en 
screening-technieken.  De beste selectie-methode is gebaseerd op een complementatie 
van de leucine auxotrofie van een E. coli gastheer. Door aan de E. coli cellen, die voor 
groei afhankelijk zijn van een bron van leucine, een geformyleerd dipeptide aan te 
bieden waaruit leucine alleen kan worden vrijgemaakt als de formyl groep eerst 
enzymatisch wordt afgesplitst, is een selectie mogelijk van cellen die een PDF met 
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gemodificeerde selectiviteit bezitten. Toepassing van deze methode vereiste 
aanpassing van het groei-medium zodanig dat stress door overexpressie van PDF werd 
onderdrukt. Ook een aantal andere methoden voor de identificatie van PDF met 
veranderde selectiviteit is getest. 
 Het gebruik van dit selectiesysteem voor de identificatie van mutanten van PDF 
is beschreven in Hoofdstuk 5. Doel was mutanten te vinden met een bredere 
specificiteit zodat N-formyl peptiden die niet beginnen met een (geformyleerde) 
methionine ook gedeformyleerd kunnen worden. Een library van PDF varianten is 
gemaakt door vier posities simultaan random te maken, hetgeen een zeer grote library 
leverde, waarin theoretisch 160,000 varianten aanwezig kunnen zijn. De gekozen 
posities vormen een hydrofobe pocket in de active site waarin de zijgroep van 
methionine past. De aminozuren op deze posities zijn niet geconserveerd in PDFs, 
hetgeen suggereert dat ze gemuteerd kunnen worden zonder de aktiviteit van het PDF 
te vernietigen. De library zal dus varianten bevatten met grote verschillen in de 
geometrie van deze methionine-bindende pocket.  
 De library were gescreened met de genoemde groei-selectie strategie. 
Verschillende clones met een veranderd substraatbereik zijn gevonden. Na sequentie-
analyse bleek dat alle mutanten op positie Cys138 waren gemuteerd. De selectiviteit 
van deze mutant-enzymen was inderdaad veranderd, hetgeen aantoonde dat de 
selectiestrategie werkte. De eigenschappen van de mutanten lieten verder zien dat 
deze postie (Cys138) uiterst belangrijk is voor substraat-herkenning. Helaas leverde 
deze aanpak tot nu toe slechts een beperkt aantal aktieve varianten op. De zijgroep-
pocket moet dus erg gevoelig zijn voor mutaties. Mogelijk is een groter aantal 
(compenserende) mutaties rond de methionine-pocket nodig om stabiele varianten te 
produceren met meer ingrijpende veranderingen in substraabereik. 
.
     
 
166









                                                                                                                                         Acknowledgements 
 
 
    
 
168
This work would not have been possible without the help of many people that in one or 
another way contributed to my research. It is a pleasure for me to acknowledge them for 
their support, guidance and patience. 
In the first place I would like to thank my promoter and co-promoter. Theo, thank you for 
choosing me as your PhD student. You have all my gratitude for the supervision, advice 
and encouragement during the years I spent at DSM. You always believed we could 
achieve great results with this project, to great results and you taught me, among many 
other things, how to be positive and passionate about my work (even on Monday 
mornings before your coffee in the Socio). Dick, I would like to thank you for the 
invaluable stimulating discussions and enthusiastic support you always gave me even 
at such long distance. I learned a lot from you, in particular accuracy in scientific writing. 
I am also very grateful to Peter Quaedflieg for his scientific advice and knowledge and 
many insightful discussions and suggestions.  
I would like to thank you the members of my reading committee Prof. dr. L. Dijkhuizen,
 Prof. dr. R. Bovenberg and Prof. dr. U. Hanefeld, for their kindness in reading 
and approving my work. 
I gratefully acknowledge Dr. Volker Wagner, his input and deep knowledge about PDF 
has been a source of inspiration for this work. 
Silvana, I will always be grateful for your support. Part of this thesis would not have 
been possible without your chemistry lessons, your enthusiasm and faith in the potential 
of “my” enzyme. Grazie mille per l’aiuto e l’amicizia che mi hai dato. John, I would like to 
thank you for your valuable input and knowledge on the PDF variants. 
A special thank you goes to Linda and Monika, my office mates. I had such a good time 
in that little box. Your support and friendship have been of great help during the Dutch 
rainy days.  
And of course Martin, always calm, inspiring and motivating. Thank you for always 
finding the time to answer to my questions. I really learned a lot from you. 
Wilco, it’s strange how I still have good memories of the fermentation room, with its 
terrible smell and the noise of the sonicator, but I had some good laughs there with you. 
Theo, I hope I still have the title of best Italian girl behind the closed doors and yes, I do 
eat banana jam to keep healthy. Thanks to both of you. 
And of course all the colleagues “behind the klapdeuren”, Elise, Elly, Natacha you made 
me feel welcome and home. Harry, I hope you did not miss too much my philosophy 
                                                                                                                                         Acknowledgements 
 
 
    
 
169
classes in the lab. Claudia, grazie per le lezioni di chimica e le chiacchierate nei 
momenti difficili. Ilse, it was great working with you. Your experience and 
professionalism have been so important for my work. I am thankful for the time you took 
to introduce me to the word of analysis and HPLC and for the effort you put in tolerating 
my messy desk and endless runs up and down the corridor. And you Lavinia, anche se 
alla fine questo caffè non l’abbiamo ancora bevuto, ti vorrei ringraziare per l’amicizia e il 
sostegno che mi hai sempre Saputo dare. 
Thanks to all my colleagues in the former ASC&D: for my first DSM Classic, for the 
good time during the department weekends, for my first TLC and for bearing with my 
Italian loudness and hand gestures during the 4 years. 
A special thank you goes to all my friends in Maastricht. I had the chance to meet many 
good people there. Luigi, Thank you for telling me “Don’t go for a PhD, it’s a sequence 
of painful moments” and for being there during all of them. Ursula, Jacob, I know I do 
not like games but I shared with you music, laughs, dinners and I hope we will keep this 
going for many more years. Maria, I would not have survived without your pet animals 
keeping me company when I started my PhD, thank you for welcoming me at your 
place, it did feel like home!  Laurent, it’s not the destination but the journey that matters. 
This was a long one but I learned so much on the way. For sure it was worth. Thank you 
for looking after me and for being a sincere friend. George, a great neighbor, a fun 
travel mate, always ready to help in each situation and most of all a superb windsurfing 
teacher.  
Chiachun, thank you for the long talks, the great Chinese food and a quick introduction 
to style and art. Masa, Sayuri, you made me discover the word of ce n’est pas elegant 
and sumimasen, a great experience!  Jim, thank you for your enigmatic humor (I know I 
am still far from getting it) and for trying to find the good intention behind my sometimes 
sharp sentences.   
I would like to mention my two paranymphs. Thank you for being good friends. 
Natascha, yes, I made it! Thank you for believing in me during all these years, for your 
continuous support and for having allowed me and my mountains of papers in your 
living room so many months! Francesca, grazie per aver sopportato i miei sfoghi, per i 
suggerimenti che mi hai saputo dare e per aver condiviso con me un pizzico di filosofia 
e tanti momenti felici. 
                                                                                                                                         Acknowledgements 
 
 
    
 
170
Ed infine la mia famiglia: mamma, papa, Andrea, grazie per aver accettato le mie scelte 
anche quando non sembravano logiche e per essermi stati vicini anche da lontano. 
 
Claudia 
